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Gelsolin is a multifunctional actin regulatory protein known to be dysregulated in 
various cancers. It has been previously shown that gelsolin plays a role in 
apoptosis and thus resistance to chemotherapy, however, the underlying 
mechanisms have not been fully understood. Independent lines of study suggest 
that the actin cytoskeleton and its regulatory proteins regulate autophagy, a 
lysosome-mediated self-digestive process which can exert cytoprotective effects 
against stresses. It is therefore conceivable that gelsolin could protect cells from 
stresses via modulating autophagy. In this study, we showed that stable 
overexpression of gelsolin in HCT116 cells increased cell survival under 
starvation and 5-fluorouracil treatment, while knockdown of gelsolin sensitized 
cells to these treatments. In response to these stresses, gelsolin-overexpressing 
cells showed increased autophagic levels whilst gelsolin knockdown cells 
possessed lower levels of autophagy. Inhibition of autophagy via lysosomal 
inhibitor chloroquine or silencing Atg7 attenuated the protective effect of gelsolin 
overexpression. These results strongly suggest a protective role of gelsolin on 
cancer cell survival and the dependence on autophagy for the gelsolin-mediated 
survival. Several possible mechanisms by which gelsolin can promote autophagy 
were identified. The trafficking of mAtg9, a protein believed to deliver lipids for 
the autophagy process, was observed to be enhanced by gelsolin overexpression. 
In addition, mAtg9 may physically interact with gelsolin, which might contribute 
to its trafficking. We also showed that gelsolin may affect late stages of 
autophagy via affecting activities of cathepsin B and cathepsin L, which are 
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important lysosomal enzymes. Moreover, gelsolin affects the mRNA levels of 
various autophagy-related genes, suggesting a role of gelsolin in transcriptional 
regulation of autophagy. In summary, this study uncovers a novel role of gelsolin 
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Chapter 1: Introduction 
1.1 Autophagy 
Autophagy is a catabolic process in which the cell’s own contents including 
organelles and protein aggregates are delivered to and degraded inside the 
lysosomes (Lebovitz et al., 2012). Autophagy plays a central role in maintaining 
homeostasis, and it has been recognized as an important player in regulating 
cellular processes such as cell death and survival (Mizushima and Komatsu, 
2011). Up to date, three main types of autophagy have been identified, namely 
macroautophagy (usually simply referred as “autophagy”), microautophagy, and 
chaperone-mediated autophagy (Mizushima and Komatsu, 2011). These three 
types of autophagy differ in their paths of entering lysosome. In microautophagy, 
lysosome engulfs cytoplasmic contents directly through the inward invagination 
of lysosomal membranes (Mizushima and Komatsu, 2011; Sahu et al., 2011), 
while protein substrates enter lysosomes via chaperone proteins such as heat 
shock cognate 70 (Hsc70) in chaperone-mediated autophagy (Orenstein and 
Cuervo, 2010). Macroautophagy, termed autophagy hereafter, is evolutionarily 
conserved from yeast to mammalian cells (Mizushima et al., 2011; Yang and 
Klionsky, 2010). The autophagy process involves the formation of a cup-shaped 
membrane structure called isolation membrane (or phagophore). Subsequently, 
the isolation membrane extends and forms an enclosed double-membrane vesicle 
called autophagosome, in where the cellular contents including organelles, protein 
aggregates, and lipids are engulfed. In the next step, an autolysosome is formed 
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by the fusion of a lysosome with the outer membrane of an autophagosome, and 
the cellular contents are degraded by the lysosomal enzymes. The 
macromolecules generated by degradation can then be recycled back to maintain 
homeostasis (Mizushima, 2007).  
1.1.1 Molecular mechanism of autophagy 
Following pioneer works in yeast, core proteins involved in regulating autophagy, 
called Atgs (autophagy-related genes), have been identified and the molecular 
mechanisms of autophagy have been largely dissected (Mizushima et al., 2011). 
The mechanistic process of autophagy can be separated into four steps, including 
1) induction or initiation, 2) nucleation of the isolation membrane assembly, 3) 
elongation of the membrane to form an enclosed autophagosome, and 4) fusion of 
the autophagosome with lysosome to form an autolysosome and degradation 
(Lebovitz et al., 2012). 
Figure 1.1 summarizes the molecular mechanism of autophagy.  
Induction 
Autophagy is activated by extracellular stresses such as nutrients starvation, 
hypoxia, and metabolic stress (Codogno et al., 2012). Once autophagy is 
triggered, the Unc51-like kinases (ULK) complex is formed and plays a critical 
role in the initiation of autophagy. The ULK complex consists of ULK1/ULK2, 
Atg13, the scaffold focal adhesion kinase (FAK)-family-interacting protein of 200 
kD (FIP200) and Atg101 (Chen and Klionsky, 2011). ULK1 and ULK2 are the 
homologs of yeast Atg1, and they are the only known Atg proteins with kinase 
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activity (Mizushima et al., 2011). The functions of ULK1 and ULK2 are partially 
redundant, but the major form involved in autophagy process could be ULK1  
 
Figure 1.1 The autophagy machinery.  





(Chan et al., 2007; Kundu et al., 2008). The ULK1-Atg13-FIP200-Atg101 
complex is stably formed in mammalian cells, and upon autophagy induction such 
as starvation, ULK1 autophosphorylates itself as well as phosphorylates other 
substrates including Atg13 and FIP200, leading to the initiation of the autophagic 
process (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009).  
The activity of ULK complex is under the control of a few proteins, such as the 
negative regulator mechanistic or mammalian target of rapamycin complex 1 
(mTORC1) and the positive regulator AMP-activated protein kinase (AMPK). 
Under nutrient rich conditions, mTORC1 binds to the ULK complex and 
phosphorylates ULK1 and Atg13, thereby inhibiting the activity of ULK1 and the 
complex (Ganley et al., 2009; Hosokawa et al., 2009; Jung et al., 2009). When 
cells are starved, the mTORC1 is inactivated, leading to the dephosphorylation 
and activation of ULK1 (Hosokawa et al., 2009). The ULK complex can then be 
activated as described previously. Meanwhile, in response to starvation, AMPK 
phosphorylates ULK1/2, resulting in the activation of ULK1/2 (Egan et al., 2011; 
Kim et al., 2011; Shang et al., 2011). Moreover, AMPK can inhibit mTORC1 via 
phosphorylating raptor, a regulatory subunit of mTORC1 and therefore causing 
the inhibition of ULK1 by mTORC1 to be attenuated (Gwinn et al., 2008; Lee et 
al., 2010a). 
Nucleation 
The key complex regulating the nucleation step is the class III phosphoinositide 3-
kinases (PI3K) complex. The core components of the PI3KIII complex comprise 
the PI3KCIII (Vps34 or PIK3C3), Beclin-1 (a mammalian homolog of yeast 
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Atg6), and p150 (a homolog of Vps15) (Cecconi and Levine, 2008). Other 
cofactors such as Atg14, activating molecule in BECN1 regulated autophagy 
protein 1 (AMBRA1), ultraviolet irradiation resistance-associated gene 
(UVRAG), Bif-1, and the RUN domain and cysteine-rich domain containing 
Beclin 1 interacting protein (RUBICON), interact with the core complex and 
confer different functions of the complex (Itakura et al., 2008; Kihara et al., 2001; 
Liang et al., 2006; Matsunaga et al., 2009; Sun et al., 2008; Takahashi et al., 
2007; Zhong et al., 2009). In general, the complex comprising of Vps34, Beclin-1, 
p150, and Atg14 as well as the complex of Vps34, Beclin-1, p150, UVRAG, and 
Bif-1 are positive regulators of autophagy (Itakura et al., 2008; Kihara et al., 
2001; Liang et al., 2006; Sun et al., 2008; Takahashi et al., 2007). Meanwhile, 
RUBICON binds to the complex containing UVRAG and inactivates the kinase 
activity of Vps34 to downregulate autophagy (Matsunaga et al., 2009; Zhong et 
al., 2009). Moreover, a recent study reveals a role of ULK1 in regulating PI3KIII 
complex, as ULK1 can phosphorylate Beclin-1 to enhance the activity of PI3KIII 
complex (Russell et al., 2013).  
Once activated, the PI3KIII complex produces phosphatidylinositol-3-phosphate 
(PtdIns3P), which recruits more proteins, such as WD repeat domain phospho 
inositide-interacting proteins (WIPIs, which are homologs of yeast Atg18) to 
participate in autophagosome formation (Tanida, 2011). WIPI-1 and WIPI-2 
binds to PtdIns(3)P generated at isolation membranes, and they are thought to be 
the effectors of PtdIns(3)P (Itakura and Mizushima, 2010; Polson et al., 2010; 
Proikas-Cezanne et al., 2007; Proikas-Cezanne et al., 2004). WIPI-1 and WIPI-2 
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are upstream of both the Atg12 and LC3 ubiquitin-like conjugation systems, 
which are important in the elongation stage (Itakura and Mizushima, 2010; 
Proikas-Cezanne et al., 2007; Mauthe et al., 2011; Polson et al., 2010).  
Besides the PI3KIII complex, another Atg protein, Atg9, is also thought to play an 
important role in the expansion of isolation membrane and autophagosome (Janku 
et al., 2011). 
Atg9 in autophagy 
Up to date, Atg9 is the only multi-spanning membrane protein identified among 
the core Atg proteins. It has six conserved transmembrane domains, and both N- 
and C-termini are exposed to cytosol (Young et al., 2006). Accumulating 
evidence suggests that Atg9 participates in autophagosome formation, as Atg9 
deficiency leads to reduced number of microtubule-associated protein 1A/1B-light 
chain 3 (LC3)-labelled autophagosome under starvation and other stimuli (Orsi et 
al., 2012; Young et al., 2006). LC3 is an essential marker of autophagy which will 
be discussed in a later section. Moreover, fewer isolation membranes were 
observed in Atg9 depleted cells, suggesting a role of Atg9 in early membrane 
formation, probably the formation of isolation membrane (Orsi et al., 2012). 
Furthermore, Atg9 displays a dynamic property, where it changes localization 
upon autophagy stimuli in both yeast and mammals (Reggiori and Tooze, 2012).  
Atg9 trafficking in yeast 
Current understanding about Atg9 mainly comes from yeast studies. In yeast, 
Atg9 has been found to localize on a few organelles such as Golgi and 
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mitochondrion, as well as the phagophore assembly site (PAS) (Reggiori and 
Klionsky, 2006; Reggiori et al., 2004). Interestingly, Atg9 has been shown to 
cycle between the PAS and peripheral sites, and it is believed that the cycling of 
Atg9 may play a role in delivering membranes for autophagosomes (Mari et al., 
2010; Mari and Reggiori, 2010; Reggiori and Klionsky, 2006; Yamamoto et al., 
2012). The trafficking event of Atg9 is regulated by a few factors. First, Atg9 can 
self-interact to form a multimeric complex, and this self-assembly is required for 
its movement to PAS (He et al., 2008). Under autophagy stimuli, Atg9 localizes 
to PAS, a process called the anterograde transport of Atg9, and this translocation 
requires the interaction with Atg17 (Sekito et al., 2009). Moreover, Atg1 regulates 
the interaction between Atg9 and Atg17 (Sekito et al., 2009). Other important 
regulators for Atg9 anterograde transport are Atg23 and Atg27, as these three 
proteins form a complex and cycles between PAS and other sites (Legakis et al., 
2007). 
After autophagosomes are formed and matured, Atg9 does not present on the 
matured autophagic vesicles. Atg9 is retrieved from the PAS and the closed 
autophagosome to its peripheral localization, a process defined as the retrograde 
transport of Atg9. The retrograde transport of Atg9 is regulated by a few factors. 
Atg1-Atg13 complex, which regulates autophagy initiation as discussed before, 
has also been shown to participate in the retrograde transport of Atg9, as depletion 
of Atg1 or Atg13 results in the aberrant accumulation of Atg9 in PAS (Reggiori et 
al., 2004). In addition, the kinase activity of Atg1 is important for the proper 
retrieval of Atg9 from PAS (Reggiori et al., 2004; Yamamoto et al., 2012). 
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Although Atg9 can be phosphorylated by Atg1, the phosphorylation of Atg9 is 
not required for its PAS retrieval, but is required for the recruitment of Atg8 and 
the subsequent formation of autophagosome (Papinski et al., 2014), suggesting 
that Atg9 may regulate autophagy at different stages. Meanwhile, PI3KIII 
complex, Atg2 and Atg18 are also important players for the retrograde transport 
of Atg9 (Cheong et al., 2005; Reggiori et al., 2004). Atg9 interacts with Atg18, 
and this interaction is dependent on Atg1 and Atg2 (Reggiori et al., 2004). In 
another study, Atg9 is also shown to interact with Atg2 (Wang et al., 2001). Since 
Atg18 is recruited by PtdIns3P produced by PI3KIII complex and it interacts with 
Atg2 (Obara et al., 2008), it is plausible that Atg2, Atg18, and Atg9 form a 
complex to regulate the retrograde transport of Atg9 under the control of PI3IIIK.  
Atg9 trafficking in mammals  
There are two mammalian homologs of yeast Atg9, Atg9A (also called Atg9L1 or 
mAtg9) that is widely expressed in various cells and tissues, while Atg9B is 
mainly expressed in placental and pituitary gland tissues (Yamada et al., 2005). It 
is first found that mAtg9 resides on trans-Golgi network (TGN) and endosomal 
systems including late endosomes, early endosomes, and recycling endosomes 
(Orsi et al., 2012; Young et al., 2006). Upon autophagy induction, mAtg9 
translocates from the perinuclear site such as TGN to peripheral sites like late 
endosomes (Takahashi et al., 2011; Tang et al., 2011; Young et al., 2006). It was 
earlier thought that Atg9 presents on LC3-positive autophagosomes at peripheral 
sites (Tang et al., 2011; Young et al., 2006), but one study reports later that Atg9 




Figure 1.2 Trafficking of mAtg9 in mammalian cells.  
Under nutrient rich conditions, mAtg9 localizes to perinuclear sites such as trans-
Golgi network and peripheral sites such as late endosomes. Under starvation and 
autophagy induction, mAtg9 translocates from perinuclear sites to dispersed 
cyotosolic pools, where it interacts transiently with autophagosome. When 
nutrients are re-supplied, mAtg9 moves back to perinuclear sites. The trafficking 
of mAtg9 is regulated by a few factors. The translocation from perinuclear site to 
peripheral site is controlled by ULK1, p38IP, Bif-1, non-muscle myosin II, and 
PI3KIII complex. Recycling of mAtg9 back to perinuclear sites from cyotosolic 






















with forming autophagosomes (Orsi et al., 2012). Therefore, the exact role of 
mAtg9 on autophagosome needs further investigation. 
Like its yeast counterpart, the redistribution of mAtg9 from TGN to peripheral 
sites is influenced by ULK1, the mammalian homologue of Atg1. Knockdown or 
inactivation of ULK1 leads to restriction of mAtg9 in TGN (Tang et al., 2011; 
Young et al., 2006). Under starvation conditions, ULK1 phosphorylates and 
activates zipper-interacting protein kinase (ZIPK), which subsequently 
phosphorylates myosin regulatory light chain (MRLC) (Tang et al., 2011). The 
phosphorylation of MRLC results in activation of non-muscle myosin II (NM 
myosin II), an actin motor protein participating in acto-myosin contractility and 
actin-dependent movement (Fukata et al., 2001). The mAtg9 redistribution to 
peripheral sites including late endosomes is dependent on the activation of NM 
myosin II (Tang et al., 2011). Moreover, mAtg9 interacts with myosin heavy 
chain, suggesting the involvement of actin-dependent trafficking of mAtg9 (Tang 
et al., 2011). Another component of the ULK1-Atg13-Fip200 complex, Atg13, 
has also been shown to mediate the trafficking of Atg9 to its diffuse cytoplasmic 
pool (Chan et al., 2009).   
The PI3KIII complex is another important regulator of Atg9 trafficking, as 
inhibition of PI3KIII and depletion of PI3KIII complex components, including 
Beclin-1 and UVRAG, prevents the redistribution of mAtg9 induced by starvation 
(Takahashi et al., 2011; Young et al., 2006). Another regulator of mAtg9 
trafficking is Bif-1, a protein that drives the curvature of membrane (Takahashi et 
al., 2011). Meanwhile, the p38 MAPK signalling pathway also plays a role in 
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mAtg9 trafficking. The p38-interacting protein (p38IP) binds with mAtg9, and 
p38IP is required for the proper redistribution of mAtg9. The p38α MAPK acts as 
a negative regulator of mAtg9 trafficking, via competing with mAtg9 to bind to 
p38IP (Webber and Tooze, 2010). 
When nutrients are supplied to starved cells, mAtg9 cycles back to its perinuclear 
localization (Young et al., 2006). The shuttling of mAtg9 back to perinuclear sites 
is less understood. Like the yeast counterpart, WIPI-2, the mammalian homologue 
of yeast Atg18, and mammalian Atg2A/B have been reported to play a role in the 
cycling of mAtg9 (Orsi et al., 2012; Velikkakath et al., 2012). Moreover, 
overexpression of Jumpy (MTMR14), a phosphatidylinositol 3-phosphate (PI3P) 
phosphatase, causes aberrant accumulation of mAtg9 at LC3 positive autophagic 
vesicles (Vergne et al., 2009). Therefore, Jumpy may negatively regulate the 
recycling of mAtg9 from autophagic structures back to perinuclear sites. 
Elongation/ Expansion  
After initiation and nucleation, the isolation membrane elongates to form an 
enclosed autophagosome. In the elongation step, two ubiquitin-like conjugation 
systems, which are Atg12-Atg5-Atg16L and LC3-phosphatidylethanolamie (PE), 
are crucial for the expansion and formation of the autophagosome (Mizushima et 
al., 2011). Atg12 is activated by the E1-like enzyme Atg7 and then transferred to 
the E2-like enzyme Atg10. Atg12 is subsequently conjugated to Atg5 via Atg10 
(Mizushima et al., 1998; Shintani et al., 1999). The Atg12-Atg5 conjugate further 







Figure 1.3 The conjugation systems in the elongation process.  
Figure is adapted from Shpilka et al., 2012. 
 









Table 1.1 Human Atg8 subfamily. 




Atg16L1 coil-coil domain to larger oligomers (Hanada et al., 2007; Mizushima et 
al., 1999). Following nucleation, the Atg12-Atg5-Atg16L1 complex localizes to 
the isolation membrane and dissociates from the membrane before the enclosed 
autophagosome is formed (Mizushima et al., 2001). The Atg12-Atg5-Atg16 
mediates the formation of the second conjugate, the Atg8-PE conjugate. The Atg8 
family members are thought to aid the elongation and proper closure of the 
membrane (Fujita et al., 2008; Weidberg et al., 2011). Human Atg8 proteins 
comprise three subfamily members, which are GATE16 (Golgi-associated 
ATPase enhancer of 16 kDa), GABARAP (γ-aminobutyric acid receptor-
associated protein), and LC3 (microtubule-associated protein 1 light chain 3) 
(Shpilka et al., 2011). LC3 together with its family members GATE16 and 
GABARAP are processed in the conjugation system in a similar manner (Kabeya 
et al., 2004; Mizushima et al., 2001). LC3 is synthesized as a precursor, which is 
processed by Atg4 to its cytosolic form called LC3-I (Kabeya et al., 2004; 
Kirisako et al., 2000). Once activated by Atg7, LC3-I is transferred to its E2-like 
enzyme Atg3, and subsequently conjugated to PE, a membrane phospholipid 
(Ichimura et al., 2000). This conjugation process generates the lipidated form of 
LC3, termed as LC3-II (Ichimura et al., 2000; Mizushima et al., 2011). LC3-II 
attaches to the isolation membrane and remains associated with both membranes 
of the formed autophagosome, unlike the Atg12-Atg5-Atg16 complex (Klionsky, 
2005). LC3-II existing on the outer membrane of autophagosome can be 
delipidated by Atg4 and recycled to cytosol, while those in the inner membrane 
will be degraded after fusion with lysosomes (Kimura et al., 2009). Due to the 
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distinct localizations of LC3-1 and LC3-II and the association of LC3-II with the 
autophagosomal membranes, LC3-II has been widely used as a marker for 
autophagosome (Klionsky, 2005). 
Maturation and degradation  
Autophagosomes undergo maturation via docking and fusing with lysosomes, 
giving rise to autolysosomes. The outer membrane of autophagosomes fuse with 
lysosomal membrane, whilst the inner membrane and the engulfed cytosolic 
contents are degraded by the lysosomal enzymes (Mizushima and Komatsu, 
2011). A few proteins have been suggested to mediate the fusion event, such as 
lysosomal-associated membrane protein 2 (LAMP2) and the small GTPase Ras-
related GTP-binding protein 7A (RAB7A) (Fortunato et al., 2009; Jager et al., 
2004). Besides, UVRAG also plays a role in autophagosome maturation by 
activating RAB7A (Liang et al., 2008). 
1.1.2 Actin cytoskeleton in autophagy regulation 
During autophagosome formation, membrane structures involved in autophagic 
vesicles are remodelled. After autophagosomes are formed, vesicles are 
transported so that the fusion and maturation can occur. The actin cytoskeleton, a 
fundamental structure of cells, could potentially be involved in these processes.  
Roles of actin cytoskeleton in yeast autophagy  
The role of actin cytoskeleton in autophagy regulation was first described in 
yeast. Interestingly, the actin cytoskeleton does not seem to be involved in 
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starvation-induced autophagy, which is usually considered as non-selective 
autophagy. Neither actin destructive drugs nor mutations in actin genes affect 
starvation-induced autophagy (Hamasaki et al., 2005; Reggiori et al., 2005a; 
Reggiori et al., 2005b). However, evidence reveals a critical role of actin 
cytoskeleton in the selective type of autophagy, including the cytoplasm to 
vacuole targeting (Cvt) pathway, an autophagy related biosynthetic pathway, 
endoplasmic reticulum (ER)-phagy (autophagic degradation of ER), and 
pexophagy (selective autophagic degradation of peroxisomes) (Hamasaki et al., 
2005; He et al., 2006; Monastyrska et al., 2008; Reggiori et al., 2005a). Actin 
cytoskeleton seems to be crucial for the formation of autophagosomes, and the 
molecular mechanism of actin cytoskeleton in autophagy regulation could be 
attributed to the trafficking of Atg9 vesicles. Disruption of actin cytoskeleton by 
mutation or destabilization agents disables the redistribution of Atg9 to PAS, 
suggesting a crucial role of actin cytoskeleton in the anterograde trafficking of 
yeast Atg9 (He et al., 2006; Monastyrska et al., 2008). The actin related protein 2 
(Arp2), one of the actin regulatory proteins, physically interacts with Atg9 and 
directs its movement (Monastyrska et al., 2008). Furthermore, other Atg proteins 
may also participate in the actin-regulated Atg9 trafficking. Atg1 and Atg11 are 
essential for the interaction between Atg9 and Arp2 (Monastyrska et al., 2008). 
Interestingly, the recruitment of Atg11, which is crucial for Atg9 anterograde 
transport, requires a functional actin cytoskeleton, highlighting the importance of 
actin in autophagy regulation (He et al., 2006). 
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Roles of actin cytoskeleton in mammalian autophagy  
In mammalian cells, it has been long known that disrupting actin dynamics, either 
by actin depolymerization agents or actin filament stabilizing agent, reduces the 
formation of autophagic vesicles (Aplin et al., 1992; Ueno et al., 1990). Current, 
evidences show that actin cytoskeleton can participate in both early and late 
stages of autophagy in mammals (Aguilera et al., 2012; Lee et al., 2010b). As a 
support for the role of actin cytoskeleton in autophagy regulation, a number of 
actin regulatory proteins have been reported to affect autophagy machinery. The 
role of actin regulatory proteins in autophagy regulation is indeed complex. While 
a few proteins like Ras homolog family member A (RhoA) and Rho-associated, 
coiled-coil-containing protein kinase (ROCK) are positively associated with 
autophagy, other proteins including RAC1 and RAC3 seem to inhibit autophagy 
(Aguilera et al., 2012; Zhu et al., 2011). Therefore, how actin regulatory proteins 
remodel actin cytoskeleton to regulate autophagy warrants further studies. 
Regulation of autophagosome formation by actin cytoskeleton 
Actin filaments colocalize with a few Atg proteins, like Atg14 and Beclin-1, 
which regulate nucleation and early autophagosome stage, suggesting that actin 
may be involved in these steps (Aguilera et al., 2012). Moreover, RhoA, a 
member of Rho family GTPase that regulates actin dynamics, also shows 
colocalization with Beclin-1 (Aguilera et al., 2012). Under starvation, ROCK1, 
which is one of the RhoA downstream effectors, interacts with and 
phosphorylates Beclin-1 to dissociate it from Bcl-2, leading to activation of 
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autophagy (Gurkar et al., 2013). Therefore, the RhoA-ROCK pathway may also 
play a role in the nucleation of autophagy.  
 
Figure 1.4 Model of actin regulator proteins in mammalian autophagy.  
The RhoA-ROCK pathway may play a critical role in autophagosome formation. 
RhoA colocalizes with Beclin-1, which may affect recruitment/activity of Beclin-
1. ROCK1 interacts with Beclin-1, leading to phosphorylation of Beclin-1 and 
activation of Beclin-1 complex. Non-muscle myosin II activation is required for 
the trafficking of mAtg9, which contributes to autophagosome formation. As 
myosin II is activated by ROCK1, the RhoA-ROCK1 pathway may play a role in 
mAtg9 trafficking as well. Actin regulator protein cortactin and actin filaments 
mediate the fusion process between autophagosome and lysosome, suggesting a 
















Like its yeast counterpart, the actin cytoskeleton may also regulate the trafficking 
of Atg9 in mammals. One recent study demonstrates that ULK1, like its yeast 
counterpart Atg1, is crucial for the trafficking of mAtg9 from its perinulcear 
localization (Tang et al., 2011). ULK1 activates ZIPK, leading to the 
phosphorylation of myosin regulatory light chain (MRLC) and activation of 
myosin II. Activated myosin II has a critical role in the trafficking of mAtg9 and 
formation of autophagosomes under starvation (Tang et al., 2011). Therefore, the 
actomyosin network may be important for the trafficking of mAtg9 and 
autophagosome formation. Interestingly, RhoA and its downstream effector 
ROCK are crucial factors for starvation-induced autophagosome formation 
(Aguilera et al., 2012). It has been shown that RhoA triggers ROCK activation to 
phosphorylate myosin light chain, leading to myosin activation (Narumiya et al., 
2009). Therefore, it is possible that the Rho-ROCK pathway mediates the myosin 
II dependent trafficking of mAtg9.  
Actin cytoskeleton in autophagosome maturation  
Actin cytoskeleton has also been suggested to mediate late stage autophagy. One 
study showed that fusion of autophagosomes with lysosomes is inhibited by actin 
depolymerization agents. Moreover, cortactin, a protein that regulates actin 
polymerization, is a critical player in regulating the fusion process (Lee et al., 
2010b). The actin cytoskeleton may thus be required for the fusion process. 
Another aspect of autophagosome maturation process is the transportation of 
autophagosomes to lysosomes for fusion to occur. Microtubules have been shown 
to mediate the movement of autophagosomes through dynein-dependent motor 
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system (Fass et al., 2006; Kimura et al., 2008; Kochl et al., 2006). However, the 
role of actin cytoskeleton is less understood. One recent study demonstrates that 
myosin VI interacts with the adaptor protein target of Myb1 (Tom1), an endocytic 
sorting complex, to deliver endosomes to autophagosomes, suggesting the 
involvement of the actin motor system in the trafficking and fusion process 
(Tumbarello et al., 2012). Since actin-based movement is important for vesicle 
trafficking (DePina et al., 2007), it is possible that actin may also regulate the 
transportation of autophagosomes and this needs further investigation. 
1.1.3 The roles of autophagy in cancer 
Autophagy has been implicated to play roles in a few pathological conditions 
including neuron degeneration and cancer (Viry et al., 2014). The roles of 
autophagy in cancer has been extensively studied, however, the exact role of 
autophagy still needs to be fully evaluated. The current understanding of 
autophagy is that it has dual effects on cancer, as numerous studies have reported 
both the tumour suppressive and tumour promoting functions of autophagy and 
will be discussed in the following sections.  
Tumour-suppressive functions of autophagy  
Autophagy was initially identified to be a tumour-suppressive process, because 
deficiencies in various autophagy-related genes lead to increased risks of cancer. 
For instance, loss of Beclin-1 has been linked to increased cancer risk (Liang et 
al., 1999; Qu et al., 2003; Yue et al., 2003). Restoring Beclin-1 expression in 
breast cancer suppresses their ability to form tumours after injecting into mouse 
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(Liang et al., 1999). Notably, a larger percentage of breast and ovarian cancers 
maintain only one copy of Beclin-1 (Liang et al., 1999). In mouse, the loss of one 
copy of Beclin-1 have decreased levels of autophagy but increased incidence of 
spontaneous tumour development (Qu et al., 2003; Yue et al., 2003), suggesting 
Beclin-1 is a haploinsufficient tumour suppressor. Loss of the Beclin-1 interacting 
partner Bif-1 is also associated with various tumours including gastric cancer, 
colon cancer, and urinary cancer (Coppola et al., 2008; Kim et al., 2008; Lee et 
al., 2006). Consistently, Bif-1 knockout mouse are predisposed to spontaneous 
tumours (Takahashi et al., 2007). In addition, deletion of Atg5 and Atg7 also 
results in development of liver tumours (Igusa et al., 2012; Takamura et al., 
2011). Therefore, autophagy might play a role in early tumorigenesis. 
The mechanism of how autophagy suppresses tumourigenesis has been partially 
resolved. Autophagy may inhibit tumorigenesis via limiting the pro-tumour 
inflammatory environment. In apoptosis deficient cells, impairment of autophagy 
promotes necrotic cell death, which promotes inflammation and tumour growth 
(Degenhardt et al., 2006). Moreover, autophagy may help to maintain genomic 
stability. Suppression of autophagy is associated with increased reactive oxygen 
species (ROS) and DNA damage (Karantza-Wadsworth et al., 2007; Mathew et 
al., 2007). Loss of Atg7 results in accumulation of poly-ubiquitinated protein 
aggregates and reactive oxygen species (ROS), which could lead to DNA damage 
(Takamura et al., 2011). Consistently, Beclin-1 depletion leads to increased DNA 
damage and aneuploidy, and the resulting genomic instability could promote 
tumour formation (Karantza-Wadsworth et al., 2007; Mathew et al., 2007). In 
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addition, p62, an LC3 interacting protein that binds to poly-ubiquitinated proteins 
for autophagic clearance, is reported to accumulate in autophagy defective cells 
(Mathew et al., 2009b). The aberrant accumulation of p62 contributes to increased 
DNA damage. Moreover, p62 may also promote tumour growth via deregulation 
of nuclear factor-κB (NF-κB) pathway and upregulation of nuclear factor 
(erythroid-derived 2)-like 2 (NRF-2) (Komatsu et al., 2010; Lau et al., 2010; 
Mathew et al., 2009b). Therefore, the tumour-suppressive function of autophagy 
may be executed via clearance of p62.  
Tumour-promoting roles of autophagy  
Accumulating evidence suggests that autophagy can promote tumour progression 
once a tumour has been established. In support of its tumour promoting functions, 
autophagy is maintained at high levels in several cancers, including pancreatic 
cancer, colon cancer, and Ras-expressing cancer cells (Guo et al., 2011; Mathew 
et al., 2009a; Sato et al., 2007). 
One reason for cancer cells to upregulate autophagy is to overcome metabolic 
stresses. During tumour progression, developing tumours usually encounter 
shortages in nutrients and oxygen in their microenvironment. The shortage in 
nutrients could trigger a few upstream regulators to activate autophagy. For 
example, nutrient depletion activates AMPK and inhibits mTOR activity, both 
leading to activation of ULK1 complex and autophagy induction (Egan et al., 
2011; Ganley et al., 2009; Hosokawa et al., 2009; Kim et al., 2011). Activation of 
autophagy potentially recycles nutrients and substrates via degrading unwanted 
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organelles and protein aggregates, therefore supporting the growth and survival of 
cancer cells (Karantza-Wadsworth et al., 2007). Under hypoxia conditions, 
autophagy can be activated by hypoxia-inducible factor-1 α (HIF-1α) via 
BCL2/adenovirus E1B 19 kDa proteininteracting protein 3 (BNIP3) (Band et al., 
2009; Bellot et al., 2009). Additionally, hypoxia can induce autophagy 
independent of HIF-1α (DeYoung et al., 2008). Hypoxia-induced autophagy can 
degrade excess ER and mitochondria to generate nutrients so that cancer cells can 
adapt to hypoxia (Band et al., 2009; Glick et al., 2010). 
Another explanation is that autophagy could eliminate toxic substrates in cancer 
cells. Despite its tumorigenic roles, excess ROS accumulation could be 
detrimental to cancer cells. Autophagy can be activated by ROS via oxidative 
modification of Atg4 and increasing high-mobility group box 1 (HMGB1) release 
(Kang et al., 2011; Scherz-Shouval and Elazar, 2011; Scherz-Shouval et al., 
2007). Activated autophagy degrades oxidized proteins and damaged 
mitochondria; which is one of the main sources of ROS. Therefore, ROS-induced 
damage can be restricted (Scherz-Shouval and Elazar, 2011). Notably, cancer 
cells have a higher amount of toxic misfolded proteins due to rapid cell division 
and high rate of mutation (Whitesell and Lindquist, 2005). Misfolded proteins are 
not only non-functional, but are also prone to form aggregates (Kopito, 2000; 
Yao, 2010). Autophagy is employed by cancer cells to eliminate misfolded 
protein aggregates accumulated. For example, once misfolded procollagen 
aggregates accumulate in ER, autophagy is triggered to degrade aggregates 
(Ishida et al., 2009). 
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Moreover, autophagy can assist tumour cells in altering metabolism. Unlike 
normal cells, many tumour cells are dependent on aerobic glycolysis to produce 
energy and metabolic intermediates to sustain cell growth (Levine and Puzio-
Kuter, 2010; Vander Heiden et al., 2009). Moreover, some cancer cells utilize the 
tricarboxylic acid cycle (TCA) cycle, which is important for energy production 
and biosynthesis of nucleic acids, hexosamine and amino acids (Wise and 
Thompson, 2010). Autophagy could potentially fuel cancer metabolism via 
generating metabolic substrates like amino acids and glucose from breaking down 
macromolecules. It has been reported that autophagy can generate glucose for 
energy production via glycogen breakdown (Kotoulas et al., 2006; Raben et al., 
2008). Moreover, the degradative substrates of autophagy can fuel the TCA cycle 
to produce ATP (Ermak et al., 2012). Glutamine might be an important substrate 
generated by autophagy for TCA cycle, as autophagy-deficient cancer cells rely 
largely on exogenous supplies of glutamine for TCA cycle and survival 
(Strohecker et al., 2013). Interestingly, tumour-associated fibroblasts with 
elevated autophagy undergo glycolysis and release metabolic intermediates to 
support tumour growth, suggesting an alternative way to fuel cancer metabolism 
by autophagy of tumour stroma cells (Pavlides et al., 2012). 
Autophagy in chemotherapy  
Similar to its functions in tumours, autophagy has been paradoxically reported to 
protect cancer cells from chemotherapeutic drugs or enhance drug efficacy in 
killing cancer cells. The different effects of autophagy on chemotherapy may be 
linked to its functions in cell fate determination. While autophagy is widely 
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thought to be a cell survival mechanism in response to stresses, under certain 
circumstances, cells can undergo a type of programmed cell death called 
autophagic cell death.  
Autophagic cell death, the type II programmed cell death, can be induced by some 
anticancer drugs. A few anticancer drugs, including tanshinone IIA (Yun et al., 
2014), cannabinoids (Vara et al., 2011), and diarylquinoline compounds (Cai et 
al., 2013), trigger autophagic cell death via different mechanisms. Autophagic cell 
death may be an important mechanism to clear cancer cells with defective 
apoptosis. For instance, human colon cancer cells deficient in PUMA (p53 
upregulated modulator of apoptosis) or Bax can be killed by 5-FU via activation 
of autophagic cell death (Xiong et al., 2010). Therefore, autophagic cell death 
may serve as an alternative death mechanism, and activating autophagy may 
enhance the efficacy of anticancer drug in apoptosis-defective cancer cells. 
However, mounting evidence also suggests that autophagy can protect cancer 
cells from anticancer drugs. The cyto-protective effects of autophagy have been 
reported to confer various cancers resistance to numerous chemotherapeutic 
agents. For instance, in colorectal cancer, studies demonstrate that cytoprotective 
autophagy is induced by 5-FU treatment, and inhibition of autophagy via 
lysosomal inhibitor or PI3KIII inhibitor markedly sensitizes cancer to 5-FU 
treatment both in vitro and in vivo (Li et al., 2010; Sasaki et al., 2012; Sasaki et al., 
2010). Combining treatment with autophagy inhibitors has been reported to 
improve the cytotoxic effects and efficacy of a number of chemotherapeutic 
agents in other types of cancers such as breast cancer and pancreatic cancer (Kang 
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et al., 2010; Mirzoeva et al., 2011; Schoenlein et al., 2009; Sun et al., 2011). 
Currently, combination therapy with autophagy inhibitors has also been tested in 





1.2.1 Introduction  
The actin cytoskeleton provides a structural support for cells. It plays a critical 
role in many cellular processes including cell proliferation, cell death, and cell 
movement. Due to its dynamic nature, actin filaments undergo polymerization at 
its barbed end (or plus end) and depolymerization at its pointed end (or minus 
end), a process called treadmilling (Dominguez and Holmes, 2011). In cells, the 
dynamics and organization of the actin cytoskeleton are controlled by a large 
number of proteins called actin-binding proteins (ABPs) (dos Remedios et al., 
2003). The ABPs are grouped according to their functions on regulating actin 
cytoskeleton, such as actin severing, capping and nucleating proteins (dos 
Remedios et al., 2003). One of the important proteins regulating actin severing 
and capping is gelsolin. 
Gelsolin is a ubiquitously expressed protein. It was identified as the founding 
member of the gelsolin superfamily proteins, which consist of adseverin, advillin, 
capG, flightless 1, villin, and supervillin (Silacci et al., 2004). These proteins 
contain core gelsolin-like domains and are mainly involved in regulating actin 
dynamics (Silacci et al., 2004). Among these proteins, gelsolin is the best 
characterized member.   
Up to date, three isoforms of gelsolin have been identified, which are plasma 
gelsolin, cytoplasmic gelsolin, and gelsolin-3 (Kwiatkowski et al., 1986; 




Figure 1.5 The structure of gelsolin.  
Gelsolin is composed of 6 gelsolin-like domains. The binding sites for actin, 
calcium, and PIP2 are shown. Figure is adapted and modified from Buki et al., 
2008. 
  


























gelsolin-3 exist intracellularly, plasma gelsolin is the only secreted form of 
gelsolin. The three isoforms are encoded by the same gene, but they differ from 
each other as a result of alternative splicing (Kwiatkowski et al., 1986; 
Vouyiouklis and Brophy, 1997; Yin et al., 1981). Compared to cytoplasmic 
gelsolin, plasma gelsolin has additional 25 amino acids at its N-terminus, which 
signals for secretion (Kwiatkowski et al., 1986). Gelsolin-3, which is identified in 
oligodendrocytes, differs from cytoplasmic gelsolin by 11 amino acid residues at 
the N-terminus (Vouyiouklis and Brophy, 1997). 
1.2.2 Roles of gelsolin in regulating actin dynamics  
The most established role of gelsolin is to mediate the dynamics of actin 
cytoskeleton. The ability of gelsolin to regulate actin dynamics has been largely 
attributed to its conformational changes when it interacts with other regulatory 
molecules such as calcium (Ca
2+
) and polyphosphoinositide 4,5-bisphosphate 
(PIP2) (Burtnick et al., 1997; Janmey and Stossel, 1987; Lin et al., 1997; Yin and 
Stossel, 1979, 1980; Yin et al., 1980).  
Gelsolin is composed of 6 gelsolin-like domains (G1-G6), which can be divided 
into 2 halves (Kamada et al., 1998; Kothakota et al., 1997). The N-terminal half 
of gelsolin (G1-G3) and C-terminal half of gelsolin (G4-G6) is separated by a 
long linker sequence, which contains the caspase-3 cleavage site (Sun et al., 
1999). There are three actin binding sites located in different domains. G1 and G4 
contain monomer actin binding sites, while the actin filament binding site locates 
in G2 (Burtnick et al., 2004; Janmey and Stossel, 1987; McGough et al., 1998; 
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Pope et al., 1995; Weeds et al., 1995). Besides, each domain contains calcium 
binding sites, although two calcium ions are sufficient to induce the conformation 
changes of gelsolin required for actin severing (Burtnick et al., 1997; Choe et al., 
2002; Pope et al., 1995). 
In the absence of calcium, gelsolin forms a compact globular structure such that 
the actin binding sites are hindered. As suggested by crystal structure analysis, a 
short tail at the C-terminus latches back and forms a close contact with the F-actin 
binding site of G2 domain, thereby preventing the interaction of F-actin with G2 
(Ashish et al., 2007; Burtnick et al., 2004; Choe et al., 2002). This “tail latch 
hypothesis” is supported by the findings that deletion of the C-terminal tail 
abolishes the Ca
2+
 requirements of actin severing (Kwiatkowski et al., 1989; Way 
et al., 1990). In addition to this C-terminal latch, G1 and G4 interact with G3 and 
G6 respectively, forming two latches (G1-G3 latch and G4-G6 latch) which hold 
gelsolin in its inactive state (Ashish et al., 2007; Burtnick et al., 1997; Burtnick et 
al., 2004; Choe et al., 2002; Way et al., 1989). In the presence of Ca
2+
, binding of 
Ca
2+
 to G6 domain induces conformational changes, releasing C-terminal tail 
from G2 domain (Ashish et al., 2007; Kiselar et al., 2003a, b). Subsequent release 
of the G2-G3 latch and G4-G6 latch opens up gelsolin, exposing actin binding 
sites (Burtnick et al., 2004; Choe et al., 2002; Robinson et al., 1999). The exposed 
actin binding sites on G2 domain targets gelsolin to the side chain of an actin 
filament, and G1 and G4 binds to actin in a cooperative manner (Burtnick et al., 
2004; Nag et al., 2009). Binding of gelsolin to actin filaments disrupts the 




Figure 1.6 Model for gelsolin in actin regulation.  
Gelsolin is presented in a compact globular conformation at resting state. Once 
activated by calcium, gelsolin is activated and undergoes conformational change 
to release actin binding sites. Activated gelsolin binds and severs actin filament, 
after that it remains binding to and caps the barbed end of actin filament. PIP2 
releases gelsolin from actin filament, leading to uncapping of the barbed end. 
Furthermore, gelsolin can binds two actin monomers to form actin nuclei. Figure 





actin filament (McLaughlin et al., 1993). After severing, gelsolin remains bound 
to the barbed end of actin, preventing the polymerization at the barbed end. 
Release of gelsolin from the barbed end, a process called uncapping, requires 
binding of PIP2. Interaction of PIP2 with gelsolin induces conformational changes 
and releases gelsolin from actin filaments, enabling actin assembly at the barbed 
end (Burtnick et al., 1997; Janmey et al., 1992; Liepina et al., 2003; Urosev et al., 
2006; Yu et al., 1992). 
The net effect of gelsolin on actin dynamics in cells is complicated. On one hand, 
gelsolin severs the existing actin filament and caps the barbed end of the filament, 
preventing the elongation at the barbed end and annealing of the severed 
filaments. Therefore, this severing-capping process generates a net disassembly 
effect of the actin filaments (Silacci et al., 2004). On the other hand, once gelsolin 
is uncapped from actin filaments, many free barbed ends are exposed and actin 
polymerization can take place at these ends (Silacci et al., 2004). Therefore, 
gelsolin can promote the assembly of actin cytoskeleton following severing-
uncapping process. In addition, gelsolin can bind with two actin monomers to 
form nuclei, where actin polymerization starts (Ditsch and Wegner, 1994, 1995; 
Tellam and Frieden, 1982). 
1.2.3 Roles of gelsolin in Apoptosis 
Accumulating evidence suggests that gelsolin plays a role in regulating cell death 
mechanisms such as apoptosis. However, both pro-and anti-apoptotic role of 
gelsolin have been reported.  
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Pro-apoptotic roles of gelsolin  
Gelsolin can be cleaved by multiple caspases, including caspase-3, -7, -8, and -9 
(Kothakota et al., 1997). After induction of apoptosis, activated caspase-3 cleaves 
gelsolin between Asp353 and Gly 353, resulting in generation of N-terminal and 
C-terminal fragments of gelsolin (Kothakota et al., 1997). The N-terminal 
fragment of gelsolin loses the calcium regulation on its severing activity, leading 
to uncontrolled cleavage of actin filament and formation of cell blebbing 
(Kothakota et al., 1997). Interestingly, in hepatic stellate cells, the N-terminal half 
of gelsolin present in culture medium is able to initiate apoptosis, through 
increasing the expression of tumour necrosis factor (TNF)-related apoptosis-
inducing ligand receptor 1 (TRAIL-R1) and TRAIL-R2 death receptors and 
activation of caspase-3 in cells (Mazumdar et al., 2012), suggesting that secreted 
gelsolin may also regulate apoptosis. 
Moreover, gelsolin may also promote apoptosis through interacting with DNase I, 
an important enzyme mediating the degradation of DNA. In the resting state, 
monomeric actin binds to DNase I, leading to the inactivation of DNase I 
(Lazarides and Lindberg, 1974). The caspase-3 generated N-terminal gelsolin 
fragment competes with DNase I to bind to actin and thus disrupts the interaction 
of actin and DNase I (Chhabra et al., 2005). Subsequently, the released unbound 
DNase I is able to cleave DNA and apoptosis is enhanced. Furthermore, gelsolin 
may also regulate the expression levels of DNase I. Li et al. found that knock out 
of gelsolin leads to decreased levels as well as reduced activities of DNase I. 




Figure 1.7 Gelsolin as a pro-apoptotic protein.  
Gelsolin can be cleaved by caspase-3. Resulting N-terminal half of gelsolin 
cleaves actin filaments in an uncontrolled manner. N-terminal gelsolin also 
competes with monomeric actin to bind to DNase-I, leading to release of active 



















which binds to and enhances the promoter activity of DNase I (Li et al., 2009a; 
Yasuda et al., 1995). 
Moreover, in the absence of gelsolin, activation of Akt as well as expression 
levels of Bcl-2, an anti-apoptotic factor, are largely increased, suggesting that 
gelsolin may inhibit the pro-survival pathways (Li et al., 2009a).  
Anti-apoptotic roles of gelsolin  
In contrast, several independent lines of studies have also suggested that gelsolin 
can be an anti-apoptotic protein in many types of cells, including human T cells 
(Koya et al., 2000; Kusano et al., 2000; Qiao and McMillan, 2007), mouse β cells 
(Yermen et al., 2007), neuronal cells (Furukawa et al., 1997; Harms et al., 2004), 
and colorectal cancer cells (Klampfer et al., 2004; Klampfer et al., 2005). 
Interestingly, unlike the N-terminal fragment of gelsolin, the full-length and C-
terminal half of gelsolin display anti-apoptotic properties. Earlier studies have 
shown that gelsolin prevents the reduction in mitochondrial membrane potential 
and subsequent cytochrome C release from the mitochondrion, thereby blocking 
the activation of downstream caspases such as caspase-9 and -3 (Kamada et al., 
1998; Koya et al., 2000). Moreover, gelsolin localizes to mitochondrion, which 
enables gelsolin to interact with mitochondrial proteins (Kusano et al., 2000). 
Indeed, voltage dependent anion channel (VDAC), one of the crucial players in 
the mitochondrial apoptotic pathway, has been shown to bind to gelsolin and its 
activity is inhibited by this interaction (Kusano et al., 2000). Not only the full 
length gelsolin, but also the C-terminal half of gelsolin could also inhibit the 
activity of VDAC and subsequent cytochrome c release, suggesting an anti-
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apoptotic role of the C-terminal half (Kusano et al., 2000). Moreover, gelsolin 
interacts with VDAC via domain 5 (G5) presented on C-terminal half, and 
transfection of G5 is sufficient to rescue T cells from apoptosis induced by HIV 
viral protein R (Qiao and McMillan, 2007). 
Besides its involvement in regulating early stages in mitochondrial apoptotic 
pathway, gelsolin could also directly inhibit caspase activity. In vitro assays show 
that gelsolin binding with phosphatidylinositol 4,5-bisphosphate (PIP2) 
significantly blocks the activity of caspase-3 and -9. This inhibitory effect could 
be due to the formation a stable complex with PI(4,5)P2-gelsolin with caspase-3 
or -9 (Azuma et al., 2000). Moreover, both PI(4,5)P2 and phosphatidylinositol 
3,4-bisphosphate (PI(3,4)P2) prevents the cleavage of gelsolin by caspase-3, 
suggesting that phospholipids may modulate the effects of gelsolin on apoptosis 
(Azuma et al., 2000). 
Another mechanism to explain the anti-apoptotic property of gelsolin is attributed 
to its role in remodelling the actin cytoskeleton. The actin severing activity of 
gelsolin is required for its control on apoptosis, as the actin stabilizing agent 
revert the protective effect of gelsolin (Harms et al., 2004). Moreover, although 
uncontrolled actin depolymerization activity leads to apoptosis, the regulated 
actin-severing activity of gelsolin and villin (a member of the gelsolin 
superfamily) is important for their anti-apoptotic effects (Wang et al., 2012). 
Therefore, actin re-organization function of gelsolin might contribute to its anti-
apoptotic effect. However, the mechanism by which actin remodelling inhibits 




Figure 1.8 Gelsolin as an anti-apoptotic protein.  
Both full-length gelsolin and the C-terminal half of gelsolin can bind voltage 
dependent anion channel (VDAC). Moreover, the binding site of VDAC may be 
located in domain 5 (G5) on the C-terminal half of gelsolin. Binding to VDAC 
prevents its opening, and subsequently blocks mitochondrial membrane potential 
(∆ψm) loss and cytochrome c release. Gelsolin can form a complex with PIP2, and 
the complex inhibits caspase-3 and caspase-8. Actin remodelling by gelsolin may 





















1.2.4 The roles of gelsolin in cancer  
The roles of gelsolin in cancer development have been debated for a long time, as 
both tumour suppressive and tumour promoting functions of gelsolin have been 
reported. 
Tumour-suppressive functions of gelsolin 
In several cancers, gelsolin has been found to be downregulated. For example, 
decreased gelsolin expression has been reported in carcinomas of breast (Winston 
et al., 2001), ovarian (Noske et al., 2005), lung (Dosaka-Akita et al., 1998), 
prostate (Lee, 1994), colon (Fan et al., 2012; Gay et al., 2008), kidney (Visapaa et 
al., 2003a; Visapaa et al., 2003b), pancreatic (Ni et al., 2008), and bladder 
(Tanaka et al., 1995; Yuan et al., 2013). In support of its tumour suppressive role, 
gelsolin overexpression reduces the colony forming ability of bladder cancer cells 
(Tanaka et al., 1995), and leads to reduced tumorigenicity as well as repressed cell 
proliferation of lung cancer cells (Sagawa et al., 2003). Moreover, gelsolin 
knockdown is shown to induce epithelial-mesenchymal transformation (Tanaka et 
al., 2006), a process that is critical for cancer development (Davis et al., 2014). 
Recent studies show that gelsolin can act as a downstream effector of both 
oncogenes and tumour suppressors. Activating transcription factor 3 (ATF3) 
suppresses bladder cancer metastasis via upregulating gelsolin expression (Yuan 
et al., 2013). Moreover, AKT1, an oncogene that can promote cancer proliferation 
and survival, suppresses the expression of gelsolin (Saji et al., 2011). 
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Currently, little is known about the mutation of gelsolin in cancer. It has been 
previously reported that no major mutations or gross chromosome rearrangements 
of gelsolin were identified in cancer (Asch et al., 1996). However, in the Ras-
transformed cells, point mutation of gelsolin changing proline residue at position 
321 to histidine has been identified (Mullauer et al., 1993). Nevertheless, the 
function of the missense mutation in tumourigenesis is still unknown. 
Tumour-promoting functions of gelsolin 
A number of studies also suggest tumour-promoting roles of gelsolin, as gelsolin 
contributes to aggressive phenotypes of cancer and poor prognosis of patients in 
some cancers. Clinically, high levels of gelsolin have been linked to aggressive 
behaviours of some types of cancer. Increased levels of gelsolin have been linked 
to invasion into lymph nodes in small cell lung cancer (Shieh et al., 1999). 
Gelsolin is also reported to be upregulated in high grade renal cell carcinoma 
(Visapaa et al., 2003b). In addition, gelsolin is upregulated and is associated with 
aggressive cancer behaviours in cervical carcinoma (Liao et al., 2011). Moreover, 
gelsolin is overexpressed in a subset of breast cancer, and co-expression of 
gelsolin with epidermal growth factor receptor (EGFR) and erbB-2 is associated 
with poorer survival of patients (Thor et al., 2001). Interestingly, gelsolin 
expression has been suggested to display a biphasic pattern where gelsolin is 
downregulated at premalignant stages and upregulated in higher grades in 
urothelial and oral carcinomas (Rao et al., 2002; Shieh et al., 2006). In colon 
adenocarcinoma, gelsolin is also reported to be downregulated in primary tumours, 
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but re-expressed at the invasive front of liver metastasis (Gay et al., 2008; Zhuo et 
al., 2012).  
The tumour promoting role of gelsolin can be explained by its ability to promote 
invasion and survival, which will be discussed in the following sections. 
Gelsolin in cancer invasion and metastasis 
It has been well established that gelsolin promotes migration and invasion of 
cancer cells. The migration of fibroblast and neutrophils are mediated by gelsolin 
(Azuma et al., 1998; Lu et al., 1997; Witke et al., 1995). In cancer cells, 
overexpression of gelsolin promotes migration and invasion, whilst 
downregulating gelsolin attenuates the ability of cancer cells to invade (Litwin et 
al., 2009; Litwin et al., 2012; Radwanska et al., 2012). Due to its critical roles in 
actin cytoskeleton, gelsolin may regulate migration and invasion via actin 
remodelling. Interestingly, gelsolin can translocate to the membrane, where it 
associates with actin filament and depolymerizes actin, leading to increased 
migration of cancer cells (Litwin et al., 2012). Moreover, gelsolin may also 
participate in formation of protrusions involved in cell movement. It is reported 
that gelsolin is required for the formation of lamellipodia and podosomes, which 
are important protrusions for motile cells (Chellaiah et al., 2000; Chou et al., 
2002). Another mechanism for increasing invasion is to secrete matrix degrading 
proteases. It has been shown that expression and secretion of urokinase 
plasminogen activator (uPA), an important protein triggering a cascade to degrade 
extracellular matrix, is dependent on gelsolin (Zhuo et al., 2012), suggesting a 
role of gelsolin in matrix protease production and secretion to enhance invasion. 
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Therefore, gelsolin may promote migration and invasion of cancer cells in 
multiple ways, leading to increased metastatic capacity. 
Up to date, gelsolin has been found to crosstalk with several proteins and 
signalling pathways in invasion and metastasis. The Ras small GTPase is one of 
the important regulators of gelsolin. PI3K activates Ras small GTPase, triggering 
gelsolin-mediated invasion (De Corte et al., 2002). Recently, Nm23-H1 (also 
known as NME1), a metastatic suppressor gene which codes for nucleoside 
diphosphate kinase A, has been shown to inhibit the gelsolin-mediated metastasis 
via disabling the actin severing function of gelsolin (Marino et al., 2013), 
highlighting the importance of gelsolin in metastasis.  
1.3 Rationale and objectives for the study 
Gelsolin, one of the most important actin-regulatory proteins, is known to play 
critical roles in cell death and survival in cancer cells. Recently, gelsolin has been 
reported to contribute to drug resistance to 5-fluorouracil (5-FU) and cisplatin 
resistance in colorectal cancer and head-and-neck cancer cells (Klampfer et al., 
2005; Wang et al., 2014), highlighting the importance of gelsolin in cancer cell 
survival. Therefore, delineating the underlying mechanisms as to how gelsolin 
protects cells from stresses would be useful in designing effective therapies 
against therapeutic resistance in cancer cells. Although gelsolin has been 
suggested to participate in apoptotic machinery, the mechanisms by which 
gelsolin promotes cell survival are not fully characterized. Moreover, whether 
gelsolin could modulate survival pathways remains to be elucidated. Interestingly, 
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the actin cytoskeleton and its regulatory proteins have been reported to regulate 
autophagy, an important pro-survival pathway induced by stresses. As autophagy 
is known to promote cell survival under various stresses including chemotherapy 
and nutrient deprivation, it is conceivable that actin-regulatory proteins can 
promote cancer cell survival via modulating autophagy. Therefore, we 
hypothesize that gelsolin may modulate the autophagy machinery to promote 
cancer cell survival under stresses. 
The objectives of this study are: 
1. To investigate the involvement of gelsolin in cancer cell survival under 
stresses 
2. To examine if gelsolin is involved in modulating autophagy levels  
3. To investigate whether the effects of gelsolin on cancer cell survival are 
mediated via autophagy 







Chapter 2: Materials and methods 
Antibodies and reagents 
Primary antibodies: 
Rabbit antibodies: LC3B antibody (L7543, Sigma-Aldrich), phospho-S6 
(CST2211, Cell signalling), S6 (CST2217, Cell signalling), mAtg9 (Atg9A, 
ab108338, Abcam), Atg7 (A2856, Sigma-Aldrich), Atg12 (A8731, Sigma-
Aldrich), β-tubulin (sc-9104, Santa cruz). 
Mouse antibodies: β-actin (A5441, Sigma-Aldrich), gelsolin (ab11081, Abcam), 
p62 (sc-28359, Santa cruz), Cathepsin B (ab26395, Abcam), Cathepsin D 
(ab40697, Abcam), Cathepsin L (ab6314, Abcam). 
Secondary antibodies:  
Goat anti-mouse IgG conjugated with HRP (sc-2005, Santa Cruz), Goat anti-
rabbit IgG conjugated with HRP (sc-2004, Santa Cruz), Alexa Fluor 568 goat 
anti-rabbit IgG (A11036, Molecular Probes, Life technologies), Alexa Fluor 350 
goat anti-mouse IgG (A-21049, Molecular Probes, Life technologies). 
Reagents: 
Earles’s balanced salt solution (EBSS, E2888, Sigma-Aldrich), chloroquine 
diphosphate (CQ, C6628, Sigma-Aldrich), Opti-MEM (31985, Gibco, Life 
technologies), Medium GC content negative control (12935112, Life 
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technologies), Lipofectamine RNAiMAX transfection reagent (13778150, Life 
technologies), propidium iodide (4170, Sigma-Aldrich), DNase-free RNase A 
(R7253, Sigma-Aldrich), geneticin G418 (10131-027, Gibco, Life technologies), 
Hoechst 33342 (H3570, Molecular Probes, Life technologies) 
siRNA sequences: 
Gelsolin: 5’ AAACGUCCAAUCUUGUUGGAGCAGG 3’ 
Atg7: 5’ UCUUCGAAGUGAAGCUUCCAGAAAU 3’  
The siRNAs were purchased from Life technologies. 
Primer sequences 
The following primers were used for detecting mRNA levels by real-time PCR. 
 
Cathepsin B Forward 5’ AACCACAGGCTGGGATGTAG 3’ 
Reverse 5’ CACTGACTGGGGTGACAATG 3’ 
Cathepsin L1 Forward 5’ GATGGAGGAGAGCAGTGTGG 3’ 
Reverse 5’ GCACTAAAAGCCCAACAAGAAC 3’ 
Cathepsin D Forward 5’ TGCTGGACATCGCTTGCTGGAT 3’ 
Reverse 5’ TGCCATCGAACTTGGCTGCGA 3’ 
WDFY3 Forward 5’ GAATCAGCTGGAGCCCAGA 3’ 
Reverse 5’ TCTTGGCTGGTTGGTGAGA 3’ 
Atg7 Forward 5’ GATCCGGGGATTTCTTTCACG 3’ 
Reverse 5’ CAGCAATGTAAGACCAGTCAAGT 3’ 
PIK3C3 Forward 5’ CTCACCAAAGCTCATCGACA 3’ 
44 
 
Reverse 5’ CATCGAAATTCAACCATCAGG 3’ 
GABARAP Forward 5’ TGCCGGTGATAGTAGAAA 3’ 
Reverse 5’ GGTGTTCCTGGTACAGCT 3’ 
GABARAPL1 Forward 5’ TGCCCTCTGACCTTACTG 3’ 
Reverse 5’ AGTCTTCCTCATGATTGTC 3’ 
GABARAPL2 Forward 5’ TCGCTGGAACACAGATG 3’ 
Reverse 5’ TGTCCCATAGTTAGGCTG 3’ 
Table 2.1 Primer sequences 




Human colorectal cancer cell lines HCT116 and RKO were obtained from Dr 
Shing Chuan Hooi (National University of Singapore, Singapore). HCT116 stably 
overexpressing gelsolin or empty vectors were generated in lab previously (Zhuo 
et al., 2012). HeLa stably transfected with GFP-LC3 was a gift from Dr Noboru 
Mizushima (University of Tokyo, Japan) (Velikkakath et al., 2012). HCT116 cells 
were cultured in McCoy’s 5A medium, and stable HCT116 cell lines were 
cultured in supplementary with 500µg/ml geneticin (Gibco). RKO cells were 
grown in Dulbecco’s Modified Eagle’s Medium (DMEM, Sigma-aldrich). HeLa 
with GFP-LC3 was cultured in DMEM supplemented with 500µg/ml geneticin. 
All media are supplemented with 10% fetal bovine serum (FBS, Hyclone). Cells 





Transfection with siRNA 
Cells were cultured for 24 hours and reached 30% confluency when transfected. 
Cells were transfected with Lipofectamine RNAiMAX (Life technologies) 
according to manufacturer’s instruction. Briefly, 10nM of siRNA was mixed with 
Lipofectamine RNAiMAX transfection reagent in Opti-MEM reduced serum 
medium (Life technologies) for 10 minutes at room temperature. The siRNA 
mixture was added to cells and incubated for 4 hours before changing to fresh 
media. Cells were cultured for 2 days before harvesting for experiments. Medium 
GC content negative control (Life technologies) was included as control for 
siRNA. 
Cell death analysis by sub-G1 
Cells were harvested and re-suspendered in PBS, after which cells were fixed 
with ice-cold 70% ethanol. After that, cells were washed with PBS, and cells were 
centrifuged to collect pellet. Cell pellets were stained with 20µg/mL propidium 
iodide (PI, Sigma-Aldrich) in PBST (PBS with 0.1% Triton X-100) containing 
200µg/mL DNase-free RNase A (Sigma-Aldrich) to degrade interfering RNA at 
room temperature for 15 minutes. The DNA content was analysed by Flow 
cytometry (BD FACSCalibur) using FL2 channel. Data was processed with 




After designated treatments, cells were lysed with RIPA lysis buffer (50 mM Tris-
HCl, pH 8.0, with 150 mM sodium chloride, 1.0% Igepal CA-630 (NP-40), 0.5% 
sodium deoxycholate, and 0.1% sodium dodecyl sulphate) that was freshly 
supplemented with protease inhibitor cocktail (Roche). Equal amounts of protein 
were separated by SDS-PAGE and transferred to PVDF membranes (Bio-Rad). 
Membranes with proteins were blocked with 5% non-fat milk prepared in TBST 
(20mM Tris-HCl, pH 7.6, 137mM NaCl, 0.1% Tween-20) for 1 hour at room 
temperature. Membranes were washed for 3 times, followed by incubation with 
primary antibodies at 4
o
C overnight. Subsequently, membranes were washed with 
TBST for 3 times and incubated with secondary antibodies at room temperature 
for 1 hour. After washing the unbound secondary antibodies, bands were detected 
using chemiluminescence substrates (Pierce, Thermo Scientific) under X-ray 
processor (Kodak) or ChemiDoc XRS+ (BioRad). Densitometric analysis of band 
intensity was carried out using ImageJ software. 
Immunofluorescence microscopy 
Cells were seeded on 12mm poly-L-lysine coated coverslips and cultured for 2 
days. After desired treatments, cells were fixed with 4% paraformaldehyde for 15 
minutes at room temperature. For immunostaining, cells were permeabilized and 
blocked with blocking buffer (5% BSA in PBS containing 0.1% saponin) for 2 
hours at room temperature., washed with PBS containing 0.05% saponin for 5 
times, and incubated with primary antibodies in blocking buffer (1:100 dilution 
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otherwise stated) for 1 hour at room temperature. After washing for 5 times, 
samples were incubated with secondary antibodies conjugated to AlexaFluor 
(Molecular Probes) for 1 hour at room temperature. After washing and 
counterstaining with Hoechst 33342 (Molecular Probes), samples were mounted 
with Mowiol medium and examined under a confocal microscope (Olympus 
Fluoview FV1000). Images were processed by Olympus Fluoview Viewer 
(Version 2.0).  
For GFP-LC3 puncta visualization, cells were fixed with 4% paraformaldehyde 
for 15 minutes at room temperature followed by washing with PBS for 3 times. 
Samples were mounted in mounting medium containing DAPI (Vector Labs) and 
visualized under a fluorescence microscope (Olympus DP72). Images were 
processed by ImageJ. 
Proximity ligation assay 
Proximity ligation assay was performed using the Duolink in situ kit (Olink 
Bioscience) following manufacturer’s protocol to detect protein interaction in situ 
(Koos et al., 2014). Briefly, 0.1 million cells were grown on a 12mm poly-L-
lysine coated coverslip for 1 day. After treatment, cells were fixed in 4% 
paraformaldehyde for 15 minutes, followed by permeabilization with 0.2% Triton 
X-100 in PBS for 10 minutes at room temperature. After blocking with 5% bovine 
serum albumin (BSA) in PBS for 2 hours at room temperature, cells were 
incubated with primary antibody against gelsolin (1:50 dilution, antibody was 





C overnight. Coverslips were washed with PBS for 3 times, followed by 
incubating with PLA probes (secondary antibodies conjugated with 
oligonucleotides) at 37
o
C for 1 hour, whereas PLA plus probe recognizing mouse 
antibody and minus probe recognizing rabbit antibody. After washing three times 
with washing buffer A, samples were incubated with ligation solution for 30 
minutes at 37
o
C to allow hybridization of oligonucleotides in close proximity into 
a closed circle. After washing for 3 times, the amplification solution was added 
and incubated at 37
o
C for 100 minutes (to enable rolling-circle amplification 
reactions (RCA) of ligated oligonucleotide circle which generate fluorescent-
labelled RCA product). Samples were washed with washing buffer B for 3 times, 
and then mounted in mounting media containing DAPI (Vector labs) to 
counterstain nuclei. PLA signals (red fluorescence) were examined under a 
fluorescent microscope (Olympus DP72) at 60X magnification. Images were 
processed with ImageJ software. 
Immunoprecipitation 
Cells were grown on 10cm dish for 1 day. After designated treatments, cells were 
washed with ice-cold PBS twice, and scraped for to collect cells. After spinning 
down, cell pellets were lysed in IP lysis buffer (50mM Tris, pH 8.0, 50Mm NaCl, 
1mM EDTA, 1% Triton X-100, 0.1% NP-40) supplemented with fresh protease 
inhibitor cocktail (Roche). A small amount of total cell lysate (40µg) was kept as 
input for IP. 1mg of cell lysate was mixed with 20µl protein A/G PLUS agarose 
beads (Santa Cruz) and incubated at 4
o
C for 1 hour to pre-clear cell lysate. 2µg 
primary antibodies or respective IgG isotype control were conjugated with 30µl 
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protein A/G agarose beads for 4 hours at 4
o
C. The pre-cleared lysate was added to 
agarose beads conjugated with primary antibodies or IgG, and incubated on an 
orbital rotator at 4
o
C overnight. On the following day, agarose beads were 
collected by centrifugation and washed extensively with IP lysis buffer for 5 
times. After spinning down the beads, beads were mixed with SDS loading buffer 
and boiled for 5 minutes to elute the precipitates. After spinning down, the 
supernatant (precipitates) was loaded to a SDS-PAGE gel for analysing. 
Real-time PCR 
Extraction of RNA 
RNA was extracted from cells using RNeasy Mini Kit (Qiagen) following 
manufacturer’s protocol. Briefly, cells were lysed and homogenized by passing 
through a 21-gauge needle for ten times. Ethanol was added at a 1:1 ratio and 
lysate were loaded into a silico membrane column followed by washing for 2 
times. Total RNA was eluted in Nuclease-free water. The concentration and 
quality of extracted RNA was measured using NanoDrop ND-1000 
Spectrophotometer.  
Reverse transcription 
1µg of total RNA was reverse transcribed into cDNA using ImProm-II Reverse 
Transcription System reagents (Promega) in a 20µl reaction buffer. Briefly, 1µg 
RNA sample was mixed with 0.25µmol random primer in RNase free water 
followed by heating up at 70
o
C for 5 minutes. The RNA mixture was chilled on 
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ice and mixed with reaction buffer containing MgCl2, dNTPs and reverse 
transcriptase. The solution was incubated at 25
o
C for 5 minutes for annealing, and 
followed by 45-minutes incubation at 42
o
C for extension. The reaction was halted 
by heating at 70
o
C for 10 minutes. 
Real-time PCR 
Synthesised cDNA was diluted 3 times in nuclease free water and mixed with 
LightCycler 480 SYBER Green master mix (Roche) and one pair of primers 
(0.5µM final concentration). Real-time PCR was carried out using LightCycler 
480 (Roche) with the following thermal cycling conditions: heat at 95
 o
C for 30 
seconds, followed by 40 cycles of denaturation at 95
 o
C for 30 seconds and 
annealing and extension at 60
 o
C for 30 seconds. For each experiment, a non-
template control was added. GAPDH was used as internal control. Samples was 
normalized to GAPDH levels, after that the relative expression levels were 
calculated (the mRNA level in vector control cells was considered as 1). 
Cathepsin B and L activity assay 
Cathepsin B and L activity was determined using Magic Red cathepsin B or 
cathepsin L reagents (Immunochemistry Technologies, LLC). In principle, active 
cathepsin B catalyses the hydrolysis of cresyl violet-conjugated (Arg-Arg)2, while 
active cathepsin L catalyses the hydrolysis of cresyl violet-conjugated (Phe-Arg)2, 
resulting in release of red fluorescence (Creasy et al., 2007). Briefly, cells were 
cultured in 24-well plates for 1 day before treatment. The Magic Red cathepsin B 
or cathepsin L reagents were added to cells and incubated for 30 minutes before 
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harvesting. Cells with live staining were trypsinized and collected, and the 
fluorescence intensities were analysed by flow cytometry (BD FACS Calibur) 
using FL3 channel. 10,000 cells were analysed, and data was processed by 
CellQuest software. 
Statistical analysis 
All numerical values were presented as mean ± SE (standard error) from at least 
three independent experiments. The p-value was calculated by student’s t-test, and 





Chapter 3: Gelsolin promotes cancer cell survival under stresses via 
modulation of autophagy levels 
3.1 Background 
Tumour cell survival is an important component throughout cancer development. 
From the initiation of the primary tumour to its dissemination to distant sites, the 
ability to withstand various stresses such as nutrient shortage, hypoxia and 
anchorage-independence growth critically influences the disease outcome. A 
strong survival ability poses further challenges for therapeutic intervention when 
tumour cells are resistant to cytotoxic chemotherapy treatments. It is hence 
imperative to understand the underlying pro-survival mechanisms employed by 
tumour cells under cellular and cytotoxic stresses in order to develop better 
strategies against the disease development. 
Accumulating evidence suggests that cancer cells utilize cytoprotective autophagy 
to survive under various stresses. Autophagy, a self-eating process, is a catabolic 
process in which cytoplasmic constituents including macromolecules and 
damaged organelles (such as mitochondria, peroxisomes and endoplasmic 
reticulum) are degraded inside autolysosomes for the recycling of 
macromolecules (Yang and Klionsky, 2010). These recycled macromolecules, 
including amino acids, provide alternative energy sources for the cells to survive 
under unfavourable conditions (Levine and Klionsky, 2004). For example, it is 
well established that autophagy promotes the survival of tumour cells under 
hypoxia and nutrient deprivation, which are key features of the tumour 
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microenvironment. Meanwhile, autophagy induced by chemotherapeutic agents 
confers cancer cells the resistance to these treatments (Amaravadi and Thompson, 
2007), therefore posing obstacles to the effective clearance of cancer cells. 
Autophagy is a dynamic process that involves the following consecutive steps, 1) 
initiation, 2) nucleation, 3) elongation, 4) fusion and maturation (Lebovitz et al., 
2012). The whole process of autophagy is under the control of a group of proteins 
named Atg proteins (discussed in details in chapter 1). In addition, a few studies 
suggest that the actin cytoskeleton elements participate in this process. The actin 
cytoskeleton has been shown to regulate autophagy via modulating the trafficking 
of Atg9 containing vesicles, which presumably deliver lipids for autophagosome 
formation (Mari et al., 2010; Reggiori et al., 2005a). More evidence of the 
involvement of actin in autophagy comes from the study of actin-binding proteins. 
A few actin binding proteins, including Arp2, myosin II, and ROCK1, have been 
found to regulate autophagy (Aguilera et al., 2012; Monastyrska et al., 2008; Tang 
et al., 2011). 
Gelsolin, an actin-binding protein, has been identified to regulate actin 
cytoskeleton dynamics through severing and capping (Silacci et al., 2004). 
Gelsolin has been shown to have dual roles in regulating cell survival (Geng et al., 
1998; Kothakota et al., 1997; Koya et al., 2000; Kusano et al., 2000). Current 
understanding of gelsolin in cell death is that the full-length gelsolin and its C-
terminal half mainly play pro-survival roles, while the N-terminal half is thought 
to be pro-apoptotic, as discussed in Introduction sections (Geng et al., 1998; 
Kothakota et al., 1997; Koya et al., 2000; Kusano et al., 2000). Although gelsolin 
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has been reported to act downstream of Ras to protect colorectal cancer cells 
against butyrate and 5-FU (Klampfer et al., 2004; Klampfer et al., 2005), the 
underlying mechanisms of gelsolin on the survival of colorectal cancer cells have 
not been addressed. Knowing that actin regulators are involved in mediating 
autophagy, we propose that gelsolin, as an important actin-regulating protein, 




To investigate the roles of gelsolin in cancer cell survival, we aim to: 
1. Determine the roles of gelsolin in cell survival induced by various stresses. 
2. Examine if gelsolin modulates autophagy. 
3. Investigate whether the involvement of gelsolin in cell survival under stress 





3.3.1 Gelsolin promotes cancer cell survival under starvation 
To investigate the roles of gelsolin in colorectal cancer survival, we use both gain-
of-function model by overexpression of gelsolin and loss-of-function model via 
siRNA silencing of gelsolin (Figure 3.1A). Our lab has previously developed a 
HCT116 cell line that stably overexpresses gelsolin through stable transfection 
with gelsolin-pIRES2-EGFP vector, and stable HCT116 control cells transfected 
with the pIRES2-EGFP vector (Zhuo et al., 2012). We first examined the role of 
gelsolin in cell survival under nutrient starvation. The gelsolin-overexpressing 
HCT116 and vector control cells were starved in Earles’ balanced salt solution 
(EBSS), which contains 1g/L glucose as the sole nutrient, or serum-free medium 
(SFM) for up to 72 hours. Our results showed that gelsolin-overexpressing 
HCT116 cells exhibited lower cell death than vector control cells in response to 
nutrient starvation (EBSS and serum starvation, respectively), as quantified by the 
flow cytometric analysis of sub-G1 percentage after staining DNA in fixed cells 
with propidium iodide (Figure 3.1B & 3.1C). We also observed an increase in 
EBSS-induced cell death when gelsolin was knocked down by siRNA in HCT116 
cells (Figure 3.1D), suggesting that gelsolin is important for protecting cancer 
cells under nutrient-deprived conditions.  
Studies have suggested that full-length gelsolin has an anti-apoptotic effect in 
many types of cells (as discussed earlier in Chapter 1). We sought to examine if 
gelsolin has anti-apoptotic effects in colorectal cancer cells undergoing nutrient 
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starvation. Apoptotic markers, indicated by cleaved caspase-3 and cleaved PARP-
1, were detected in cells deprived of nutrients. Interestingly, reduced cleavage of 
caspase-3 and PARP-1 were observed in gelsolin-overexpressed cells when 
compared to vector control cells induced with starvation (Figure 3.1E). In order to 
confirm the role of gelsolin in prolonging cell survival, we next performed genetic 
knockdown of gelsolin. Consistent with the earlier observation, gelsolin siRNA 
knockdown increased the cleavage of caspase-3 and PARP-1 (Figure 3.1F). Our 
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Figure 3.1 Gelsolin promotes cell survival under starvation.  
A. Gelsolin levels were detected in gelsolin-overexpressing cells versus vector 
control cells (left panel), and gelsolin siRNA transfected cells versus control 
siRNA transfected cells (right panel). B. Overexpression of gelsolin protects cells 
from EBSS-induced cell death. Gelsolin-overexpressing cells (GSN) and vector 
control cells (Vector) were starved in EBSS from 6 hours to 48 hours. C. 
Overexpression of gelsolin protects cells from serum depletion induced cell death. 
Gelsolin-overexpressing cells and vector control cells were starved in serum free 
medium (SFM) for 24 hours to 72 hours. Cells were treated as above mentioned 
in B and C, and then harvested and fixed with 70% ethanol, followed by staining 
with propidium iodide. DNA contents were analysed by flow cytometry. Sub-G1 
percentage was analysed and assessed as cell death, and presented as means±SE 
of three independent experiments. D. Gelsolin knockdown sensitizes HCT116 
cells to EBSS-induced cell death. Gelsolin were knocked down in HCT116 cells. 
The knockdown (GSN siRNA) and siRNA control cells (Control siRNA) are 
starved in EBSS for 6 hours and 18 hours. Cell death was measured as described 
in B. E and F, Cleavage of apoptotic markers, PARP-1 and caspase-3, were 
assessed in gelsolin-overexpressing cells versus vector control cells (E), and 
gelsolin knockdown cells versus control cells (F) after starvation in EBSS for 24 















3.3.2 Gelsolin protects colorectal cancer cells from 5-fluorouracil treatment 
5-Fluorouracil (5-FU) is widely used in many cancers, including colorectal 
cancer. 5-FU-based chemotherapy improves the survival chances of patients with 
resected stage III colorectal cancer (Andrea et al., 2014; Stein and Bokemeyer, 
2014). However, along with the treatment, development of resistance to 5-FU in 
cancer has become a common problem, which poses the main obstacles to the 
chemotherapy treatment of cancer (Xu et al., 2006).  
It is therefore important to identify the factors protecting cancer cells from 5-FU-
induced cell death. As gelsolin is observed to have pro-survival roles under 
nutrient starvation, we next investigated if gelsolin contributes to 5-FU-induced 
cell death. We first performed a dose-dependent experiment to study the effects of 
5-FU treatment in control cells as well as in gelsolin-overexpressed cells (Figure 
3.2A). As expected, gelsolin-overexpressing cells were significantly more 
resistant to 5-FU-induced cell death (Figure 3.2A). Meanwhile, knockdown of 
gelsolin sensitized cells to 5-FU with increasing dosage (Figure 3.2B). Our 
observations thus strongly suggest that gelsolin may contribute to drug resistance 
by protecting cells from 5-FU-induced cell death. 
Furthermore, we also sought to investigate if gelsolin protects cells from 
apoptosis induced by 5-FU. Consistent with previously reported study (Klampfer 
et al., 2005), 5-FU treatment induced apoptosis of colorectal cancer cells, 
indicated by enhanced PARP-1 and caspase-3 cleavages (as shown in Figure 
3.2C). Notably, gelsolin overexpression significantly abrogated the cleavage of 
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caspase-3 and PARP-1 (last two lanes in Figure 3.2C), indicating that gelsolin 
possesses anti-apoptotic property that may be involved in colorectal cancer. 





Figure 3.2 Gelsolin protects cells from 5-FU.  
A. Overexpression of gelsolin protects HCT116 cells from 5-FU-induced cell 
death. Gelsolin-overexpressing cells (GSN) and vector control cells (Vector) were 
treated with 10µM to 150µM 5-FU for 24 hours. B. Silencing of gelsolin 
sensitizes HCT116 cells to 5-FU. Gelsolin knockdown and siRNA control cells 
were treated with 5-FU as indicated for 24 hours. Cells treated as above 
mentioned in A and B were fixed with 70% ethanol and stained with propidium 
iodide. DNA contents were analysed by flow cytometry. Sub-G1 percentage were 
assessed as cell death and presented as means±SE of three independent 
experiments (*p<0.05, t-test).  
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Figure 3.2 (continued) Gelsolin protects cells from 5-FU.  
C. Gelsolin protects cells from apoptosis induced by 5-FU. Gelsolin-
overexpressing cells (GSN) and vector control cells (Vector) were treated with 
150µM 5-FU for 24 hours. Apoptotic markers (cleaved PARP-1 and cleaved 
caspase-3) were assessed by Western blot. Representative Western blot of at least 





















3.3.3 Gelsolin regulates stress-induced autophagy  
Autophagy, an important degradative mechanism that maintains homeostasis, has 
been shown to be activated by various stress stimuli, including starvation and 
chemotherapeutic reagents (Cecconi and Levine, 2008; Mizushima and Komatsu, 
2011). As autophagy is well-documented to be activated under nutrient starvation, 
we sought to investigate if autophagy is a potential pathway regulated by gelsolin 
to promote survival under nutrient deprivation. Two autophagic markers, LC3-II 
and p62 were used to assess levels of autophagic flux, the turnover of autophagic 
substrates (Mizushima et al., 2010). The first autophagic assay is the measurement 
of LC3-II levels. Upon autophagy induction, LC3-I is lipidated to LC3-II to 
incorporate into autophagosomes (Kabeya et al., 2004). However, the increase of 
LC3-II can result from either the increased generation of autophagosomes 
(potentially increase in autophagic flux) or a blockade in autophagosomal 
maturation and degradation (suppression of autophagic flux at late stage). One 
approach to differentiate the two possibilities is to combine treatment with 
lysosomal inhibitor chloroquine diphosphate (CQ), which blocks autophagic 
degradation via neutralizing the lysosomal pH (Mizushima et al., 2010; Solomon 
and Lee, 2009). Compared to treatment without CQ, a higher level of LC3-II in 
presence of CQ indicates more autophagosome synthesis, while non-altered LC3-
II levels after CQ addition suggests a block in autophagic degradation 
(Mizushima et al., 2010). Another widely used autophagy marker is the 
measurement of the steady state levels of p62, which binds to poly-ubiquitinated 
proteins and is degraded inside autolysosomes (Bjorkoy et al., 2005). A decreased 
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level of p62 correlates with a higher capacity of autophagic degradation and thus 
increased autophagic flux levels (Mizushima et al., 2010). 
To examine the effects gelsolin on autophagy, we performed above mentioned 
autophagy assays in gelsolin over-expressing cells and vector control cells, as 
well as gelsolin knockdown cells and control cells. 
EBSS-induced autophagy in gelsolin-overexpressing and knockdown 
HCT116 cells 
We first treated both vector and gelsolin-overexpressing cells with EBSS in a 
time-dependent setting. Compared to vector control cells, gelsolin-overexpressing 
cells exhibited higher LC3-II levels under EBSS starvation for up to 4 hours and 
lower p62 levels, suggesting a possible increase in autophagy levels of the cells 
with gelsolin overexpression (Figure 3.3A). We then performed the autophagy 
flux assay by measuring LC3-II levels with CQ addition. As expected, EBSS 
induced significant increases in LC3-II, seen especially in the presence of CQ in 
gelsolin-overexpressed cells (Figure 3.3B). Notably, under starvation with CQ 
treatment, the levels of LC3-II in gelsolin-overexpressing cells were higher than 
the vector control cells. Therefore, both assays suggest a higher autophagic flux in 
gelsolin-overexpressing cells as compared to the vector control cells. 
To confirm our earlier observation on the involvement of gelsolin in mediating 
autophagy process in HCT116 cells, we next performed gelsolin knockdown as 
indicated in Figure3.3D. As expected, knocking down gelsolin in HCT116 cells 
led to diminishing LC3-II and an accumulation of p62 protein levels under 
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starvation when treated with EBSS for up to 4 hours (Figure 3.3D). When 
starvation and CQ are combined for the flux assay, we found a markedly lower 
LC3-II level in gelsolin knockdown cells as compared to the control cells (Figure 
3.3E).  
EBSS-induced autophagy in gelsolin-knockdown HeLa and RKO cells 
To further confirm the observation that gelsolin positively modulates autophagy 
levels, the effect of gelsolin on autophagy was examined in HeLa cells that have 
been stably transfected with GFP-LC3, which labels autophagic vesicles (appear 
as GFP-LC3 puncta) (Velikkakath et al., 2012; Zhou et al., 2013). EBSS 
starvation induced accumulation of GFP-LC3 puncta, and addition of CQ further 
enhanced both the number and the size of puncta in control cells (Figure 3.3G), 
suggesting an increased autophagic flux with increased number of autophagic 
vesicles. Knockdown of gelsolin significantly reduced GFP-LC3 puncta 
formation induced by EBSS starvation, further confirming that autophagy is 
downregulated by gelsolin knockdown.  
Consistent with our earlier results, siRNA silencing of gelsolin in RKO cells, a 
colorectal cancer cell line, had attenuated the autophagy level as suggested by the 
LC3-II autophagy flux assay (Figure 3.3H). Collectively, our results strongly 
suggest an inhibitory effect of gelsolin knockdown on starvation-induced 
autophagy. 
5-FU-induced autophagy in gelsolin-knockdown HCT116 cells 
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It has been earlier suggested that 5-FU is able to trigger cytoprotective autophagy 
(Sasaki et al., 2010). To examine if gelsolin could modulate 5-FU induced 
autophagy, gelsolin was knocked down in HCT116 cells and cells were subjected 
to 5-FU treatment. Consistent with previous report (Sasaki et al., 2010), 5-FU 
treatment has led to increased LC3-II levels in control cells, in the presence of CQ 
(Figure 3.3I). Gelsolin knockdown abolished the increase of LC3-II levels, 
suggesting an inhibitory effect of gelsolin knockdown on 5-FU-induced 
autophagy. 
Taken together, our data suggests that gelsolin is a potential positive regulator of 
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Figure 3.3 Gelsolin regulates stress-induced autophagy.  
A. Gelsolin-overexpressing cells (GSN) and vector control cells (Vector) were 
starved in EBSS for 1h to 4h, and then harvested and subjected to Western blot 
analysis. Representative Western blot was shown. B. Gelsolin-overexpressing 
cells and vector control cells were starved in EBSS for 1h, with or without 25uM 
chloroquine (CQ). Representative Western blot was shown. C. The quantification 
of LC3-II bands for B. The levels of LC3-II for each sample was measured by 
ImageJ software and normalized to β-actin. The normalized LC3-II level of vector 
control cells in full medium with 25uM chloroquine were considered as 1, folder 
changes in LC3-II level of other samples were calculated accordingly (*p < 0.05, 
2-tailed Mann-Whitney U test. For CQ treatment, p=0.014. For EBSS treatment, 
p=0.043. For EBSS and CQ treatment, p=0.043.). Data were presented as 
mean±SE for at least three independent experiments. D. Gelsolin knockdown 
HCT116 cells (GSN siRNA) and siRNA control cells (control siRNA) were 
subjected to the same treatment in A, and then harvested and subjected to Western 
blot analysis. E. Gelsolin knockdown HCT116 cells and siRNA control cells were 
subjected to the same treatment in B, with or without 25uM chloroquine. 
Representative Western blot was shown. F. The quantification of LC3-II bands 
for panel E. The levels of LC3-II for each sample was measured by ImageJ 
software and normalized to β-actin. The normalized LC3-II level of control 
siRNA transfected cells in full medium with 25uM chloroquine treatment were 
considered as 1, fold changes in LC3-II level of other samples were calculated 
accordingly. Data were presented as mean±SE for at least three independent 
experiments (*p ≤ 0.05,2-tailed Mann-Whitney U test. For CQ treatment, p=0.037. 
For EBSS treatment, p=0.05. For EBSS and CQ treatment, p=0.05). G. HeLa cells 
stably transfected with GFP-LC3 were starved in EBSS for 1h, in the presence or 
absence of chloroquine. GFP-LC3 puncta were visualized by fluorescent 
microscope. FM: Full medium. Scale bar: 10 µm. H. RKO cells were transfected 
with gelsolin siRNA or control siRNA for 48 hours, followed by starvation in 
EBSS for 2 hours with or without chloroquine. Autophagic flux was assessed 
using Western blotting for LC3-II level. I. Gelsolin siRNA or control siRNA 
transfected HCT116 cells were treated with 150μM 5-FU for 24 hours. 
Chloroquine was added in the last 2 hours of treatment. A representative Western 




3.3.4 The pro-survival role of gelsolin is autophagy-dependent 
To determine whether autophagy is required for gelsolin-mediated cell survival, 
we suppressed autophagy and examined the impact of autophagy inhibition on 
EBSS-induced cell death in gelsolin-overexpressing cells and vector control cells. 
Autophagy was inhibited by two approaches: 1) silencing of Atg7 which is 
essential for LC3 processing and autophagosome formation by siRNA, and 2) 
treating cells with autophagy inhibitors such as chloroquine (CQ), which blocks 
autophagosomal maturation and degradation (Cecconi and Levine, 2008; Ng et al., 
2011). The silencing efficiency of Atg7 was confirmed by Western blot (Figure 
3.4A). After silencing Atg7, gelsolin-overexpressing cells were sensitized to 
starvation-induced cell death, as seen by the increased sub-G1 percentage 
compared to control siRNA transfected cells (Figure 3.4 B&C). The effect of 
Atg7 knockdown on cell death was minimal on vector control cells. Moreover, 
Atg7 knockdown increased cell death in gelsolin-overexpressing cells to similar 
levels of vector control cells under starvation (Figure 3.4B&C), suggesting that 
the protective effect of gelsolin against starvation is dependent on Atg7 and 
autophagy. Similarly, when chloroquine was added to cells starved in EBSS, cell 
death in gelsolin-overexpressing cells was increased to similar levels compared to 
vector control cells (Fig 3.4D&E). These data suggest that the pro-survival effect 
of gelsolin in nutrient starvation is dependent on autophagy. 
Meanwhile, an increase in 5-FU-induced cell death in gelsolin-overexpressing 
cells was observed when Atg7 was silenced (Figure 3.5). However, the effect of 
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Atg7 knockdown on vector control cells was minimal (Figure 3.5). Therefore, the 
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Figure 3.4 Suppression of autophagy sensitizes cells to starvation induced cell 
death.  
A-C. Atg7 was knocked down in gelsolin-overexpressing and vector control cells. 
Non-specific siRNA (NS siRNA) was used as control for Atg7 siRNA. After 
knocking down, gelsolin-overexpressing and vector control cells were treated 
with EBSS for 10 hours. Cells were fixed and stained with propidium iodide, and 
DNA contents were analysed by flow cytometry. Cell death was measured by 
sub-G1 percentage. A. Representative Western blot for Atg7 levels was shown. B. 
Representative histogram of DNA content was shown. C. Cell death was 
quantified and presented as mean±SE for three independent experiments. D&E. 
Cells were treated in full medium or in EBSS for 12 hours, with or without 10µM 
chloroquine (CQ). Cell death was measured by sub-G1 percentage as described in 
A. D. Representative histogram of DNA content was shown. E. Cell death was 
quantified and presented as mean±SE for at least three independent experiments, 



























































































































Figure 3.5 Suppression of autophagy sensitizes cells to 5-FU induced cell 
death.  
A. Gelsolin-overexpressing and vector control cells were transfected with either 
non-specific siRNA (NS siRNA) or Atg7 siRNA. After transfection, cells were 
treated with 150µM 5-FU for 24 hours. Cells were fixed and stained with 
propidium iodide, and DNA contents were analysed by flow cytometry. Cell 
death was measured by sub-G1 percentage. Represented histogram of DNA was 
shown. B. Cell death of three independent experiments was quantified and data 
was presented as mean±SE (*p<0.05, 2-tailed Mann-Whitney U test. The p value 





3.4.1 Gelsolin exerts an anti-apoptotic effect in colorectal cancer cells 
In the present study, we found that gelsolin acts as a pro-survival protein in 
colorectal cancer cells. We have found that gelsolin overexpression effectively 
protects colorectal cancer cells from nutrient deprivation and 5-FU treatment, 
while gelsolin knockdown sensitizes cells to these treatments. More importantly, 
gelsolin blocks the induction of apoptosis by starvation and 5-FU, suggesting an 
anti-apoptotic role of gelsolin in colorectal cancer cells. Our findings are 
generally consistent with earlier studies that full-length gelsolin inhibits apoptosis 
induced by various stimuli (Klampfer et al., 2004; Klampfer et al., 2005; Koya et 
al., 2000; Kusano et al., 2000; Wang et al., 2012). Previous studies have 
uncovered that full-length gelsolin plays anti-apoptotic roles via its ability to 
directly interact with apoptotic machinery, where it binds and inhibits caspases 
and VDAC (Azuma et al., 2000; Koya et al., 2000; Kusano et al., 2000). Our 
study uncovers a novel pro-survival ,mechanism, which is autophagy, employed 
by gelsolin to inhibit apoptosis under stresses. Therefore, full-length gelsolin can 
exert its anti-apoptotic function via both direct interference with apoptotic 
machinery and indirect regulation via enhancing pro-survival pathways.  
On the other hand, independent lines of studies also report contradictory pro-
apoptotic roles of gelsolin. There might be several explanations for the 
discrepancy in literature. One possibility is that the death stimuli are different, 
leading to different responses and different functions of gelsolin. Gelsolin 
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overexpression has been reported to prevent cell death induced by Fas, 
camptothecin, ceramide, staurosporine, cycloheximide and dexamethasone 
(Kamada et al., 1998; Koya et al., 2000; Kusano et al., 2000; Ohtsu et al., 1997; 
Wang et al., 2012). On the other hand, reduced expression of gelsolin is generally 
reported to protect cells from apoptosis induced by tumour necrosis factor (TNF-
α) (Kothakota et al., 1997; Li et al., 2009c). Besides, the effects of gelsolin vary in 
different types of cells even under the same apoptotic stimulus. For example, 
gelsolin deficiency effectively protects breast cancer cells from TNF-α induced 
apoptosis, while cervical cancer cells and osteosarcoma cells become sensitive to 
the TNF-α induced apoptosis after gelsolin knockdown (Li et al., 2009c). Another 
possible reason is that the effect of gelsolin is determined by its predominant 
forms, whether it presents in full length or cleaved fragments. It has been 
suggested that the full-length gelsolin and its C-terminal fragments are generally 
anti-apoptotic, while the N-terminal half of gelsolin generated by caspase-3 
cleavage is pro-apoptotic (Geng et al., 1998; Kamada et al., 1998; Kothakota et al., 
1997; Koya et al., 2000; Kusano et al., 2000). After exposure to apoptotic stimuli, 
the balance between these three forms may determine the cell fate. It is possible 
that the full length gelsolin blocks apoptosis induction, but once the stimuli is 
overwhelming and fragmented gelsolin is generated, the N-terminal gelsolin 
counteracts the protective effect of full-length gelsolin, resulting in enhancement 
of apoptosis. In support of this, introducing N-terminal half gelsolin into cells 
with endogenous full-length gelsolin expression effectively causes cell death, 
even in the absence of other apoptotic stimuli (Geng et al., 1998; Kothakota et al., 
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1997). However, the appearance of fragmented gelsolin after Fas ligand or 
ceramide exposure does not further enhance apoptosis (Posey et al., 2000), 
suggesting the actual role of gelsolin and its fragments in cell death may be 
complicated and further studies need to be done to address this issue.  
3.4.2 Gelsolin is a novel modulator of autophagy 
In the present study, we have identified gelsolin as a novel modulator of 
autophagy under starvation and 5-FU treatment. By using both overexpression 
and siRNA mediated silencing of gelsolin, we found that the expression levels of 
gelsolin positively correlate with starvation and 5-FU induced autophagy. 
Gelsolin was previously identified as one of the most potent actin 
depolymerization factors (Silacci et al., 2004). It has been known that the actin 
cytoskeleton plays critical roles in regulating autophagy, however the regulatory 
mechanisms are not well understood. Pioneering studies in yeast reveal that the 
actin cytoskeleton is required for Cvt pathway, a biosynthetic pathway sharing 
similar machinery with autophagy, and pexophagy (the selective autophagic 
degradation of peroxisomes), but is dispensable for starvation-induced autophagy 
(Reggiori et al., 2005a). Studies have also unveiled that the actin cytoskeleton 
participates in the trafficking of Atg9-containing vesicles, one of the proposed 
lipid sources for the generation of autophagosomes. Moreover, actin mutants with 
defects in actin-cable formation or disassembly exhibit inhibition in autophagy 
(Reggiori et al., 2005a). This suggests the importance of actin dynamics and 
remodelling in regulating autophagy. In mammalian cells, actin is shown to be 
important for starvation-induced autophagy. As a functional and dynamic actin 
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network is crucial, actin-binding proteins which control the dynamics of actin 
cytoskeleton should play important roles in autophagy machinery. Indeed, a few 
actin cytoskeletal proteins have been implicated in the regulation of autophagy, 
including the nucleation factor Arp2, the motor protein myosin II and its upstream 
regulator ROCK1 and RhoA (Aguilera et al., 2012; Monastyrska et al., 2008; 
Tang et al., 2011). These data are in agreement with our observation that actin-
regulator proteins are involved in autophagy. As the above mentioned studies 
focused on actin polymerization proteins and motor proteins, our work 
demonstrates the novel roles of gelsolin, which could mediate actin 
depolymerization, in regulating autophagy. It would also be interesting to 
examine if other depolymerization proteins such as cofilin and other gelsolin 
family members could modulate autophagy. 
3.4.3 Autophagy is a pro-survival mechanism employed by gelsolin to protect 
cancer cells 
Numerous studies have reported both the pro-survival and pro-death role of 
autophagy. It has been previously reported that colorectal cancer cells have higher 
tolerance to starvation compared to normal human cells, and the resistance to 
starvation is conferred by autophagy activation (Izuishi et al., 2000; Sato et al., 
2007). Moreover, autophagy also has a protective role in 5-FU treatment, as it has 
been reported that autophagy inhibition enhanced the inhibition effect of 5-FU on 
growth of cancer cells both in vivo and in vitro (Choi et al., 2012; Li et al., 2009b; 
Sasaki et al., 2012; Sasaki et al., 2010; Schonewolf et al., 2014). Consistent with 
these reports, we also observed pro-survival effects of autophagy under starvation 
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and 5-FU, as inhibition of autophagy increased cell death (Figure 3.4&3.5). 
Interestingly, Xiong et al. reported that autophagy inhibition reduced levels of cell 
death under 5-FU treatment in colorectal cancer cells with Bax and PUMA 
deficiency (Xiong et al., 2010). Since cells lacking Bax and PUMA are defective 
in undergoing apoptosis, autophagy induced by 5-FU may act as a cell death 
mechanism. These results suggest a paradoxical and complicated role of 
autophagy in cancer cells undergoing chemotherapeutic drug treatment. 
Autophagy can play a cytoprotective role in cells with intact apoptotic machinery, 
but it may also act as an alternative cell death mechanism in apoptosis-defective 
cells. Therefore, whether one should inhibit or activate autophagy to potentiate 
chemotherapy efficacy can be largely dependent on the nature of cancer cells. 
Our study has revealed that autophagy was enhanced by gelsolin, and inhibition 
of autophagy caused a more evident increase of cell death in gelsolin-over-
expressing cells as compared to vector control cells. Therefore, our in vitro data 
suggest that cells with high gelsolin levels become more dependent on autophagy 
while being more vulnerable to treatment when autophagy is blocked. The present 
ability of gelsolin to promote autophagy found in this study would possibly be a 
good strategy to combine chemotherapeutic drugs with autophagy inhibitors in 





In summary, our findings suggest that gelsolin plays a pro-survival role, as 
gelsolin overexpression protects cells from starvation and 5-FU-induced cell 
death, whilst gelsolin knockdown sensitizes cells to these treatments. We also 
demonstrate a novel pro-autophagy function of gelsolin, whereby gelsolin 
overexpression enhances stress-induced autophagy, and gelsolin knockdown 
reduces levels of autophagy in various cell lines. Our data support a pro-survival 
role of autophagy, and that gelsolin-mediated cell survival is dependent on 
autophagy. Inhibition of autophagy (by Atg7 knockdown and chloroquine 
treatment) sensitizes gelsolin-overexpressing cells to cell death induced by 
starvation and 5-FU. Therefore, combining chemotherapy with autophagic 
inhibitors in cancer cells with high gelsolin levels may be a good strategy to 
enhance the efficacy of chemotherapy. 










Chapter 4 Mechanisms of gelsolin in regulating autophagy 
4.1 Background 
Autophagy is a multi-step process involving 1) initiation, 2) nucleation, 3) 
elongation, and 4) fusion and maturation. A large network of proteins participates 
in autophagy processes and its regulation. Under nutrient starvation, the 
inactivation of mTOR leads to dephosphorylation and activation of ULK1/2 
complex, resulting in subsequently autophagy initiation (Hosokawa et al., 2009; 
Jung et al., 2009). Recruitment of other players such as PI3K class III complex 
and its effectors mediates the formation of isolation membrane. Elongation of the 
membrane structure to form enclosed autophagosomes requires the Atg12-Atg5-
Atg16 and LC3-PE conjugation systems. Finally, the autophagosome fuses with 
lysosome, a process mediated by many proteins such as Rab7 (Jager et al., 2004). 
The actin cytoskeleton and its associated proteins have been shown to participate 
in multiple steps of autophagy. Actin cytoskeleton and its regulatory proteins such 
as non-muscle myosin II can regulate the autophagosome formation via the 
trafficking of Atg9, an essential protein thought to deliver lipids for 
autophagosome (Tang et al., 2011). Moreover, the Rho family member RhoA and 
its downstream effector ROCK1, which are important regulators of actin 
remodelling, may also be involved in autophagosome formation (Aguilera et al., 
2012; Gurkar et al., 2013). Actin regulator proteins may also play critical roles for 
the fusion of autophagosomes with lysosomes (Lee et al., 2010b; Tumbarello et 
al., 2012). Since gelsolin regulates actin cytoskeleton in many aspects, via 
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severing, capping, uncapping, and nucleating of actin filament (Silacci et al., 
2004), it is possible that gelsolin could modulate the steps of autophagy involving 
actin cytoskeleton. As we have shown that gelsolin enhances starvation- and 5-
FU-induced autophagy, it is therefore imperative to dissect the steps of autophagy 
in which gelsolin are involved. 
Besides the regulation of autophagy by a network of proteins, autophagy levels 
can also be regulated at the transcription level. Up to date, several transcription 
factors have been identified to regulate the expression of autophagy-related 
proteins. Some of the important transcription factors are the conserved forkhead 
box O (FOXO), E2F Transcription Factor 1 (E2F1), and transcription factor EB 
(TFEB), where they show autophagy promotion or inhibition function (Fiorentino 
et al., 2013; Liu et al., 2009; Xiong et al., 2012; Xu et al., 2011). Notably, gelsolin 
has been reported to affect the activity of several transcription factors (Kim et al., 
2007; Nishimura et al., 2003). It has been previously reported that gelsolin can 
modulate the mRNA levels of proteins like urokinase plasminogen (uPA) (Zhuo 
et al., 2012). Therefore, it is possible that gelsolin modulates the expression of 






To investigate the mechanism by which gelsolin promotes autophagy, the 
following studies will be addressed: 
1. Determine the regulation of gelsolin on mTOR activity. 
2. Investigate the role of gelsolin on mAtg9 trafficking. 
3. Examine the effects of gelsolin on lysosomal functions. 





4.3 Results  
4.3.1 The effect of gelsolin on autophagy is independent of mTOR 
During nutrient starvation, the mTOR complex 1 (mTORC1) is inactivated, 
leading to activation of downstream ULK1 complex and autophagy initiation 
(Ganley et al., 2009; Hosokawa et al., 2009). We sought to determine if gelsolin 
could affect mTORC1 activity to regulate autophagy. The mTORC1 activity was 
examined by the phosphorylation of ribosomal protein S6, which is 
phosphorylated by ribosomal protein S6 kinase upon mTOR activation (Ma and 
Blenis, 2009). Under nutrient rich conditions, phosphorylated S6 was detected 
(Figure 4.1 A&B). Starvation led to decreased phosphorylated S6 levels, 
indicating an inhibition of mTORC1 activity (Figure 4.1A&B). Nevertheless, the 
S6 phosphorylation was undetectable in both gelsolin-overexpressing cells and 
vector control cells after starvation in EBSS for 1 hour, suggesting a similar 
inhibition of mTORC1 activity in both cells (Figure 4.1A). Meanwhile, starvation 
in EBSS induced a time-dependent decrease in phosphorylated S6 levels in both 
gelsolin knockdown and control cells (Figure 4.1B). However, S6 
phosphorylation was not detected after 1 hour starvation in both gelsolin 
knockdown and control cells. Therefore, gelsolin expression does not affect the 







Figure 4.1 Gelsolin does not affect mTOR acitivity.  
A. Gelsolin-overexressing cells and vector control cells were starved in EBSS for 
indicated periods. B. Gelsolin siRNA or control siRNA transfected cells were 
treated with EBSS for the indicated period of time. The mTORC1 activities of 
cells treated in A and B were assessed using Western blotting for the S6 














EBSS 30m 60m 30m 60m




4.3.2 Gelsolin affects the trafficking of mAtg9  
It has been reported that the actin cytoskeleton and its regulatory proteins 
participate in the movement of Atg9, an essential protein that is required for 
autophagosome formation (Monastyrska et al., 2008; Reggiori et al., 2005a; Tang 
et al., 2011). In mammalian cells, mAtg9 (Atg9L1) cycles between TGN and a 
dispersed peripheral pool. Upon starvation, mAtg9 moves from TGN to the 
periphery sites (Tang et al., 2011; Young et al., 2006). We first examined the 
localization of mAtg9 by immunostaining of endogenous mAtg9 and TGN 
markers in gelsolin-overexpressing and vector control cells. Consistent with 
previous reports, we found that mAtg9 displayed an intense perinuclear staining 
as well as peripheral staining in both gelsolin-overexpressing and vector control 
cells. Moreover, the perinuclear mAtg9 seems to colocalize with TGN markers, 
TGN46 (Fig 4.2A). Such colocalization of mAtg9 with TGN is also observed 
using another TGN marker, golgin-97 (Figure 4.2B). To address the mechanism 
by which gelsolin mediates autophagy, we then examined if gelsolin could 
mediate the trafficking of mAtg9. The localization of mAtg9 (analysed by 
immunofluorescence) between gelsolin-overexpressing cells and vector control 
cells after starvation were compared. Under nutrient rich condition, mAtg9 in 
both gelsolin-overexpressing and vector control cells showed distinct perinuclear 
localization without distinct perinuclear staining (Figure 4.2C). During starvation 
by EBSS for respective 30 minutes and 60 minutes, mAtg9 in gelsolin-
overexpressing cells was dispersed to cytosol, showing diffuse peripheral staining 
(Fig 4.2C). The redistribution of mAtg9 to peripheral sites was not evident in 
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vector control cells. Therefore, gelsolin overexpression enhances the 
redistribution of mAtg9 from TGN to peripheral sites upon starvation, suggesting 







Figure 4.2 Gelsolin overexpression enhances trafficking of Atg9A.  
A. Gelsolin-overexpressing cells and vector control cells were cultured in full 
medium before fixation and staining with antibodies against mAtg9 and TGN46. 
The localizations of mAtg9 and TGN46 were visualized under a confocal 
microscope. B. Gelsolin-overexpressing cells and vector control cells were treated 
and fixed as described in A. After fixation, cells were stained with antibodies 
against mAtg9 and golgin-97. The localizations of mAtg9 and golgin-97 were 
examined as described in A. Representative pictures of gelsolin-overexpressing 
and vector control cells were shown. Arrow head indicates co-localization. Scale 
car: 20 µm. Co-localization analysis was performed using colocalization plugin of 





































Figure 4.2 (continued) Gelsolin overexpression enhances trafficking of 
Atg9A.  
C. Gelsolin-overexpressing cells and vector control cells were cultured in full 
medium or starved in EBSS for the indicated period. Subsequently, cells were 
fixed, permeabilized and stained with mAtg9A antibody and counterstained with 
Hoechst. The mAtg9 localization was visualized using confocal microscopy. 
Scale bar: 20 µm. D. The percentage of cells with diffuse staining pattern of 
mAtg9 was quantified by manual counting. More than 200 cells were counted for 
each sample per experiment. The average value with SE of at least three 
independent experiments was shown (*P<0.05 by student’s t-test).  
  














































4.3.3 Gelsolin interacts with mAtg9 
A few actin regulatory proteins, such as non-muscle myosin II, have been shown 
to interact with Atg9 and mediate its trafficking (Monastyrska et al., 2008; Tang 
et al., 2011). We sought to check if gelsolin physically interacts with mAtg9. 
Proximity ligation assay, which detects protein-protein interaction in situ (Koos et 
al., 2014), was performed in HCT116 cells. Cells were stained with mAtg9 
antibody and gelsolin antibody followed by PLA reagents, and the appearance of 
red fluorescent signals indicates the interaction of these two proteins in situ. There 
were PLA signals when cells were cultured under full medium (Fig 4.3A), 
suggesting an interaction or close proximity of mAtg9 and gelsolin. PLA signals 
were not detected in cells stained with only one antibody (either mAtg9 or 
gelsolin antibody) or IgG isotype control, suggesting that signals are not 
background signals. Moreover, the PLA signals increased during starvation (Fig 
4.3A), indicating that the association of mAtg9 and gelsolin may be enhanced by 
starvation.  
To validate the interaction of mAtg9 and gelsolin as seen by PLA assay, co-
immunoprecipitation was performed. Consistent with our findings on PLA, 
gelsolin was detected in the immunoprecipitates of mAtg9 in HCT116 cells, as 
observed in Figure 4.3B. A reverse immunoprecipitation was also performed to 
further validate the finding. Consistently, mAtg9 was detected after pulling down 
gelsolin (Figure 4.4B). In addition, NM myosin II, which is known to interact 
with both mAtg9 and gelsolin (Arora et al., 2011; Tang et al., 2011), was also 
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detected in both experiments, validating the pull-down results. Therefore, this 
suggests that gelsolin and mAtg9 are potential interacting partners that may be 





Figure 4.3  Gelsolin interacts with mAtg9.  
A. HCT116 cells were cultured in full medium or starved in EBSS for 60 minutes 
before fixation and staining with gelsolin and mAtg9 antibody. Subsequently, 
proximity ligation assay (PLA) was performed following manufacturer's protocol. 
Nuclei were counterstainned with DAPI. PLA signals (red fluoresence) were 
detected using a fluorescene microscope. Single antibody (Ab) control was 
performed using indicated antibody with the isotype control for the other 
antibody. IgG control were perforemd by stainning cells with both IgG isotypes 
for gelsolin and mAtg9 antibody. Data is a representative of at least three 
















Figure 4.3 (continued) Gelsolin interacts with mAtg9.  
B. Endogenous mAtg9 was immunoprecipitated from lysate of HCT116 cells 
using mAtg9 antibody (produced in rabbit). Rabbit IgG was used as negative 
control. C. Endogenous gelsolin was pulled down from lysate of HCT116 cells 
using gelsolin antibody (produced in mouse) respectively. Mouse IgG was used as 
negative control. The immunoprecipitates (from B and C) and total cell lysate 
(input) were analysed by Western blot. Data shown was a representative of three 






4.3.4 Gelsolin affects the lysosomal enzyme activity 
The last step of autophagy involves the fusion of autophagosomes to lysosomes 
and degradation of unwanted components inside the autolysosomes (Shen and 
Mizushima, 2014). ). The degradation of delivered cytosolic contents is executed 
by the release of proteolytic lysosomal enzymes such as cathepsin B and 
cathepsin L (Dennemarker et al., 2010; Tatti et al., 2013; Zhou et al., 2013). In 
order to check if gelsolin could affect degradation ability, the activities of 
cathepsin B and L were examined in gelsolin-overexpressing and vector control 
cells using fluorogenic substrates of cathepsin B and L coupled with flow 
cytometric analysis of fluorescence intensity, as described in Materials and 
Methods (Creasy et al., 2007; Zhou et al., 2013). Bafilomycin A1 (BA) was used 
as negative control, as it is an inhibitor of V-ATPase and thus inhibits lysosome 
acidification and lysosome enzyme activation (Yamamoto et al., 1998). 
Interestingly, under nutrient-rich conditions, gelsolin overexpression resulted in a 
higher cathepsin B activity (Figure 4.4A&B), and BA treatment effectively 
blocked the activity of cathepsin B in both gelsolin-overexpressing and vector 
control cells. The activity of cathepsin B was further increased by starvation in 
both cells, and gelsolin-overexpressing cells exhibited a higher cathepsin B 
activity compared to vector control cells. Similar results were also observed for 
cathepsin L activity (Figure 4.4C&D). Therefore, gelsolin may also promote 
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Figure 4.4 Gelsolin overexpression increases lysosomal enzyme activity.  
A. Gelsolin overexpression increases cathepsin B activity. Gelsolin-
overexpressing cells and vector control cells were cultured in full medium (vector 
and GSN controls) or starved with EBSS for the indicated periods. Bafilomycin 
treatment (in full medium) was used as negative controls (Vector and GSN 
Bafilomycin). At the last 30 minutes of treatments, Magic Red Cathepsin B 
reagents were added to cells. Cells were harvested and red fluorescence was 
analysed by flow cytometry using FL3 channel. Data shown was representative of 
three independent experiments. B. Cathepsion B activities were quantified by the 
medium fluorescence, and presented as fold change to vector control cells under 
nutrient rich conditions of at least three independent experiments (*p<0.05, t-test). 
C. Gelsolin overexpression increases cathepsin L activity. Gelsolin-
overexpressing cells and vector control cells were cultured in full medium (vector 
and GSN controls) or starved with EBSS for the indicated periods. At the last 30 
minutes of treatments, Magic Red Cathepsin L reagents were added to cells. Cells 
were harvested and red fluorescence was analysed by flow cytometry using FL3 
channel. Data shown was representative of three independent experiments. D. 
Cathepsion L activities were quantified by the medium fluorescence, and 
presented as fold change to vector control cells under nutrient rich conditions of at 





4.3.5 Gelsolin affects mRNA levels of autophagy-related genes 
The mRNA levels of several autophagy-related genes have been reported to be 
altered, leading to either promotion or inhibition of autophagy (Liu et al., 2009; 
Pike et al., 2012; Xu et al., 2011). To assess if gelsolin expression is associated 
with any gene expression of autophagy-related proteins, microarray data from 
1820 colon carcinoma samples were analysed (Method and Figure S1 in 
Appendix I). Spearman’s correlation coefficient (Rho) between expression levels 
of autophagy-related genes and gelsolin expression was determined, and statistical 
significance was evaluated by Spearman correlation test. Our results showed that 
mRNA levels of gelsolin positively correlate with mRNA levels of several 
autophagy-related genes (Table 4.1). Amongst the autophagy-related genes 
examined, GABARAP (Gamma-aminobutyric acid receptor-associated protein), 
GABARAPL1 (Gamma-aminobutyric acid receptor-associated protein like 1), 
and GABARAPL2 (Gamma-aminobutyric acid receptor-associated protein like 
2), which are the family members of mammalian Atg8-related proteins controlling 
autophagosome formation (Kabeya et al., 2004; Weidberg et al., 2010), showed 
positive correlation with gelsolin expression. A few proteins that participate in 
autophagosome formation, including Atg7, PI3KC3 (also called Vps34, the 
catalytic subunit of class III PI3K), and WD repeat and FYVE domain containing 
3 (WDFY3) (Kaiser et al., 2013; Komatsu et al., 2005; Simonsen et al., 2004; 
Simonsen and Tooze, 2009), also showed increased expression levels with 
increased gelsolin expression (Table 4.1). Notably, cathepsin B, cathepsin D, and 
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cathepsin L, which are important lysosomal enzymes, were also among the 
proteins showing positive correlation with gelsolin (Table 4.1).  
We sought to validate if manipulating gelsolin levels could affect the gene 
expression of above mentioned proteins. The mRNA levels of autophagy-related 
genes were quantified by real-time PCR in gelsolin-overexpressing cells and 
vector control cells. Among the genes screened, the mammalian Atg8-related 
proteins, GABARAP and GABARAPL2 showed increased mRNA expressions in 
gelsolin-overexpressing cells (Figure 4.5A). The mRNA levels of PI3KC3 and 
Atg7, which are proteins that are known to participate in autophagosome 
formation, was also higher in gelsolin-overexpressing cells (Figure 4.5B). 
Moreover, the mRNA levels of cathepsin B and D were upregulated in gelsolin-
overexpressing cells (Figure 4.5C). When protein levels were examined, there 
were increased cathepsin B and L protein levels in gelsolin-overexpressing cells 
compared to control cells (Figure 4.5D). Therefore, data from here indicate that 






Table 4.1 Gelsolin expression positively associates with expression of several 
autophagy-related genes.  
Gene expression microarray data of colon cancer on U133A or U133Plus2 
platform were extracted from Gene Omnibus (GEO), and a final dataset of 1,820 
colon carcinoma was used. The association of gelsolin gene expression and 
autophagy-related genes expression was analysed. Genes with Rho value bigger 
than 0.2 were shown. Statistical significance was evaluated by Spearman 
correlation test. 
  
Protein name Rho p-value 
GABARAPL2 0.244 7.27E-26 
GABARAP 0.35 3.80E-53 
GABARAPL1 0.448 1.46E-89 
Atg7 0.22 2.76E-21 
PIK3C3 0.228 1.13E-22 
WDFY3 0.236 2.43E-24 
Cathepsin L 0.307 1.42E-40 
Cathepsin B 0.332 1.54E-47 













































































































































Figure 4.5 Gelsolin overexpression increases genes involved in autophagy.  
Total RNA were extracted from gelsolin-overexpressing cells and vector control 
cells and reverse transcribed into cDNA. The mRNA levels were quantified by 
real-time PCR. GAPDH was used as internal control for gelsolin-overexpressing 
cells and vector control cells. Gene expression of designated gene was expressed 
as fold change relative to vector control cells. A. The mRNA levels of LC3 
isoforms in gelsolin-overexpressing cells and vector control cells were shown. B. 
The mRNA levels of genes regulating autophagosome formation were shown. C. 
The mRNA levels of lysosomal enzymes were assessed. Data was represented as 











4.4 Discussion  
4.4.1 Gelsolin enhances trafficking of Atg9  
As gelsolin has been found to protect the cells from death during starvation 
conditions (Chapter 3), we further explored the role of gelsolin in the regulation 
of autophagy in this study. Here, we have demonstrated that gelsolin could 
positively affect the trafficking of Atg9. It is well-established that Atg9 is 
essential for autophagosome formation in both yeast and mammals as knockdown 
of Atg9 leads to impaired autophagosome formation and autophagic degradation 
of long lived proteins (Lang et al., 2000; Noda et al., 2000; Young et al., 2006). 
Moreover, as the only transmembrane protein in the core Atg proteins, Atg9 is 
thought to mediate lipid delivery to form autophagosomes. Indeed, Yamamoto et 
al showed that yeast Atg9 is integrated into outer membranes of autophagosomes 
and vesicles containing Atg9 contribute to autophagosome formation (Yamamoto 
et al., 2012). The transport of Atg9 is also important for its function in the 
autophagosome formation. In yeast, Atg9 cycles between peripheral pools like 
Golgi and PAS, a putative site for autophagosome to assemble (Mari et al., 2010; 
Reggiori et al., 2005b; Sekito et al., 2009; Yamamoto et al., 2012). The location 
of mAtg9 also displays a cyclic manner like its yeast counterpart, as mAtg9 cycles 
between perinuclear regions like the trans-Golgi network and peripheral sites like 
late endosomes (Takahashi et al., 2011; Tang et al., 2011; Young et al., 2006). 
Under starvation, a proportion of mAtg9 translocates from TGN to peripheral 
sites like late endosomes (Tang et al., 2011; Young et al., 2006). In agreement 
with these findings, we also observed that mAtg9 locates trans-Golgi network and 
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peripheral sites (Figure 4.3A&B). Under starvation, mAtg9 was observed to 
redistribute from perinuclear localization to diffuse cytosolic sites, and the 
redistribution of mAtg9 is more obvious in gelsolin-overexpressing cells (Figure 
4.2C). 
In fact, the trafficking of Atg9 is dependent on a few factors, such as ULK1 
(Young et al., 2006). As the cytoskeleton plays a central role in vesicle 
trafficking, it is not surprising that the transport of Atg9 is regulated by actin 
cytoskeleton. Indeed, both yeast and mammalian studies suggest an essential role 
of actin cytoskeleton in Atg9 trafficking. For example, the actin cytoskeleton 
mediates the anterograde trafficking of Atg9 from periphery sites to PAS in yeast 
(He et al., 2006; Monastyrska et al., 2008; Reggiori et al., 2005a). Moreover, the 
actin regulatory proteins have been demonstrated to regulate trafficking process. 
The actin nucleating factor Arp2 and actin motor protein myosin II interact with 
Atg9 and regulate its anterograde trafficking in yeast and mammals respectively 
(Monastyrska et al., 2008; Tang et al., 2011). These findings highlight the 
function of actin polymerization and actin-dependent movement in regulating 
Atg9 trafficking. Here we demonstrate that gelsolin, an actin regulatory protein 
that can regulate actin severing and capping, also plays a role in Atg9 trafficking. 
We showed that gelsolin enhances the movement of Atg9 from perinuclear sites 
to peripheral sites after starvation (Figure 4.2C). Gelsolin is an actin regulatory 
protein that controls actin cytoskeleton in different aspects. Gelsolin can sever 
long actin filaments into shorter filaments. After severing, gelsolin remains bound 
to and caps the fast growing end of actin filament. Once inactivated by PIP2, 
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gelsolin detaches from and uncaps the fast growing end, enabling polymerization 
to happen (Silacci et al., 2004). Gelsolin may enhance the depolymerization of 
actin filaments via severing and capping, and it may also contribute to actin 
polymerization via uncapping to release more free fast growing ends. Moreover, 
gelsolin could contribute to the turnover of actin filaments (Silacci et al., 2004). 
Due to its role in actin remodelling, gelsolin has been reported to mediate a few 
cellular processes involving membrane remodelling and trafficking. For example, 
gelsolin has been shown to mediate collagen phagocytosis (Arora et al., 2005), 
and endocytosis of vacuolar H
+
-ATPase (V-ATPase) (Beaulieu et al., 2005). Our 
findings on gelsolin suggest that the dynamics of actin cytoskeleton and 
remodelling of the actin cytoskeleton is important in regulating Atg9 trafficking. 
However, since gelsolin has several functions on the actin cytoskeleton such as 
severing and capping, future work needs to address which actin remodelling 
function of gelsolin is crucial for its role in Atg9 trafficking.  
A few proteins have been reported to interact with Atg9 to regulate its transport, 
such as the MAPK-interacting protein, p38IP (Webber and Tooze, 2010). The 
actin regulator proteins Arp2 and myosin II have also been reported to bind to 
Atg9 to mediate its trafficking (Monastyrska et al., 2008; Tang et al., 2011). Here 
we identified that gelsolin is another novel interacting partner of Atg9. 
Interestingly, the interaction of gelsolin and mAtg9 is increased by starvation as 
suggested by the PLA assay (Figure 4.3A). Although the consequences of their 
interaction are not known yet, it is possible that gelsolin is recruited by Atg9 to 
remodel the actin cytoskeleton for the redistribution of mAtg9. Moreover, gelsolin 
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is found to interact with NM myosin II to mediate collagen phagocytosis (Arora et 
al., 2011). NM myosin II is also reported to bind to mAtg9, the activation of NM 
myosin II is required for mAtg9 trafficking (Tang et al., 2011). Consistent with 
their finding, we also observed the interaction of gelsolin and mAtg9 with NM 
myosin II (Figure 4.3B&C). It is possible that gelsolin, NM myosin II, and mAtg9 
are present in a protein complex, whereby gelsolin remodels the actin 
cytoskeleton whilst NM myosin II directs the trafficking of mAtg9. Interestingly, 
gelsolin seems to regulate the activation of NM myosin II, as knockout of gelsolin 
leads to decreased phosphorylation of myosin light chain, which is required for 
the activation of non-muscle myosin II (Arora et al., 2011). Moreover, the direct 
interaction between gelsolin and myosin II has been reported to promote myosin 
filament assembly in vitro (Arora et al., 2011). Therefore, gelsolin may also 
enhance the activation of NM myosin II to promote the myosin-dependent 
trafficking of mAtg9, and it is an interesting topic to study in future. 
4.4.2 Gelsolin may affect autophagy independently of mTOR or downstream 
of mTOR  
One of the most important nutrient sensors of the autophagy machinery is 
mTORC1. Under nutrient rich conditions, mTORC1 phosphorylates ULK1, 
leading to suppression of autophagy (Ganley et al., 2009; Hosokawa et al., 2009). 
It is known that under starvation condition, mTORC1 is inactivated, leading to 
activation of ULK1 and autophagy induction (Ganley et al., 2009; Hosokawa et 
al., 2009). Nevertheless, our results show that neither knockdown of gelsolin nor 
overexpression of gelsolin could affect mTORC1 activity (Figure 4.1). This 
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suggests that the effect of gelsolin on autophagy is likely to be mTOR-
independent. It may be also possible that the regulation of autophagy by gelsolin 
is downstream of mTORC1. However, it does not exclude the possibility that 
gelsolin may affect the initiation process of autophagy by affecting ULK1 
activity. We showed that gelsolin mediates the trafficking of mAtg9. Notably, 
mAtg9 redistribution from TGN is dependent on ULK1 kinase activity (Tang et 
al., 2011; Young et al., 2006). Therefore, it needs to be further evaluated if 
gelsolin could affect the ULK1 complex activity and autophagy initiation process. 
4.4.3 Gelsolin affects transcriptional levels of autophagy-regulatory proteins  
We found that mRNA levels of several autophagy-related genes are affected by 
gelsolin expression. These genes include proteins involved in both early and late 
autophagy including PIK3C3, family members of mammalian Atg8 homolog, and 
cathepsins. Notably, gelsolin has been reported to modulate the gene expression 
levels of several proteins like urokinase-type plasminogen activator (uPA), which 
is essential for cancer invasion (Zhuo et al., 2012). The mechanism of gelsolin on 
regulating gene expression could be attributed to its roles in affecting the activity 
of transcription factors, such as hormone receptors (Kim et al., 2007; Nishimura 
et al., 2003). For instance, gelsolin is a coactivator of androgen receptor by 
interacting with androgen receptor to enhance its transactivation activity 
(Nishimura et al., 2003). In addition, gelsolin is also reported to increase activities 
of glucocorticoid receptor, estrogen receptor, peroxisome proliferating activator 
receptor γ (PPARγ) (Nishimura et al., 2003). There is evidence suggesting that 
gelsolin interacts with other transcription factors including HIF-1α and thyroid 
113 
 
receptor β1 (Kim et al., 2007; Li et al., 2009a). The interaction between gelsolin 
and above mentioned nuclear receptors occur at the DNA binding sites of these 
nuclear receptors, suggesting that gelsolin could affect their transcription activity 
(Kim et al., 2007; Li et al., 2009a; Nishimura et al., 2003). More recently, gelsolin 
has also been reported to affect the complex of estrogen receptor α (ERα) with 
nuclear actin, which has a role in regulating transcription processes (Ambrosino et 
al., 2010; Gettemans et al., 2005). Interestingly, gelsolin is present in the nuclear 
complex of ERα, suggesting that gelsolin may be directly involved in the ERα 
transcriptional machinery (Ambrosino et al., 2010). The possible direct 
involvement of gelsolin in transcription machinery is supported by studies 
showing the presence of gelsolin in the nucleus (Kim et al., 2007; Nishimura et 
al., 2003; Zhuo et al., 2012). Therefore, in our study, we postulate that it is 
possible for gelsolin to affect activities of transcription factors controlling 
expression of genes in the autophagy pathway.  
The transcription of autophagy-related genes is regulated by a few transcription 
factors. The conserved forkhead box O (FOXO) proteins generally activate 
autophagy via increasing transcription of a few autophagic proteins including 
ATG5, ATG12, ATG14, BECN1, BNIP3, LC3, and VPS34 (Fiorentino et al., 
2013; Liu et al., 2009; Xiong et al., 2012; Xu et al., 2011). Another transcription 
factor, transcription factor EB (TFEB), an important regulator of lysosome 
biogenesis, can also contribute to autophagy via transcriptional regulation. The 
gene targets of TFEB include lysosome-related genes such as lysosomal 
hydrolases (including cathepsins) and autophagy-related genes (ATG4, ATG9, 
114 
 
LC3 etc.) (Palmieri et al., 2011; Settembre et al., 2013). Other transcription 
factors involved in autophagy regulation are E2F1, HIF1, ATF, NF-κB (Bellot et 
al., 2009; Copetti et al., 2009; Pike et al., 2012; Polager et al., 2008; Shaw et al., 
2008). It is possible that gelsolin may affect some of these transcription factors 
such as FOXO and TFEB to regulate the gene expression of autophagy-related 
proteins. Future work should be performed to identify possible transcription 
factors involved in gelsolin-mediated gene changes in the modulation of 
autophagy process. 
4.4.4 Gelsolin promotes lysosomal functions  
One important aspect of autophagy is autophagosome maturation and degradation, 
which involves fusion with lysosome and degradation by the lysosomal enzymes 
(Shen and Mizushima, 2014). We showed that gelsolin overexpression increases 
the activities of cathepsins B and L, which are important lysosomal proteases 
(Dennemarker et al., 2010; Tatti et al., 2013; Zhou et al., 2013). Thus, in addition 
to its roles in autophagosome formation, gelsolin may promote lysosomal 
degradative activity to mediate the late stage of autophagy. Notably, there is 
evidence that particular molecules can regulate both early and late autophagy. For 
instance, mTORC1 has been well-known for its suppression of autophagy via 
inactivating ULK1 complex involved in early autophagy (Hosokawa et al., 2009; 
Jung et al., 2009). In addition, recent studies reveal that the inhibition of 
autophagy by mTORC1 can be executed via suppression of lysosomal function, 
which is involved in the later autophagic degradation phase (Zhou et al., 2013). 
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We observed an increase in lysosomal enzyme activity after starvation; which is 
consistent with previous reports (Zhou et al., 2013). In Drosophila fat body, 
starvation leads to decreased pH of lysosomes/autolysosomes (Scott et al., 2004). 
In yeast, lysosomal enzyme activity as well as lysosomal antimicrobial activity 
are increased by starvation (Yoon et al., 2010). Such starvation-dependent 
increase in lysosomal function is also observed in mammalian cells (Zhou et al., 
2013). Interestingly, fusion of autophagosome and lysosome seems to enhance the 
reduction of lysosome pH and lysosomal enzyme activity (Zhou et al., 2013). 
Notably, the actin cytoskeleton is essential in autophagosome-lysosome fusion in 
quality control autophagy (Lee et al., 2010b). Cortactin, a critical protein 
mediating actin polymerization, is recruited to protein aggregates and regulate the 
autophagosome-lysosome fusion (Lee et al., 2010b). Therefore, the actin 
cytoskeleton and its regulator proteins may enhance lysosomal/autolysosomal 
function via promoting autophagosome-lysosome fusion. Interestingly, we also 
observed higher lysosomal enzyme activity in gelsolin-overexpressing cells 
compared to control cells under starvation (Figure 4.4). A possible reason for the 
increase in cathepsin B activity is due to the increased cathepsin B expression 
detected in gelsolin-overexpressing cells (as shown in figure 4.5). Another 
possibility may be that gelsolin, as an actin-regulating protein, also promotes the 
fusion of autophagosomes and lysosomes to enhance lysosomal activity. 
However, whether gelsolin can promote the fusion of autophagosomes and 





In summary, our data suggests that gelsolin can modulate autophagy at different 
stages. Gelsolin promotes the trafficking of mAtg9 from trans-Golgi network to 
peripheral sites, which can contribute to autophagosome formation. Gelsolin 
interacts with mAtg9, which may contribute to its regulation on mAtg9 trafficking. 
Moreover, gelsolin may promote late stage autophagy via increasing activities of 
cathepsin B and cathepsin L, which are important lysosomal enzymes. The 
enhanced activities of cathepsin B and L might be due to increased protein and 
mRNA expressions by gelsolin overexpression. In addition, we provide evidence 
showing that gelsolin may regulate the mRNA expression levels of autophagy-
related genes, which include genes participating in autophagosome formation 
(PIK3C3, Atg7, GABARAP, GABARAPL1, GABARAPL2) and autophagic 



































Chapter 5 Conclusion and future work 
5.1 Summary of evidence 
In this study, we provide evidence for the pro-survival role of gelsolin in 
colorectal cancer cells against starvation and 5-FU treatment. Autophagy, an 
important pro-survival pathway especially during starvation, was found to be 
modulated by gelsolin expression. Gelsolin overexpression promoted stress-
induced autophagy, whilst knockdown of gelsolin reduced autophagic levels. 
Moreover, the protective effect of gelsolin against both starvation and 5-FU was 
dependent on autophagy, suggesting a critical role of autophagy in gelsolin-
mediated cell survival. Therefore, gelsolin confers protective effect on colorectal 
cancer cells via modulating autophagic levels. 
In an attempt to dissect the mechanisms by which gelsolin promotes autophagy, 
mAtg9 was found to be positively affected by gelsolin expression. The trafficking 
of mAtg9 from perinuclear sites to peripheral pools was observed to be enhanced 
by gelsolin overexpression. Moreover, mAtg9 seems to interact with gelsolin, 
which might contribute to its trafficking. Gelsolin may also promote autophagy at 
late stages, as suggested by increased lysosomal enzyme activities as well as 
expression levels when gelsolin was overexpressed. In addition, gelsolin may also 
upregulate the expression of autophagy-related proteins, including PIK3C3, 
mammalian Atg8 homologue family members (GABARAP, GABARAPL1, 
GABARAPL2), and cathepsins (cathepsin B and D). This thus opens another 
avenue for studying gelsolin’s roles in autophagy regulation.  
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In conclusion, this study suggests a novel role of gelsolin in promoting cancer cell 
survival via enhancing autophagy during cellular stress. Our new findings on 
gelsolin support a pro-cancer survival role of gelsolin. Taken together with its 
pro-invasive effect, gelsolin may exert its oncogenic effects on cancer via 
promoting cell survival and cancer spread. Moreover, our results suggest that 
cancer cells with higher gelsolin expression are more sensitive to autophagy 
blockage under stresses. Therefore, a potential strategy to address resistance of 
tumour cells to death may be to combine autophagy inhibitors with chemotherapy 
in treating cancers (especially those with high gelsolin expression), in order to 



































5.2 Future work 
We have demonstrated that gelsolin affects autophagy via promoting the 
trafficking of mAtg9. However, whether the actin severing function of gelsolin is 
involved in the trafficking process is not known yet at present. Gelsolin mutants 
with severing defects can be generated and transfected into cells to study the 
effect on mAtg9 trafficking as well as in autophagy regulation. If severing activity 
is required, severing mutant would not enhance the trafficking of mAtg9 
compared to wild-type gelsolin. 
This study has also demonstrated that gelsolin is a potential interacting partner of 
mAtg9. However, the functional significance of their interaction is unclear 
presently. Interestingly, both gelsolin and mAtg9 have been reported to interact 
with non-muscle myosin II (Arora et al., 2011; Tang et al., 2011). In fact, the 
trafficking of mAtg9 is dependent on the activation of NM myosin II, and gelsolin 
is required for the phosphorylation of myosin light chain, which is critical in NM 
myosin activation. Therefore, it is conceivable that gelsolin may enhance the 
activation of NM myosin II to promote the myosin II-dependent trafficking of 
mAtg9. The activation of NM myosin II can be detected by examining myosin 
light chain phosphorylation in gelsolin-overexpressing cells and vector control 
cells. Moreover, blebbistatin, a pharmacological inhibitor for myosin II (Kovacs 
et al., 2004), can be used to examine if it can attenuate the effect of gelsolin 
overexpression on mAtg9 trafficking. 
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Moreover, we have demonstrated that gelsolin affects the mRNA levels of a few 
autophagy-related genes. Expression of these autophagy-related genes is under the 
control of transcription factors, such as TFEB and FOXO. It is interesting to know 
if gelsolin could enhance their transactivation activity. To test this, luciferase 
assay can be performed to determine if the activities of these transcription factors 
are influenced by gelsolin overexpression or knockdown in cells. Moreover, 
Chromatin Immunoprecipitation (ChIP) can be done to examine if gelsolin could 
bind to the promote region of the autophagy-related genes (either direct binding or 
indirect binding) for autophagy regulation. 
Our in vitro study has revealed a protective effect of gelsolin against both 
starvation and 5-FU treatment. It is interesting to investigate if gelsolin can also 
help tumours to survive under chemotherapeutic treatment in vivo. Gelsolin-
overexpressing HCT116 cells and vector control cells can be injected into mouse 
to develop tumour xenograft models. After establishing tumours in mouse, mouse 
can be treated with 5-FU. The tumour size after 5-FU treatment can be compared 
between gelsolin-overexpressing and vector control groups to examine if gelsolin 









Aguilera, M.O., Beron, W., and Colombo, M.I. (2012). The actin cytoskeleton participates 
in the early events of autophagosome formation upon starvation induced autophagy. 
Autophagy 8, 1590-1603. 
Amaravadi, R.K., and Thompson, C.B. (2007). The roles of therapy-induced autophagy 
and necrosis in cancer treatment. Clinical cancer research : an official journal of the 
American Association for Cancer Research 13, 7271-7279. 
Ambrosino, C., Tarallo, R., Bamundo, A., Cuomo, D., Franci, G., Nassa, G., Paris, O., Ravo, 
M., Giovane, A., Zambrano, N., et al. (2010). Identification of a hormone-regulated 
dynamic nuclear actin network associated with estrogen receptor alpha in human breast 
cancer cell nuclei. Molecular & cellular proteomics : MCP 9, 1352-1367. 
Andrea, C., Fausto, P., Francesca, B.K., Mary, C., Mara, G., Veronica, L., and Sandro, B. 
(2014). Which strategy after first-line therapy in advanced colorectal cancer? World 
journal of gastroenterology : WJG 20, 8921-8927. 
Arora, P.D., Chan, M.W., Anderson, R.A., Janmey, P.A., and McCulloch, C.A. (2005). 
Separate functions of gelsolin mediate sequential steps of collagen phagocytosis. 
Molecular biology of the cell 16, 5175-5190. 
Arora, P.D., Wang, Y., Janmey, P.A., Bresnick, A., Yin, H.L., and McCulloch, C.A. (2011). 
Gelsolin and non-muscle myosin IIA interact to mediate calcium-regulated collagen 
phagocytosis. The Journal of biological chemistry 286, 34184-34198. 
Asch, H.L., Head, K., Dong, Y., Natoli, F., Winston, J.S., Connolly, J.L., and Asch, B.B. 
(1996). Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer 
research 56, 4841-4845. 
Ashish, Paine, M.S., Perryman, P.B., Yang, L., Yin, H.L., and Krueger, J.K. (2007). Global 
structure changes associated with Ca2+ activation of full-length human plasma gelsolin. 
The Journal of biological chemistry 282, 25884-25892. 
Azuma, T., Koths, K., Flanagan, L., and Kwiatkowski, D. (2000). Gelsolin in complex with 
phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic 
progression. The Journal of biological chemistry 275, 3761-3766. 
Azuma, T., Witke, W., Stossel, T.P., Hartwig, J.H., and Kwiatkowski, D.J. (1998). Gelsolin 
is a downstream effector of rac for fibroblast motility. The EMBO journal 17, 1362-1370. 
Band, M., Joel, A., Hernandez, A., and Avivi, A. (2009). Hypoxia-induced BNIP3 
expression and mitophagy: in vivo comparison of the rat and the hypoxia-tolerant mole 
rat, Spalax ehrenbergi. FASEB journal : official publication of the Federation of American 
Societies for Experimental Biology 23, 2327-2335. 
Beaulieu, V., Da Silva, N., Pastor-Soler, N., Brown, C.R., Smith, P.J., Brown, D., and 
Breton, S. (2005). Modulation of the actin cytoskeleton via gelsolin regulates vacuolar 
H+-ATPase recycling. The Journal of biological chemistry 280, 8452-8463. 
Bellot, G., Garcia-Medina, R., Gounon, P., Chiche, J., Roux, D., Pouyssegur, J., and 
Mazure, N.M. (2009). Hypoxia-induced autophagy is mediated through hypoxia-
inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Molecular and 
cellular biology 29, 2570-2581. 
Bjorkoy, G., Lamark, T., Brech, A., Outzen, H., Perander, M., Overvatn, A., Stenmark, H., 
and Johansen, T. (2005). p62/SQSTM1 forms protein aggregates degraded by autophagy 
123 
 
and has a protective effect on huntingtin-induced cell death. The Journal of cell biology 
171, 603-614. 
Burtnick, L.D., Koepf, E.K., Grimes, J., Jones, E.Y., Stuart, D.I., McLaughlin, P.J., and 
Robinson, R.C. (1997). The crystal structure of plasma gelsolin: implications for actin 
severing, capping, and nucleation. Cell 90, 661-670. 
Burtnick, L.D., Urosev, D., Irobi, E., Narayan, K., and Robinson, R.C. (2004). Structure of 
the N-terminal half of gelsolin bound to actin: roles in severing, apoptosis and FAF. The 
EMBO journal 23, 2713-2722. 
Cai, Y., Wan, Z., Sun, T., Shi, Y., Sun, Y., Huang, P., Li, S., and Jiang, W. (2013). 
Diarylquinoline compounds induce autophagy-associated cell death by inhibiting the Akt 
pathway and increasing reactive oxygen species in human nasopharyngeal carcinoma 
cells. Oncology reports 29, 983-992. 
Cecconi, F., and Levine, B. (2008). The role of autophagy in mammalian development: 
cell makeover rather than cell death. Developmental cell 15, 344-357. 
Chan, E.Y., Kir, S., and Tooze, S.A. (2007). siRNA screening of the kinome identifies ULK1 
as a multidomain modulator of autophagy. The Journal of biological chemistry 282, 
25464-25474. 
Chan, E.Y., Longatti, A., McKnight, N.C., and Tooze, S.A. (2009). Kinase-inactivated ULK 
proteins inhibit autophagy via their conserved C-terminal domains using an Atg13-
independent mechanism. Molecular and cellular biology 29, 157-171. 
Chellaiah, M., Kizer, N., Silva, M., Alvarez, U., Kwiatkowski, D., and Hruska, K.A. (2000). 
Gelsolin deficiency blocks podosome assembly and produces increased bone mass and 
strength. The Journal of cell biology 148, 665-678. 
Chen, Y., and Klionsky, D.J. (2011). The regulation of autophagy - unanswered questions. 
Journal of cell science 124, 161-170. 
Cheong, H., Yorimitsu, T., Reggiori, F., Legakis, J.E., Wang, C.W., and Klionsky, D.J. 
(2005). Atg17 regulates the magnitude of the autophagic response. Molecular biology of 
the cell 16, 3438-3453. 
Chhabra, D., Nosworthy, N.J., and dos Remedios, C.G. (2005). The N-terminal fragment 
of gelsolin inhibits the interaction of DNase I with isolated actin, but not with the cofilin-
actin complex. Proteomics 5, 3131-3136. 
Choe, H., Burtnick, L.D., Mejillano, M., Yin, H.L., Robinson, R.C., and Choe, S. (2002). The 
calcium activation of gelsolin: insights from the 3A structure of the G4-G6/actin 
complex. Journal of molecular biology 324, 691-702. 
Choi, J.H., Yoon, J.S., Won, Y.W., Park, B.B., and Lee, Y.Y. (2012). Chloroquine enhances 
the chemotherapeutic activity of 5-fluorouracil in a colon cancer cell line via cell cycle 
alteration. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 120, 
597-604. 
Chou, J., Stolz, D.B., Burke, N.A., Watkins, S.C., and Wells, A. (2002). Distribution of 
gelsolin and phosphoinositol 4,5-bisphosphate in lamellipodia during EGF-induced 
motility. The international journal of biochemistry & cell biology 34, 776-790. 
Codogno, P., Mehrpour, M., and Proikas-Cezanne, T. (2012). Canonical and non-
canonical autophagy: variations on a common theme of self-eating? Nature reviews 
Molecular cell biology 13, 7-12. 
Copetti, T., Bertoli, C., Dalla, E., Demarchi, F., and Schneider, C. (2009). p65/RelA 




Coppola, D., Oliveri, C., Sayegh, Z., Boulware, D., Takahashi, Y., Pow-Sang, J., Djeu, J.Y., 
and Wang, H.G. (2008). Bax-interacting factor-1 expression in prostate cancer. Clinical 
genitourinary cancer 6, 117-121. 
Creasy, B.M., Hartmann, C.B., White, F.K., and McCoy, K.L. (2007). New assay using 
fluorogenic substrates and immunofluorescence staining to measure cysteine cathepsin 
activity in live cell subpopulations. Cytometry Part A : the journal of the International 
Society for Analytical Cytology 71, 114-123. 
Davis, F.M., Stewart, T.A., Thompson, E.W., and Monteith, G.R. (2014). Targeting EMT in 
cancer: opportunities for pharmacological intervention. Trends in pharmacological 
sciences. 
De Corte, V., Bruyneel, E., Boucherie, C., Mareel, M., Vandekerckhove, J., and 
Gettemans, J. (2002). Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac 
signaling. The EMBO journal 21, 6781-6790. 
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, 
C., Shi, Y., Gelinas, C., Fan, Y., et al. (2006). Autophagy promotes tumor cell survival and 
restricts necrosis, inflammation, and tumorigenesis. Cancer cell 10, 51-64. 
Dennemarker, J., Lohmuller, T., Muller, S., Aguilar, S.V., Tobin, D.J., Peters, C., and 
Reinheckel, T. (2010). Impaired turnover of autophagolysosomes in cathepsin L 
deficiency. Biological chemistry 391, 913-922. 
DePina, A.S., Wollert, T., and Langford, G.M. (2007). Membrane associated nonmuscle 
myosin II functions as a motor for actin-based vesicle transport in clam oocyte extracts. 
Cell motility and the cytoskeleton 64, 739-755. 
DeYoung, M.P., Horak, P., Sofer, A., Sgroi, D., and Ellisen, L.W. (2008). Hypoxia regulates 
TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 
shuttling. Genes & development 22, 239-251. 
Ditsch, A., and Wegner, A. (1994). Nucleation of actin polymerization by gelsolin. 
European journal of biochemistry / FEBS 224, 223-227. 
Ditsch, A., and Wegner, A. (1995). Two low-affinity Ca(2+)-binding sites of gelsolin that 
regulate association with actin. European journal of biochemistry / FEBS 229, 512-516. 
Dominguez, R., and Holmes, K.C. (2011). Actin structure and function. Annual review of 
biophysics 40, 169-186. 
dos Remedios, C.G., Chhabra, D., Kekic, M., Dedova, I.V., Tsubakihara, M., Berry, D.A., 
and Nosworthy, N.J. (2003). Actin binding proteins: regulation of cytoskeletal 
microfilaments. Physiological reviews 83, 433-473. 
Dosaka-Akita, H., Hommura, F., Fujita, H., Kinoshita, I., Nishi, M., Morikawa, T., Katoh, 
H., Kawakami, Y., and Kuzumaki, N. (1998). Frequent loss of gelsolin expression in non-
small cell lung cancers of heavy smokers. Cancer research 58, 322-327. 
Egan, D.F., Shackelford, D.B., Mihaylova, M.M., Gelino, S., Kohnz, R.A., Mair, W., 
Vasquez, D.S., Joshi, A., Gwinn, D.M., Taylor, R., et al. (2011). Phosphorylation of ULK1 
(hATG1) by AMP-activated protein kinase connects energy sensing to mitophagy. 
Science 331, 456-461. 
Ermak, G., Sojitra, S., Yin, F., Cadenas, E., Cuervo, A.M., and Davies, K.J. (2012). Chronic 
expression of RCAN1-1L protein induces mitochondrial autophagy and metabolic shift 
from oxidative phosphorylation to glycolysis in neuronal cells. The Journal of biological 
chemistry 287, 14088-14098. 
Fan, N.J., Gao, C.F., Wang, C.S., Lv, J.J., Zhao, G., Sheng, X.H., Wang, X.L., Li, D.H., Liu, 
Q.Y., and Yin, J. (2012). Discovery and verification of gelsolin as a potential biomarker of 
colorectal adenocarcinoma in the Chinese population: Examining differential protein 
125 
 
expression using an iTRAQ labelling-based proteomics approach. Canadian journal of 
gastroenterology = Journal canadien de gastroenterologie 26, 41-47. 
Fass, E., Shvets, E., Degani, I., Hirschberg, K., and Elazar, Z. (2006). Microtubules support 
production of starvation-induced autophagosomes but not their targeting and fusion 
with lysosomes. The Journal of biological chemistry 281, 36303-36316. 
Fiorentino, L., Cavalera, M., Menini, S., Marchetti, V., Mavilio, M., Fabrizi, M., Conserva, 
F., Casagrande, V., Menghini, R., Pontrelli, P., et al. (2013). Loss of TIMP3 underlies 
diabetic nephropathy via FoxO1/STAT1 interplay. EMBO molecular medicine 5, 441-455. 
Fortunato, F., Burgers, H., Bergmann, F., Rieger, P., Buchler, M.W., Kroemer, G., and 
Werner, J. (2009). Impaired autolysosome formation correlates with Lamp-2 depletion: 
role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology 137, 350-
360, 360 e351-355. 
Fujita, N., Hayashi-Nishino, M., Fukumoto, H., Omori, H., Yamamoto, A., Noda, T., and 
Yoshimori, T. (2008). An Atg4B mutant hampers the lipidation of LC3 paralogues and 
causes defects in autophagosome closure. Molecular biology of the cell 19, 4651-4659. 
Fukata, Y., Amano, M., and Kaibuchi, K. (2001). Rho-Rho-kinase pathway in smooth 
muscle contraction and cytoskeletal reorganization of non-muscle cells. Trends in 
pharmacological sciences 22, 32-39. 
Furukawa, K., Fu, W., Li, Y., Witke, W., Kwiatkowski, D.J., and Mattson, M.P. (1997). The 
actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities 
and vulnerability to excitotoxicity in hippocampal neurons. The Journal of neuroscience : 
the official journal of the Society for Neuroscience 17, 8178-8186. 
Ganley, I.G., Lam du, H., Wang, J., Ding, X., Chen, S., and Jiang, X. (2009). 
ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. 
The Journal of biological chemistry 284, 12297-12305. 
Gay, F., Estornes, Y., Saurin, J.C., Joly-Pharaboz, M.O., Friederich, E., Scoazec, J.Y., and 
Abello, J. (2008). In colon carcinogenesis, the cytoskeletal protein gelsolin is down-
regulated during the transition from adenoma to carcinoma. Human pathology 39, 
1420-1430. 
Geng, Y.J., Azuma, T., Tang, J.X., Hartwig, J.H., Muszynski, M., Wu, Q., Libby, P., and 
Kwiatkowski, D.J. (1998). Caspase-3-induced gelsolin fragmentation contributes to actin 
cytoskeletal collapse, nucleolysis, and apoptosis of vascular smooth muscle cells 
exposed to proinflammatory cytokines. European journal of cell biology 77, 294-302. 
Gettemans, J., Van Impe, K., Delanote, V., Hubert, T., Vandekerckhove, J., and De Corte, 
V. (2005). Nuclear actin-binding proteins as modulators of gene transcription. Traffic 6, 
847-857. 
Glick, D., Barth, S., and Macleod, K.F. (2010). Autophagy: cellular and molecular 
mechanisms. The Journal of pathology 221, 3-12. 
Guo, J.Y., Chen, H.Y., Mathew, R., Fan, J., Strohecker, A.M., Karsli-Uzunbas, G., 
Kamphorst, J.J., Chen, G., Lemons, J.M., Karantza, V., et al. (2011). Activated Ras 
requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes & 
development 25, 460-470. 
Gurkar, A.U., Chu, K., Raj, L., Bouley, R., Lee, S.H., Kim, Y.B., Dunn, S.E., Mandinova, A., 
and Lee, S.W. (2013). Identification of ROCK1 kinase as a critical regulator of Beclin1-
mediated autophagy during metabolic stress. Nature communications 4, 2189. 
Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., 
Turk, B.E., and Shaw, R.J. (2008). AMPK phosphorylation of raptor mediates a metabolic 
checkpoint. Molecular cell 30, 214-226. 
126 
 
Hamasaki, M., Noda, T., Baba, M., and Ohsumi, Y. (2005). Starvation triggers the delivery 
of the endoplasmic reticulum to the vacuole via autophagy in yeast. Traffic 6, 56-65. 
Hanada, T., Noda, N.N., Satomi, Y., Ichimura, Y., Fujioka, Y., Takao, T., Inagaki, F., and 
Ohsumi, Y. (2007). The Atg12-Atg5 conjugate has a novel E3-like activity for protein 
lipidation in autophagy. The Journal of biological chemistry 282, 37298-37302. 
Harms, C., Bosel, J., Lautenschlager, M., Harms, U., Braun, J.S., Hortnagl, H., Dirnagl, U., 
Kwiatkowski, D.J., Fink, K., and Endres, M. (2004). Neuronal gelsolin prevents apoptosis 
by enhancing actin depolymerization. Molecular and cellular neurosciences 25, 69-82. 
He, C., Baba, M., Cao, Y., and Klionsky, D.J. (2008). Self-interaction is critical for Atg9 
transport and function at the phagophore assembly site during autophagy. Molecular 
biology of the cell 19, 5506-5516. 
He, C., Song, H., Yorimitsu, T., Monastyrska, I., Yen, W.L., Legakis, J.E., and Klionsky, D.J. 
(2006). Recruitment of Atg9 to the preautophagosomal structure by Atg11 is essential 
for selective autophagy in budding yeast. The Journal of cell biology 175, 925-935. 
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S., 
Natsume, T., Takehana, K., Yamada, N., et al. (2009). Nutrient-dependent mTORC1 
association with the ULK1-Atg13-FIP200 complex required for autophagy. Molecular 
biology of the cell 20, 1981-1991. 
Ichimura, Y., Kirisako, T., Takao, T., Satomi, Y., Shimonishi, Y., Ishihara, N., Mizushima, 
N., Tanida, I., Kominami, E., Ohsumi, M., et al. (2000). A ubiquitin-like system mediates 
protein lipidation. Nature 408, 488-492. 
Igusa, Y., Yamashina, S., Izumi, K., Inami, Y., Fukada, H., Komatsu, M., Tanaka, K., Ikejima, 
K., and Watanabe, S. (2012). Loss of autophagy promotes murine acetaminophen 
hepatotoxicity. Journal of gastroenterology 47, 433-443. 
Ishida, Y., Yamamoto, A., Kitamura, A., Lamande, S.R., Yoshimori, T., Bateman, J.F., 
Kubota, H., and Nagata, K. (2009). Autophagic elimination of misfolded procollagen 
aggregates in the endoplasmic reticulum as a means of cell protection. Molecular 
biology of the cell 20, 2744-2754. 
Itakura, E., Kishi, C., Inoue, K., and Mizushima, N. (2008). Beclin 1 forms two distinct 
phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Molecular 
biology of the cell 19, 5360-5372. 
Itakura, E., and Mizushima, N. (2010). Characterization of autophagosome formation 
site by a hierarchical analysis of mammalian Atg proteins. Autophagy 6, 764-776. 
Izuishi, K., Kato, K., Ogura, T., Kinoshita, T., and Esumi, H. (2000). Remarkable tolerance 
of tumor cells to nutrient deprivation: possible new biochemical target for cancer 
therapy. Cancer research 60, 6201-6207. 
Jager, S., Bucci, C., Tanida, I., Ueno, T., Kominami, E., Saftig, P., and Eskelinen, E.L. 
(2004). Role for Rab7 in maturation of late autophagic vacuoles. Journal of cell science 
117, 4837-4848. 
Janku, F., McConkey, D.J., Hong, D.S., and Kurzrock, R. (2011). Autophagy as a target for 
anticancer therapy. Nature reviews Clinical oncology 8, 528-539. 
Janmey, P.A., Lamb, J., Allen, P.G., and Matsudaira, P.T. (1992). Phosphoinositide-
binding peptides derived from the sequences of gelsolin and villin. The Journal of 
biological chemistry 267, 11818-11823. 
Janmey, P.A., and Stossel, T.P. (1987). Modulation of gelsolin function by 
phosphatidylinositol 4,5-bisphosphate. Nature 325, 362-364. 
127 
 
Jung, C.H., Jun, C.B., Ro, S.H., Kim, Y.M., Otto, N.M., Cao, J., Kundu, M., and Kim, D.H. 
(2009). ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy 
machinery. Molecular biology of the cell 20, 1992-2003. 
Kabeya, Y., Mizushima, N., Yamamoto, A., Oshitani-Okamoto, S., Ohsumi, Y., and 
Yoshimori, T. (2004). LC3, GABARAP and GATE16 localize to autophagosomal membrane 
depending on form-II formation. Journal of cell science 117, 2805-2812. 
Kaiser, S.E., Qiu, Y., Coats, J.E., Mao, K., Klionsky, D.J., and Schulman, B.A. (2013). 
Structures of Atg7-Atg3 and Atg7-Atg10 reveal noncanonical mechanisms of E2 
recruitment by the autophagy E1. Autophagy 9, 778-780. 
Kamada, S., Kusano, H., Fujita, H., Ohtsu, M., Koya, R.C., Kuzumaki, N., and Tsujimoto, Y. 
(1998). A cloning method for caspase substrates that uses the yeast two-hybrid system: 
cloning of the antiapoptotic gene gelsolin. Proceedings of the National Academy of 
Sciences of the United States of America 95, 8532-8537. 
Kang, R., Livesey, K.M., Zeh, H.J., 3rd, Lotze, M.T., and Tang, D. (2011). HMGB1 as an 
autophagy sensor in oxidative stress. Autophagy 7, 904-906. 
Kang, R., Tang, D., Schapiro, N.E., Livesey, K.M., Farkas, A., Loughran, P., Bierhaus, A., 
Lotze, M.T., and Zeh, H.J. (2010). The receptor for advanced glycation end products 
(RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell 
survival. Cell death and differentiation 17, 666-676. 
Karantza-Wadsworth, V., Patel, S., Kravchuk, O., Chen, G., Mathew, R., Jin, S., and White, 
E. (2007). Autophagy mitigates metabolic stress and genome damage in mammary 
tumorigenesis. Genes & development 21, 1621-1635. 
Kihara, A., Noda, T., Ishihara, N., and Ohsumi, Y. (2001). Two distinct Vps34 
phosphatidylinositol 3-kinase complexes function in autophagy and carboxypeptidase Y 
sorting in Saccharomyces cerevisiae. The Journal of cell biology 152, 519-530. 
Kim, C.S., Furuya, F., Ying, H., Kato, Y., Hanover, J.A., and Cheng, S.Y. (2007). Gelsolin: a 
novel thyroid hormone receptor-beta interacting protein that modulates tumor 
progression in a mouse model of follicular thyroid cancer. Endocrinology 148, 1306-
1312. 
Kim, J., Kundu, M., Viollet, B., and Guan, K.L. (2011). AMPK and mTOR regulate 
autophagy through direct phosphorylation of Ulk1. Nature cell biology 13, 132-141. 
Kim, S.Y., Oh, Y.L., Kim, K.M., Jeong, E.G., Kim, M.S., Yoo, N.J., and Lee, S.H. (2008). 
Decreased expression of Bax-interacting factor-1 (Bif-1) in invasive urinary bladder and 
gallbladder cancers. Pathology 40, 553-557. 
Kimura, S., Fujita, N., Noda, T., and Yoshimori, T. (2009). Monitoring autophagy in 
mammalian cultured cells through the dynamics of LC3. Methods in enzymology 452, 1-
12. 
Kimura, S., Noda, T., and Yoshimori, T. (2008). Dynein-dependent movement of 
autophagosomes mediates efficient encounters with lysosomes. Cell structure and 
function 33, 109-122. 
Kirisako, T., Ichimura, Y., Okada, H., Kabeya, Y., Mizushima, N., Yoshimori, T., Ohsumi, 
M., Takao, T., Noda, T., and Ohsumi, Y. (2000). The reversible modification regulates the 
membrane-binding state of Apg8/Aut7 essential for autophagy and the cytoplasm to 
vacuole targeting pathway. The Journal of cell biology 151, 263-276. 
Kiselar, J.G., Janmey, P.A., Almo, S.C., and Chance, M.R. (2003a). Structural analysis of 




Kiselar, J.G., Janmey, P.A., Almo, S.C., and Chance, M.R. (2003b). Visualizing the Ca2+-
dependent activation of gelsolin by using synchrotron footprinting. Proceedings of the 
National Academy of Sciences of the United States of America 100, 3942-3947. 
Klampfer, L., Huang, J., Sasazuki, T., Shirasawa, S., and Augenlicht, L. (2004). Oncogenic 
Ras promotes butyrate-induced apoptosis through inhibition of gelsolin expression. The 
Journal of biological chemistry 279, 36680-36688. 
Klampfer, L., Swaby, L.A., Huang, J., Sasazuki, T., Shirasawa, S., and Augenlicht, L. (2005). 
Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis. 
Oncogene 24, 3932-3941. 
Klionsky, D.J. (2005). The molecular machinery of autophagy: unanswered questions. 
Journal of cell science 118, 7-18. 
Kochl, R., Hu, X.W., Chan, E.Y., and Tooze, S.A. (2006). Microtubules facilitate 
autophagosome formation and fusion of autophagosomes with endosomes. Traffic 7, 
129-145. 
Komatsu, M., Kurokawa, H., Waguri, S., Taguchi, K., Kobayashi, A., Ichimura, Y., Sou, Y.S., 
Ueno, I., Sakamoto, A., Tong, K.I., et al. (2010). The selective autophagy substrate p62 
activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. 
Nature cell biology 12, 213-223. 
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, 
N., Ohsumi, Y., Uchiyama, Y., et al. (2005). Impairment of starvation-induced and 
constitutive autophagy in Atg7-deficient mice. The Journal of cell biology 169, 425-434. 
Koos, B., Andersson, L., Clausson, C.M., Grannas, K., Klaesson, A., Cane, G., and 
Soderberg, O. (2014). Analysis of protein interactions in situ by proximity ligation assays. 
Current topics in microbiology and immunology 377, 111-126. 
Kopito, R.R. (2000). Aggresomes, inclusion bodies and protein aggregation. Trends in cell 
biology 10, 524-530. 
Kothakota, S., Azuma, T., Reinhard, C., Klippel, A., Tang, J., Chu, K., McGarry, T.J., 
Kirschner, M.W., Koths, K., Kwiatkowski, D.J., et al. (1997). Caspase-3-generated 
fragment of gelsolin: effector of morphological change in apoptosis. Science 278, 294-
298. 
Kotoulas, O.B., Kalamidas, S.A., and Kondomerkos, D.J. (2006). Glycogen autophagy in 
glucose homeostasis. Pathology, research and practice 202, 631-638. 
Kovacs, M., Toth, J., Hetenyi, C., Malnasi-Csizmadia, A., and Sellers, J.R. (2004). 
Mechanism of blebbistatin inhibition of myosin II. The Journal of biological chemistry 
279, 35557-35563. 
Koya, R.C., Fujita, H., Shimizu, S., Ohtsu, M., Takimoto, M., Tsujimoto, Y., and Kuzumaki, 
N. (2000). Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss 
and cytochrome c release. The Journal of biological chemistry 275, 15343-15349. 
Kundu, M., Lindsten, T., Yang, C.Y., Wu, J., Zhao, F., Zhang, J., Selak, M.A., Ney, P.A., and 
Thompson, C.B. (2008). Ulk1 plays a critical role in the autophagic clearance of 
mitochondria and ribosomes during reticulocyte maturation. Blood 112, 1493-1502. 
Kusano, H., Shimizu, S., Koya, R.C., Fujita, H., Kamada, S., Kuzumaki, N., and Tsujimoto, Y. 
(2000). Human gelsolin prevents apoptosis by inhibiting apoptotic mitochondrial 
changes via closing VDAC. Oncogene 19, 4807-4814. 
Kwiatkowski, D.J., Janmey, P.A., and Yin, H.L. (1989). Identification of critical functional 
and regulatory domains in gelsolin. The Journal of cell biology 108, 1717-1726. 
129 
 
Kwiatkowski, D.J., Stossel, T.P., Orkin, S.H., Mole, J.E., Colten, H.R., and Yin, H.L. (1986). 
Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated 
actin-binding domain. Nature 323, 455-458. 
Lang, T., Reiche, S., Straub, M., Bredschneider, M., and Thumm, M. (2000). Autophagy 
and the cvt pathway both depend on AUT9. Journal of bacteriology 182, 2125-2133. 
Lau, A., Wang, X.J., Zhao, F., Villeneuve, N.F., Wu, T., Jiang, T., Sun, Z., White, E., and 
Zhang, D.D. (2010). A noncanonical mechanism of Nrf2 activation by autophagy 
deficiency: direct interaction between Keap1 and p62. Molecular and cellular biology 30, 
3275-3285. 
Lazarides, E., and Lindberg, U. (1974). Actin is the naturally occurring inhibitor of 
deoxyribonuclease I. Proceedings of the National Academy of Sciences of the United 
States of America 71, 4742-4746. 
Lebovitz, C.B., Bortnik, S.B., and Gorski, S.M. (2012). Here, there be dragons: charting 
autophagy-related alterations in human tumors. Clinical cancer research : an official 
journal of the American Association for Cancer Research 18, 1214-1226. 
Lee, J.W., Jeong, E.G., Soung, Y.H., Nam, S.W., Lee, J.Y., Yoo, N.J., and Lee, S.H. (2006). 
Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax 
activator, in gastric carcinomas. Pathology 38, 312-315. 
Lee, J.W., Park, S., Takahashi, Y., and Wang, H.G. (2010a). The association of AMPK with 
ULK1 regulates autophagy. PloS one 5, e15394. 
Lee, J.Y., Koga, H., Kawaguchi, Y., Tang, W., Wong, E., Gao, Y.S., Pandey, U.B., Kaushik, S., 
Tresse, E., Lu, J., et al. (2010b). HDAC6 controls autophagosome maturation essential for 
ubiquitin-selective quality-control autophagy. The EMBO journal 29, 969-980. 
Lee, W.M. (1994). Gastroenterologists: get to know gelsolin! Gastroenterology 106, 813-
814. 
Legakis, J.E., Yen, W.L., and Klionsky, D.J. (2007). A cycling protein complex required for 
selective autophagy. Autophagy 3, 422-432. 
Levine, A.J., and Puzio-Kuter, A.M. (2010). The control of the metabolic switch in cancers 
by oncogenes and tumor suppressor genes. Science 330, 1340-1344. 
Levine, B., and Klionsky, D.J. (2004). Development by self-digestion: molecular 
mechanisms and biological functions of autophagy. Developmental cell 6, 463-477. 
Li, G.H., Shi, Y., Chen, Y., Sun, M., Sader, S., Maekawa, Y., Arab, S., Dawood, F., Chen, M., 
De Couto, G., et al. (2009a). Gelsolin regulates cardiac remodeling after myocardial 
infarction through DNase I-mediated apoptosis. Circulation research 104, 896-904. 
Li, J., Hou, N., Faried, A., Tsutsumi, S., and Kuwano, H. (2010). Inhibition of autophagy 
augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo 
model. European journal of cancer 46, 1900-1909. 
Li, J., Hou, N., Faried, A., Tsutsumi, S., Takeuchi, T., and Kuwano, H. (2009b). Inhibition of 
autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. 
Annals of surgical oncology 16, 761-771. 
Li, Q., Ye, Z., Wen, J., Ma, L., He, Y., Lian, G., Wang, Z., Wei, L., Wu, D., and Jiang, B. 
(2009c). Gelsolin, but not its cleavage, is required for TNF-induced ROS generation and 
apoptosis in MCF-7 cells. Biochemical and biophysical research communications 385, 
284-289. 
Liang, C., Feng, P., Ku, B., Dotan, I., Canaani, D., Oh, B.H., and Jung, J.U. (2006). 
Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. 
Nature cell biology 8, 688-699. 
130 
 
Liang, C., Lee, J.S., Inn, K.S., Gack, M.U., Li, Q., Roberts, E.A., Vergne, I., Deretic, V., Feng, 
P., Akazawa, C., et al. (2008). Beclin1-binding UVRAG targets the class C Vps complex to 
coordinate autophagosome maturation and endocytic trafficking. Nature cell biology 10, 
776-787. 
Liang, X.H., Jackson, S., Seaman, M., Brown, K., Kempkes, B., Hibshoosh, H., and Levine, 
B. (1999). Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 
402, 672-676. 
Liao, C.J., Wu, T.I., Huang, Y.H., Chang, T.C., Wang, C.S., Tsai, M.M., Hsu, C.Y., Tsai, M.H., 
Lai, C.H., and Lin, K.H. (2011). Overexpression of gelsolin in human cervical carcinoma 
and its clinicopathological significance. Gynecologic oncology 120, 135-144. 
Liepina, I., Czaplewski, C., Janmey, P., and Liwo, A. (2003). Molecular dynamics study of 
a gelsolin-derived peptide binding to a lipid bilayer containing phosphatidylinositol 4,5-
bisphosphate. Biopolymers 71, 49-70. 
Lin, K.M., Wenegieme, E., Lu, P.J., Chen, C.S., and Yin, H.L. (1997). Gelsolin binding to 
phosphatidylinositol 4,5-bisphosphate is modulated by calcium and pH. The Journal of 
biological chemistry 272, 20443-20450. 
Litwin, M., Mazur, A.J., Nowak, D., Mannherz, H.G., and Malicka-Blaszkiewicz, M. (2009). 
Gelsolin in human colon adenocarcinoma cells with different metastatic potential. Acta 
biochimica Polonica 56, 739-743. 
Litwin, M., Nowak, D., Mazur, A.J., Baczynska, D., Mannherz, H.G., and Malicka-
Blaszkiewicz, M. (2012). Gelsolin affects the migratory ability of human colon 
adenocarcinoma and melanoma cells. Life sciences 90, 851-861. 
Liu, H.Y., Han, J., Cao, S.Y., Hong, T., Zhuo, D., Shi, J., Liu, Z., and Cao, W. (2009). Hepatic 
autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: 
inhibition of FoxO1-dependent expression of key autophagy genes by insulin. The 
Journal of biological chemistry 284, 31484-31492. 
Lu, M., Witke, W., Kwiatkowski, D.J., and Kosik, K.S. (1997). Delayed retraction of 
filopodia in gelsolin null mice. The Journal of cell biology 138, 1279-1287. 
Ma, X.M., and Blenis, J. (2009). Molecular mechanisms of mTOR-mediated translational 
control. Nature reviews Molecular cell biology 10, 307-318. 
Mari, M., Griffith, J., Rieter, E., Krishnappa, L., Klionsky, D.J., and Reggiori, F. (2010). An 
Atg9-containing compartment that functions in the early steps of autophagosome 
biogenesis. The Journal of cell biology 190, 1005-1022. 
Mari, M., and Reggiori, F. (2010). Atg9 reservoirs, a new organelle of the yeast 
endomembrane system? Autophagy 6, 1221-1223. 
Marino, N., Marshall, J.C., Collins, J.W., Zhou, M., Qian, Y., Veenstra, T., and Steeg, P.S. 
(2013). Nm23-h1 binds to gelsolin and inactivates its actin-severing capacity to promote 
tumor cell motility and metastasis. Cancer research 73, 5949-5962. 
Mathew, R., Karantza-Wadsworth, V., and White, E. (2009a). Assessing metabolic stress 
and autophagy status in epithelial tumors. Methods in enzymology 453, 53-81. 
Mathew, R., Karp, C.M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.Y., Bray, K., Reddy, 
A., Bhanot, G., Gelinas, C., et al. (2009b). Autophagy suppresses tumorigenesis through 
elimination of p62. Cell 137, 1062-1075. 
Mathew, R., Kongara, S., Beaudoin, B., Karp, C.M., Bray, K., Degenhardt, K., Chen, G., Jin, 
S., and White, E. (2007). Autophagy suppresses tumor progression by limiting 
chromosomal instability. Genes & development 21, 1367-1381. 
Matsunaga, K., Saitoh, T., Tabata, K., Omori, H., Satoh, T., Kurotori, N., Maejima, I., 
Shirahama-Noda, K., Ichimura, T., Isobe, T., et al. (2009). Two Beclin 1-binding proteins, 
131 
 
Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nature cell 
biology 11, 385-396. 
Mazumdar, B., Meyer, K., and Ray, R. (2012). N-terminal region of gelsolin induces 
apoptosis of activated hepatic stellate cells by a caspase-dependent mechanism. PloS 
one 7, e44461. 
McGough, A., Chiu, W., and Way, M. (1998). Determination of the gelsolin binding site 
on F-actin: implications for severing and capping. Biophysical journal 74, 764-772. 
McLaughlin, P.J., Gooch, J.T., Mannherz, H.G., and Weeds, A.G. (1993). Structure of 
gelsolin segment 1-actin complex and the mechanism of filament severing. Nature 364, 
685-692. 
Mirzoeva, O.K., Hann, B., Hom, Y.K., Debnath, J., Aftab, D., Shokat, K., and Korn, W.M. 
(2011). Autophagy suppression promotes apoptotic cell death in response to inhibition 
of the PI3K-mTOR pathway in pancreatic adenocarcinoma. Journal of molecular 
medicine 89, 877-889. 
Mizushima, N. (2007). Autophagy: process and function. Genes & development 21, 
2861-2873. 
Mizushima, N., and Komatsu, M. (2011). Autophagy: renovation of cells and tissues. Cell 
147, 728-741. 
Mizushima, N., Noda, T., and Ohsumi, Y. (1999). Apg16p is required for the function of 
the Apg12p-Apg5p conjugate in the yeast autophagy pathway. The EMBO journal 18, 
3888-3896. 
Mizushima, N., Noda, T., Yoshimori, T., Tanaka, Y., Ishii, T., George, M.D., Klionsky, D.J., 
Ohsumi, M., and Ohsumi, Y. (1998). A protein conjugation system essential for 
autophagy. Nature 395, 395-398. 
Mizushima, N., Yamamoto, A., Hatano, M., Kobayashi, Y., Kabeya, Y., Suzuki, K., 
Tokuhisa, T., Ohsumi, Y., and Yoshimori, T. (2001). Dissection of autophagosome 
formation using Apg5-deficient mouse embryonic stem cells. The Journal of cell biology 
152, 657-668. 
Mizushima, N., Yoshimori, T., and Levine, B. (2010). Methods in mammalian autophagy 
research. Cell 140, 313-326. 
Mizushima, N., Yoshimori, T., and Ohsumi, Y. (2011). The role of Atg proteins in 
autophagosome formation. Annual review of cell and developmental biology 27, 107-
132. 
Monastyrska, I., He, C., Geng, J., Hoppe, A.D., Li, Z., and Klionsky, D.J. (2008). Arp2 links 
autophagic machinery with the actin cytoskeleton. Molecular biology of the cell 19, 
1962-1975. 
Mullauer, L., Fujita, H., Ishizaki, A., and Kuzumaki, N. (1993). Tumor-suppressive function 
of mutated gelsolin in ras-transformed cells. Oncogene 8, 2531-2536. 
Nag, S., Ma, Q., Wang, H., Chumnarnsilpa, S., Lee, W.L., Larsson, M., Kannan, B., 
Hernandez-Valladares, M., Burtnick, L.D., and Robinson, R.C. (2009). Ca2+ binding by 
domain 2 plays a critical role in the activation and stabilization of gelsolin. Proceedings 
of the National Academy of Sciences of the United States of America 106, 13713-13718. 
Narumiya, S., Tanji, M., and Ishizaki, T. (2009). Rho signaling, ROCK and mDia1, in 
transformation, metastasis and invasion. Cancer metastasis reviews 28, 65-76. 
Ng, S., Wu, Y.T., Chen, B., Zhou, J., and Shen, H.M. (2011). Impaired autophagy due to 
constitutive mTOR activation sensitizes TSC2-null cells to cell death under stress. 
Autophagy 7, 1173-1186. 
132 
 
Ni, X.G., Zhou, L., Wang, G.Q., Liu, S.M., Bai, X.F., Liu, F., Peppelenbosch, M.P., and Zhao, 
P. (2008). The ubiquitin-proteasome pathway mediates gelsolin protein downregulation 
in pancreatic cancer. Molecular medicine 14, 582-589. 
Nishimura, K., Ting, H.J., Harada, Y., Tokizane, T., Nonomura, N., Kang, H.Y., Chang, H.C., 
Yeh, S., Miyamoto, H., Shin, M., et al. (2003). Modulation of androgen receptor 
transactivation by gelsolin: a newly identified androgen receptor coregulator. Cancer 
research 63, 4888-4894. 
Noda, T., Kim, J., Huang, W.P., Baba, M., Tokunaga, C., Ohsumi, Y., and Klionsky, D.J. 
(2000). Apg9p/Cvt7p is an integral membrane protein required for transport vesicle 
formation in the Cvt and autophagy pathways. The Journal of cell biology 148, 465-480. 
Noske, A., Denkert, C., Schober, H., Sers, C., Zhumabayeva, B., Weichert, W., Dietel, M., 
and Wiechen, K. (2005). Loss of Gelsolin expression in human ovarian carcinomas. 
European journal of cancer 41, 461-469. 
Obara, K., Sekito, T., Niimi, K., and Ohsumi, Y. (2008). The Atg18-Atg2 complex is 
recruited to autophagic membranes via phosphatidylinositol 3-phosphate and exerts an 
essential function. The Journal of biological chemistry 283, 23972-23980. 
Ohtsu, M., Sakai, N., Fujita, H., Kashiwagi, M., Gasa, S., Shimizu, S., Eguchi, Y., Tsujimoto, 
Y., Sakiyama, Y., Kobayashi, K., et al. (1997). Inhibition of apoptosis by the actin-
regulatory protein gelsolin. The EMBO journal 16, 4650-4656. 
Orenstein, S.J., and Cuervo, A.M. (2010). Chaperone-mediated autophagy: molecular 
mechanisms and physiological relevance. Seminars in cell & developmental biology 21, 
719-726. 
Orsi, A., Razi, M., Dooley, H.C., Robinson, D., Weston, A.E., Collinson, L.M., and Tooze, 
S.A. (2012). Dynamic and transient interactions of Atg9 with autophagosomes, but not 
membrane integration, are required for autophagy. Molecular biology of the cell 23, 
1860-1873. 
Palmieri, M., Impey, S., Kang, H., di Ronza, A., Pelz, C., Sardiello, M., and Ballabio, A. 
(2011). Characterization of the CLEAR network reveals an integrated control of cellular 
clearance pathways. Human molecular genetics 20, 3852-3866. 
Papinski, D., Schuschnig, M., Reiter, W., Wilhelm, L., Barnes, C.A., Maiolica, A., 
Hansmann, I., Pfaffenwimmer, T., Kijanska, M., Stoffel, I., et al. (2014). Early steps in 
autophagy depend on direct phosphorylation of Atg9 by the Atg1 kinase. Molecular cell 
53, 471-483. 
Pavlides, S., Vera, I., Gandara, R., Sneddon, S., Pestell, R.G., Mercier, I., Martinez-
Outschoorn, U.E., Whitaker-Menezes, D., Howell, A., Sotgia, F., et al. (2012). Warburg 
meets autophagy: cancer-associated fibroblasts accelerate tumor growth and 
metastasis via oxidative stress, mitophagy, and aerobic glycolysis. Antioxidants & redox 
signaling 16, 1264-1284. 
Pike, L.R., Phadwal, K., Simon, A.K., and Harris, A.L. (2012). ATF4 orchestrates a program 
of BH3-only protein expression in severe hypoxia. Molecular biology reports 39, 10811-
10822. 
Polager, S., Ofir, M., and Ginsberg, D. (2008). E2F1 regulates autophagy and the 
transcription of autophagy genes. Oncogene 27, 4860-4864. 
Polson, H.E., de Lartigue, J., Rigden, D.J., Reedijk, M., Urbe, S., Clague, M.J., and Tooze, 
S.A. (2010). Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores 
and positively regulates LC3 lipidation. Autophagy 6, 506-522. 
133 
 
Pope, B., Maciver, S., and Weeds, A. (1995). Localization of the calcium-sensitive actin 
monomer binding site in gelsolin to segment 4 and identification of calcium binding 
sites. Biochemistry 34, 1583-1588. 
Posey, S.C., Martelli, M.P., Azuma, T., Kwiatkowski, D.J., and Bierer, B.E. (2000). Failure 
of gelsolin overexpression to regulate lymphocyte apoptosis. Blood 95, 3483-3488. 
Proikas-Cezanne, T., Ruckerbauer, S., Stierhof, Y.D., Berg, C., and Nordheim, A. (2007). 
Human WIPI-1 puncta-formation: a novel assay to assess mammalian autophagy. FEBS 
letters 581, 3396-3404. 
Proikas-Cezanne, T., Waddell, S., Gaugel, A., Frickey, T., Lupas, A., and Nordheim, A. 
(2004). WIPI-1alpha (WIPI49), a member of the novel 7-bladed WIPI protein family, is 
aberrantly expressed in human cancer and is linked to starvation-induced autophagy. 
Oncogene 23, 9314-9325. 
Qiao, H., and McMillan, J.R. (2007). Gelsolin segment 5 inhibits HIV-induced T-cell 
apoptosis via Vpr-binding to VDAC. FEBS letters 581, 535-540. 
Qu, X., Yu, J., Bhagat, G., Furuya, N., Hibshoosh, H., Troxel, A., Rosen, J., Eskelinen, E.L., 
Mizushima, N., Ohsumi, Y., et al. (2003). Promotion of tumorigenesis by heterozygous 
disruption of the beclin 1 autophagy gene. The Journal of clinical investigation 112, 
1809-1820. 
Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E., and Plotz, P. 
(2008). Suppression of autophagy in skeletal muscle uncovers the accumulation of 
ubiquitinated proteins and their potential role in muscle damage in Pompe disease. 
Human molecular genetics 17, 3897-3908. 
Radwanska, A., Litwin, M., Nowak, D., Baczynska, D., Wegrowski, Y., Maquart, F.X., and 
Malicka-Blaszkiewicz, M. (2012). Overexpression of lumican affects the migration of 
human colon cancer cells through up-regulation of gelsolin and filamentous actin 
reorganization. Experimental cell research 318, 2312-2323. 
Rao, J., Seligson, D., Visapaa, H., Horvath, S., Eeva, M., Michel, K., Pantuck, A., 
Belldegrun, A., and Palotie, A. (2002). Tissue microarray analysis of cytoskeletal actin-
associated biomarkers gelsolin and E-cadherin in urothelial carcinoma. Cancer 95, 1247-
1257. 
Reggiori, F., and Klionsky, D.J. (2006). Atg9 sorting from mitochondria is impaired in 
early secretion and VFT-complex mutants in Saccharomyces cerevisiae. Journal of cell 
science 119, 2903-2911. 
Reggiori, F., Monastyrska, I., Shintani, T., and Klionsky, D.J. (2005a). The actin 
cytoskeleton is required for selective types of autophagy, but not nonspecific 
autophagy, in the yeast Saccharomyces cerevisiae. Molecular biology of the cell 16, 
5843-5856. 
Reggiori, F., Shintani, T., Nair, U., and Klionsky, D.J. (2005b). Atg9 cycles between 
mitochondria and the pre-autophagosomal structure in yeasts. Autophagy 1, 101-109. 
Reggiori, F., and Tooze, S.A. (2012). Autophagy regulation through Atg9 traffic. The 
Journal of cell biology 198, 151-153. 
Reggiori, F., Tucker, K.A., Stromhaug, P.E., and Klionsky, D.J. (2004). The Atg1-Atg13 
complex regulates Atg9 and Atg23 retrieval transport from the pre-autophagosomal 
structure. Developmental cell 6, 79-90. 
Robinson, R.C., Mejillano, M., Le, V.P., Burtnick, L.D., Yin, H.L., and Choe, S. (1999). 
Domain movement in gelsolin: a calcium-activated switch. Science 286, 1939-1942. 
134 
 
Russell, R.C., Tian, Y., Yuan, H., Park, H.W., Chang, Y.Y., Kim, J., Kim, H., Neufeld, T.P., 
Dillin, A., and Guan, K.L. (2013). ULK1 induces autophagy by phosphorylating Beclin-1 
and activating VPS34 lipid kinase. Nature cell biology 15, 741-750. 
Sagawa, N., Fujita, H., Banno, Y., Nozawa, Y., Katoh, H., and Kuzumaki, N. (2003). 
Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung 
cancer cell line, PC10. British journal of cancer 88, 606-612. 
Sahu, R., Kaushik, S., Clement, C.C., Cannizzo, E.S., Scharf, B., Follenzi, A., Potolicchio, I., 
Nieves, E., Cuervo, A.M., and Santambrogio, L. (2011). Microautophagy of cytosolic 
proteins by late endosomes. Developmental cell 20, 131-139. 
Saji, M., Narahara, K., McCarty, S.K., Vasko, V.V., La Perle, K.M., Porter, K., Jarjoura, D., 
Lu, C., Cheng, S.Y., and Ringel, M.D. (2011). Akt1 deficiency delays tumor progression, 
vascular invasion, and distant metastasis in a murine model of thyroid cancer. Oncogene 
30, 4307-4315. 
Sasaki, K., Tsuno, N.H., Sunami, E., Kawai, K., Hongo, K., Hiyoshi, M., Kaneko, M., 
Murono, K., Tada, N., Nirei, T., et al. (2012). Resistance of colon cancer to 5-fluorouracil 
may be overcome by combination with chloroquine, an in vivo study. Anti-cancer drugs 
23, 675-682. 
Sasaki, K., Tsuno, N.H., Sunami, E., Tsurita, G., Kawai, K., Okaji, Y., Nishikawa, T., Shuno, 
Y., Hongo, K., Hiyoshi, M., et al. (2010). Chloroquine potentiates the anti-cancer effect of 
5-fluorouracil on colon cancer cells. BMC cancer 10, 370. 
Sato, K., Tsuchihara, K., Fujii, S., Sugiyama, M., Goya, T., Atomi, Y., Ueno, T., Ochiai, A., 
and Esumi, H. (2007). Autophagy is activated in colorectal cancer cells and contributes 
to the tolerance to nutrient deprivation. Cancer research 67, 9677-9684. 
Scherz-Shouval, R., and Elazar, Z. (2011). Regulation of autophagy by ROS: physiology 
and pathology. Trends in biochemical sciences 36, 30-38. 
Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., and Elazar, Z. (2007). Reactive 
oxygen species are essential for autophagy and specifically regulate the activity of Atg4. 
The EMBO journal 26, 1749-1760. 
Schoenlein, P.V., Periyasamy-Thandavan, S., Samaddar, J.S., Jackson, W.H., and Barrett, 
J.T. (2009). Autophagy facilitates the progression of ERalpha-positive breast cancer cells 
to antiestrogen resistance. Autophagy 5, 400-403. 
Schonewolf, C.A., Mehta, M., Schiff, D., Wu, H., Haffty, B.G., Karantza, V., and Jabbour, 
S.K. (2014). Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells 
to concurrent chemoradiation. World journal of gastrointestinal oncology 6, 74-82. 
Scott, R.C., Schuldiner, O., and Neufeld, T.P. (2004). Role and regulation of starvation-
induced autophagy in the Drosophila fat body. Developmental cell 7, 167-178. 
Sekito, T., Kawamata, T., Ichikawa, R., Suzuki, K., and Ohsumi, Y. (2009). Atg17 recruits 
Atg9 to organize the pre-autophagosomal structure. Genes to cells : devoted to 
molecular & cellular mechanisms 14, 525-538. 
Settembre, C., De Cegli, R., Mansueto, G., Saha, P.K., Vetrini, F., Visvikis, O., Huynh, T., 
Carissimo, A., Palmer, D., Klisch, T.J., et al. (2013). TFEB controls cellular lipid 
metabolism through a starvation-induced autoregulatory loop. Nature cell biology 15, 
647-658. 
Shang, L., Chen, S., Du, F., Li, S., Zhao, L., and Wang, X. (2011). Nutrient starvation elicits 
an acute autophagic response mediated by Ulk1 dephosphorylation and its subsequent 
dissociation from AMPK. Proceedings of the National Academy of Sciences of the United 
States of America 108, 4788-4793. 
135 
 
Shaw, J., Yurkova, N., Zhang, T., Gang, H., Aguilar, F., Weidman, D., Scramstad, C., 
Weisman, H., and Kirshenbaum, L.A. (2008). Antagonism of E2F-1 regulated Bnip3 
transcription by NF-kappaB is essential for basal cell survival. Proceedings of the 
National Academy of Sciences of the United States of America 105, 20734-20739. 
Shen, H.M., and Mizushima, N. (2014). At the end of the autophagic road: an emerging 
understanding of lysosomal functions in autophagy. Trends in biochemical sciences 39, 
61-71. 
Shieh, D.B., Chen, I.W., Wei, T.Y., Shao, C.Y., Chang, H.J., Chung, C.H., Wong, T.Y., and 
Jin, Y.T. (2006). Tissue expression of gelsolin in oral carcinogenesis progression and its 
clinicopathological implications. Oral oncology 42, 599-606. 
Shieh, D.B., Godleski, J., Herndon, J.E., 2nd, Azuma, T., Mercer, H., Sugarbaker, D.J., and 
Kwiatkowski, D.J. (1999). Cell motility as a prognostic factor in Stage I nonsmall cell lung 
carcinoma: the role of gelsolin expression. Cancer 85, 47-57. 
Shintani, T., Mizushima, N., Ogawa, Y., Matsuura, A., Noda, T., and Ohsumi, Y. (1999). 
Apg10p, a novel protein-conjugating enzyme essential for autophagy in yeast. The 
EMBO journal 18, 5234-5241. 
Shpilka, T., Weidberg, H., Pietrokovski, S., and Elazar, Z. (2011). Atg8: an autophagy-
related ubiquitin-like protein family. Genome biology 12, 226. 
Silacci, P., Mazzolai, L., Gauci, C., Stergiopulos, N., Yin, H.L., and Hayoz, D. (2004). 
Gelsolin superfamily proteins: key regulators of cellular functions. Cellular and 
molecular life sciences : CMLS 61, 2614-2623. 
Simonsen, A., Birkeland, H.C., Gillooly, D.J., Mizushima, N., Kuma, A., Yoshimori, T., 
Slagsvold, T., Brech, A., and Stenmark, H. (2004). Alfy, a novel FYVE-domain-containing 
protein associated with protein granules and autophagic membranes. Journal of cell 
science 117, 4239-4251. 
Simonsen, A., and Tooze, S.A. (2009). Coordination of membrane events during 
autophagy by multiple class III PI3-kinase complexes. The Journal of cell biology 186, 
773-782. 
Solomon, V.R., and Lee, H. (2009). Chloroquine and its analogs: a new promise of an old 
drug for effective and safe cancer therapies. European journal of pharmacology 625, 
220-233. 
Stein, A., and Bokemeyer, C. (2014). How to select the optimal treatment for first line 
metastatic colorectal cancer. World journal of gastroenterology : WJG 20, 899-907. 
Strohecker, A.M., Guo, J.Y., Karsli-Uzunbas, G., Price, S.M., Chen, G.J., Mathew, R., 
McMahon, M., and White, E. (2013). Autophagy sustains mitochondrial glutamine 
metabolism and growth of BrafV600E-driven lung tumors. Cancer discovery 3, 1272-
1285. 
Sui, X., Chen, R., Wang, Z., Huang, Z., Kong, N., Zhang, M., Han, W., Lou, F., Yang, J., 
Zhang, Q., et al. (2013). Autophagy and chemotherapy resistance: a promising 
therapeutic target for cancer treatment. Cell death & disease 4, e838. 
Sun, H.Q., Yamamoto, M., Mejillano, M., and Yin, H.L. (1999). Gelsolin, a multifunctional 
actin regulatory protein. The Journal of biological chemistry 274, 33179-33182. 
Sun, Q., Fan, W., Chen, K., Ding, X., Chen, S., and Zhong, Q. (2008). Identification of 
Barkor as a mammalian autophagy-specific factor for Beclin 1 and class III 
phosphatidylinositol 3-kinase. Proceedings of the National Academy of Sciences of the 
United States of America 105, 19211-19216. 
136 
 
Sun, W.L., Chen, J., Wang, Y.P., and Zheng, H. (2011). Autophagy protects breast cancer 
cells from epirubicin-induced apoptosis and facilitates epirubicin-resistance 
development. Autophagy 7, 1035-1044. 
Takahashi, Y., Coppola, D., Matsushita, N., Cualing, H.D., Sun, M., Sato, Y., Liang, C., 
Jung, J.U., Cheng, J.Q., Mule, J.J., et al. (2007). Bif-1 interacts with Beclin 1 through 
UVRAG and regulates autophagy and tumorigenesis. Nature cell biology 9, 1142-1151. 
Takahashi, Y., Meyerkord, C.L., Hori, T., Runkle, K., Fox, T.E., Kester, M., Loughran, T.P., 
and Wang, H.G. (2011). Bif-1 regulates Atg9 trafficking by mediating the fission of Golgi 
membranes during autophagy. Autophagy 7, 61-73. 
Takamura, A., Komatsu, M., Hara, T., Sakamoto, A., Kishi, C., Waguri, S., Eishi, Y., Hino, 
O., Tanaka, K., and Mizushima, N. (2011). Autophagy-deficient mice develop multiple 
liver tumors. Genes & development 25, 795-800. 
Tanaka, H., Shirkoohi, R., Nakagawa, K., Qiao, H., Fujita, H., Okada, F., Hamada, J., 
Kuzumaki, S., Takimoto, M., and Kuzumaki, N. (2006). siRNA gelsolin knockdown induces 
epithelial-mesenchymal transition with a cadherin switch in human mammary epithelial 
cells. International journal of cancer Journal international du cancer 118, 1680-1691. 
Tanaka, M., Mullauer, L., Ogiso, Y., Fujita, H., Moriya, S., Furuuchi, K., Harabayashi, T., 
Shinohara, N., Koyanagi, T., and Kuzumaki, N. (1995). Gelsolin: a candidate for 
suppressor of human bladder cancer. Cancer research 55, 3228-3232. 
Tang, H.W., Wang, Y.B., Wang, S.L., Wu, M.H., Lin, S.Y., and Chen, G.C. (2011). Atg1-
mediated myosin II activation regulates autophagosome formation during starvation-
induced autophagy. The EMBO journal 30, 636-651. 
Tanida, I. (2011). Autophagosome formation and molecular mechanism of autophagy. 
Antioxidants & redox signaling 14, 2201-2214. 
Tatti, M., Motta, M., Di Bartolomeo, S., Cianfanelli, V., and Salvioli, R. (2013). Cathepsin-
mediated regulation of autophagy in saposin C deficiency. Autophagy 9, 241-243. 
Tellam, R., and Frieden, C. (1982). Cytochalasin D and platelet gelsolin accelerate actin 
polymer formation. A model for regulation of the extent of actin polymer formation in 
vivo. Biochemistry 21, 3207-3214. 
Thor, A.D., Edgerton, S.M., Liu, S., Moore, D.H., 2nd, and Kwiatkowski, D.J. (2001). 
Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive 
epidermal growth factor receptor-positive breast cancers. Clinical cancer research : an 
official journal of the American Association for Cancer Research 7, 2415-2424. 
Tumbarello, D.A., Waxse, B.J., Arden, S.D., Bright, N.A., Kendrick-Jones, J., and Buss, F. 
(2012). Autophagy receptors link myosin VI to autophagosomes to mediate Tom1-
dependent autophagosome maturation and fusion with the lysosome. Nature cell 
biology 14, 1024-1035. 
Urosev, D., Ma, Q., Tan, A.L., Robinson, R.C., and Burtnick, L.D. (2006). The structure of 
gelsolin bound to ATP. Journal of molecular biology 357, 765-772. 
Vander Heiden, M.G., Cantley, L.C., and Thompson, C.B. (2009). Understanding the 
Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-
1033. 
Vara, D., Salazar, M., Olea-Herrero, N., Guzman, M., Velasco, G., and Diaz-Laviada, I. 
(2011). Anti-tumoral action of cannabinoids on hepatocellular carcinoma: role of AMPK-
dependent activation of autophagy. Cell death and differentiation 18, 1099-1111. 
Velikkakath, A.K., Nishimura, T., Oita, E., Ishihara, N., and Mizushima, N. (2012). 
Mammalian Atg2 proteins are essential for autophagosome formation and important for 
137 
 
regulation of size and distribution of lipid droplets. Molecular biology of the cell 23, 896-
909. 
Vergne, I., Roberts, E., Elmaoued, R.A., Tosch, V., Delgado, M.A., Proikas-Cezanne, T., 
Laporte, J., and Deretic, V. (2009). Control of autophagy initiation by phosphoinositide 
3-phosphatase Jumpy. The EMBO journal 28, 2244-2258. 
Viry, E., Paggetti, J., Baginska, J., Mgrditchian, T., Berchem, G., Moussay, E., and Janji, B. 
(2014). Autophagy: An adaptive metabolic response to stress shaping the antitumor 
immunity. Biochemical pharmacology. 
Visapaa, H., Bui, M., Huang, Y., Seligson, D., Tsai, H., Pantuck, A., Figlin, R., Rao, J.Y., 
Belldegrun, A., Horvath, S., et al. (2003a). Correlation of Ki-67 and gelsolin expression to 
clinical outcome in renal clear cell carcinoma. Urology 61, 845-850. 
Visapaa, H., Seligson, D., Huang, Y., Rao, J.Y., Belldegrun, A., Horvath, S., and Palotie, A. 
(2003b). Ki67, gelsolin and PTEN expression in sarcomatoid renal tumors. Urological 
research 30, 387-389. 
Vouyiouklis, D.A., and Brophy, P.J. (1997). A novel gelsolin isoform expressed by 
oligodendrocytes in the central nervous system. Journal of neurochemistry 69, 995-
1005. 
Wang, C.W., Kim, J., Huang, W.P., Abeliovich, H., Stromhaug, P.E., Dunn, W.A., Jr., and 
Klionsky, D.J. (2001). Apg2 is a novel protein required for the cytoplasm to vacuole 
targeting, autophagy, and pexophagy pathways. The Journal of biological chemistry 276, 
30442-30451. 
Wang, P.W., Abedini, M.R., Yang, L.X., Ding, A.A., Figeys, D., Chang, J.Y., Tsang, B.K., and 
Shieh, D.B. (2014). Gelsolin regulates cisplatin sensitivity in human head-and-neck 
cancer. International journal of cancer Journal international du cancer. 
Wang, Y., George, S.P., Srinivasan, K., Patnaik, S., and Khurana, S. (2012). Actin 
reorganization as the molecular basis for the regulation of apoptosis in gastrointestinal 
epithelial cells. Cell death and differentiation 19, 1514-1524. 
Way, M., Gooch, J., Pope, B., and Weeds, A.G. (1989). Expression of human plasma 
gelsolin in Escherichia coli and dissection of actin binding sites by segmental deletion 
mutagenesis. The Journal of cell biology 109, 593-605. 
Way, M., Pope, B., Gooch, J., Hawkins, M., and Weeds, A.G. (1990). Identification of a 
region in segment 1 of gelsolin critical for actin binding. The EMBO journal 9, 4103-4109. 
Webber, J.L., and Tooze, S.A. (2010). Coordinated regulation of autophagy by p38alpha 
MAPK through mAtg9 and p38IP. The EMBO journal 29, 27-40. 
Weeds, A.G., Gooch, J., McLaughlin, P., Pope, B., Bengtsdotter, M., and Karlsson, R. 
(1995). Identification of the trapped calcium in the gelsolin segment 1-actin complex: 
implications for the role of calcium in the control of gelsolin activity. FEBS letters 360, 
227-230. 
Weidberg, H., Shpilka, T., Shvets, E., Abada, A., Shimron, F., and Elazar, Z. (2011). LC3 
and GATE-16 N termini mediate membrane fusion processes required for 
autophagosome biogenesis. Developmental cell 20, 444-454. 
Weidberg, H., Shvets, E., Shpilka, T., Shimron, F., Shinder, V., and Elazar, Z. (2010). LC3 
and GATE-16/GABARAP subfamilies are both essential yet act differently in 
autophagosome biogenesis. The EMBO journal 29, 1792-1802. 
Whitesell, L., and Lindquist, S.L. (2005). HSP90 and the chaperoning of cancer. Nature 
reviews Cancer 5, 761-772. 
138 
 
Winston, J.S., Asch, H.L., Zhang, P.J., Edge, S.B., Hyland, A., and Asch, B.B. (2001). 
Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast 
cancer research and treatment 65, 11-21. 
Wise, D.R., and Thompson, C.B. (2010). Glutamine addiction: a new therapeutic target in 
cancer. Trends in biochemical sciences 35, 427-433. 
Witke, W., Sharpe, A.H., Hartwig, J.H., Azuma, T., Stossel, T.P., and Kwiatkowski, D.J. 
(1995). Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking 
gelsolin. Cell 81, 41-51. 
Xiong, H.Y., Guo, X.L., Bu, X.X., Zhang, S.S., Ma, N.N., Song, J.R., Hu, F., Tao, S.F., Sun, K., 
Li, R., et al. (2010). Autophagic cell death induced by 5-FU in Bax or PUMA deficient 
human colon cancer cell. Cancer letters 288, 68-74. 
Xiong, X., Tao, R., DePinho, R.A., and Dong, X.C. (2012). The autophagy-related gene 14 
(Atg14) is regulated by forkhead box O transcription factors and circadian rhythms and 
plays a critical role in hepatic autophagy and lipid metabolism. The Journal of biological 
chemistry 287, 39107-39114. 
Xu, P., Das, M., Reilly, J., and Davis, R.J. (2011). JNK regulates FoxO-dependent 
autophagy in neurons. Genes & development 25, 310-322. 
Xu, R., Zhou, B., Fung, P.C., and Li, X. (2006). Recent advances in the treatment of colon 
cancer. Histology and histopathology 21, 867-872. 
Yamamoto, A., Tagawa, Y., Yoshimori, T., Moriyama, Y., Masaki, R., and Tashiro, Y. 
(1998). Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion 
between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell 
structure and function 23, 33-42. 
Yamamoto, H., Kakuta, S., Watanabe, T.M., Kitamura, A., Sekito, T., Kondo-Kakuta, C., 
Ichikawa, R., Kinjo, M., and Ohsumi, Y. (2012). Atg9 vesicles are an important membrane 
source during early steps of autophagosome formation. The Journal of cell biology 198, 
219-233. 
Yang, Z., and Klionsky, D.J. (2010). Mammalian autophagy: core molecular machinery 
and signaling regulation. Current opinion in cell biology 22, 124-131. 
Yao, T.P. (2010). The role of ubiquitin in autophagy-dependent protein aggregate 
processing. Genes & cancer 1, 779-786. 
Yasuda, T., Kishi, K., Yanagawa, Y., and Yoshida, A. (1995). Structure of the human 
deoxyribonuclease I (DNase I) gene: identification of the nucleotide substitution that 
generates its classical genetic polymorphism. Annals of human genetics 59, 1-15. 
Yermen, B., Tomas, A., and Halban, P.A. (2007). Pro-survival role of gelsolin in mouse 
beta-cells. Diabetes 56, 80-87. 
Yin, H.L., Albrecht, J.H., and Fattoum, A. (1981). Identification of gelsolin, a Ca2+-
dependent regulatory protein of actin gel-sol transformation, and its intracellular 
distribution in a variety of cells and tissues. The Journal of cell biology 91, 901-906. 
Yin, H.L., and Stossel, T.P. (1979). Control of cytoplasmic actin gel-sol transformation by 
gelsolin, a calcium-dependent regulatory protein. Nature 281, 583-586. 
Yin, H.L., and Stossel, T.P. (1980). Purification and structural properties of gelsolin, a 
Ca2+-activated regulatory protein of macrophages. The Journal of biological chemistry 
255, 9490-9493. 
Yin, H.L., Zaner, K.S., and Stossel, T.P. (1980). Ca2+ control of actin gelation. Interaction 
of gelsolin with actin filaments and regulation of actin gelation. The Journal of biological 
chemistry 255, 9494-9500. 
139 
 
Yoon, J., Chang, S.T., Park, J.S., Kim, Y.H., and Min, J. (2010). Functional characterization 
of starvation-induced lysosomal activity in Saccharomyces cerevisiae. Applied 
microbiology and biotechnology 88, 283-289. 
Young, A.R., Chan, E.Y., Hu, X.W., Kochl, R., Crawshaw, S.G., High, S., Hailey, D.W., 
Lippincott-Schwartz, J., and Tooze, S.A. (2006). Starvation and ULK1-dependent cycling 
of mammalian Atg9 between the TGN and endosomes. Journal of cell science 119, 3888-
3900. 
Yu, F.X., Sun, H.Q., Janmey, P.A., and Yin, H.L. (1992). Identification of a 
polyphosphoinositide-binding sequence in an actin monomer-binding domain of 
gelsolin. The Journal of biological chemistry 267, 14616-14621. 
Yuan, X., Yu, L., Li, J., Xie, G., Rong, T., Zhang, L., Chen, J., Meng, Q., Irving, A.T., Wang, 
D., et al. (2013). ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-
mediated remodeling of the actin cytoskeleton. Cancer research 73, 3625-3637. 
Yue, Z., Jin, S., Yang, C., Levine, A.J., and Heintz, N. (2003). Beclin 1, an autophagy gene 
essential for early embryonic development, is a haploinsufficient tumor suppressor. 
Proceedings of the National Academy of Sciences of the United States of America 100, 
15077-15082. 
Yun, S.M., Jung, J.H., Jeong, S.J., Sohn, E.J., Kim, B., and Kim, S.H. (2014). Tanshinone IIA 
induces autophagic cell death via activation of AMPK and ERK and inhibition of mTOR 
and p70 S6K in KBM-5 leukemia cells. Phytotherapy research : PTR 28, 458-464. 
Zhong, Y., Wang, Q.J., Li, X., Yan, Y., Backer, J.M., Chait, B.T., Heintz, N., and Yue, Z. 
(2009). Distinct regulation of autophagic activity by Atg14L and Rubicon associated with 
Beclin 1-phosphatidylinositol-3-kinase complex. Nature cell biology 11, 468-476. 
Zhou, J., Tan, S.H., Nicolas, V., Bauvy, C., Yang, N.D., Zhang, J., Xue, Y., Codogno, P., and 
Shen, H.M. (2013). Activation of lysosomal function in the course of autophagy via 
mTORC1 suppression and autophagosome-lysosome fusion. Cell research 23, 508-523. 
Zhu, W.L., Hossain, M.S., Guo, D.Y., Liu, S., Tong, H., Khakpoor, A., Casey, P.J., and Wang, 
M. (2011). A role for Rac3 GTPase in the regulation of autophagy. The Journal of 
biological chemistry 286, 35291-35298. 
Zhuo, J., Tan, E.H., Yan, B., Tochhawng, L., Jayapal, M., Koh, S., Tay, H.K., Maciver, S.K., 
Hooi, S.C., Salto-Tellez, M., et al. (2012). Gelsolin induces colorectal tumor cell invasion 












Data pre-processing of Affymetrix microarray gene expression 
Analysis of tissue microarray was performed by Dr Tan Tuan Zea. Gene 
expression microarray data of colon cancer on U133A or U133Plus2 platform 
were downloaded from Gene Omnibus (GEO), including GSE10961 (n = 18), 
GSE12945 (n = 62), GSE13067 (n = 74), GSE13294 (n = 155), GSE14333 (n = 
290), GSE15960 (n = 12), GSE17536 (n = 177), GSE17537 (n = 55), GSE18088 
(n = 53), GSE18105 (n = 77), GSE20916 (n = 101), GSE23878 (n = 35), 
GSE24514 (n = 34), GSE26682 (n = 331), GSE31595 (n = 37), GSE33113 (n = 
90), GSE4045 (n = 37), GSE5851 (n = 80), GSE8671 (n = 32), and GSE9348 (n = 
70).  For this study, we included all of publicly available dataset in U133A or 
U133Plus2 platform at the time that the analysis was initiated in May 2012.   
Robust Multichip Average (RMA) normalization was performed on each dataset.  
The normalized data was compiled and subsequently standardized using ComBat 
(Johnson, Li, and Rabinovic, 2007) to remove batch effect.  The standardized data 
yielded a dataset of 1,820 colon carcinoma.  
Statistical analysis 
Statistical significance evaluation by Spearman correlation test was computed 





Figure S1 Heatmap of Spearman’s correlation Rho between gelsolin 
expression level and autophagy-related gene expression levels.  
Gene expression microarray data of colon cancer on U133A or U133Plus2 
platform were extracted, and a final dataset of 1,820 colon carcinoma was used. 
The association of gelsolin gene expression and autophagy-related genes 
expression was analysed. Green: negative association of indicated gene 
expression with gelsolin expression. Pink: positive association of indicated gene 
















































































































LIST OF PUBLICATIONS 
Tochhawng L, Deng S, Pervaiz S, Yap CT. Redox regulation of cancer cell 
migration and invasion. Mitochondrion. 2013 May. 13(3):246-53. 
Deng S, Tochhawng L, Shen HM, Yap CT. Gelsolin promotes colon cancer cell 
survival under stress via modulating autophagy. (In preparation) 
LIST OF CONFERENCES 
Deng S, Tochhawng L, Dinh TD, Shen HM, Yap CT. Gelsolin promotes the 
survival of cancer cells under stress by modulating autophagy. 23rd Biennial 
Congress of the European Association for Cancer Research EACR-23. 2014 Jul 
Vol 50 (Suppl) S73. 
Tochhawng L, Deng S, Pervaiz S, Yap CT. The role of gelsolin in tumour cell 
survival. International Cell Death Society. Cell death: Aging, metabolism and 
ramifications for therapeutics and drug development proceedings, pg-68. 
Singapore, 10-13 Oct 2011 
Deng S, Yap CT. Gelsolin promotes colon cancer cell survival via modulating 
autophagy. Microscopy Society of Singapore Annual General Scientific Meeting. 
2012. Oral presentation. 
 
